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Viruses are obligate intracellular parasites that are highly dependent on many cellular 
components and processes. Using genome type and replication strategy, the Baltimore 
classification system distinguishes double-stranded (ds)DNA, single-stranded (ss)DNA, 
dsRNA, positive (+)ssRNA, and negative (-)ssRNA genomes. Additionally, there are 
+ssRNA viruses that replicate via a DNA intermediate and dsDNA viruses that replicate 
through a ssRNA intermediate [1]. The +RNA viruses are the largest virus group, which 
contains many important human and animal pathogens, such as SARS coronavirus 
[2-4], poliovirus [5], hepatitis C virus [6], dengue virus [7], chikungunya virus [8], foot 
and mouth disease virus [9] and porcine reproductive and respiratory syndrome virus 
[10, 11].
All +RNA viruses encode an RNA-dependent RNA polymerase (RdRp) to replicate their 
genomes and several virus groups transcribe subgenomic RNAs to express the genes 
encoding their structural and accessory proteins [12]. +RNA viral genome replication is 
associated with modified cellular membranes to which components of the viral replica-
tion complex are anchored. The origin of these membranes differs between virus groups, 
but membrane-associated replication might serve the same fundamental purpose(s), as 
it is a general feature of all eukaryotic +RNA viruses [13].
Chikungunya virus
The work described in this first part of my thesis focuses on chikungunya virus (CHIKV). 
CHIKV is a reemerging arthropod-borne human pathogen that was first discovered in 
Tanzania in 1952, during an outbreak on the Makonde Plateau in the Southern region 
of Tanganyika [8]. Before 2005 only occasional small-scale outbreaks were reported. 
CHIKV reemerged around 2005 on the east coast of Africa and several Indian Ocean 
islands, and subsequently spread across the Asian continent while infecting millions of 
people [14, 15]. This outbreak was closely associated with the occurrence of a single 
point mutation in the viral genome, resulting in an A226V substitution in the CHIKV 
envelope protein E1. This mutation increased the epidemic potential of CHIKV, as it al-
lowed the virus to be more efficiently spread by a new vector, Aedes albopictus (Asian 
tiger mosquito). The global distribution of Ae. albopictus, which includes urban areas in 
southern Europe and the USA, is wider than for Ae. aegypti, which was the main vector 
before 2005 [16]. CHIKV spread to the Americas around the end of 2013 and has since 
caused an explosive outbreak in the Caribbean and South/Central America [17]. Infected 
travelers have returned to Europe, Australia, the USA and Canada [18-25]. In countries 
with Ae. aegypti or Ae. albopictus populations this poses the risk of establishing new 
CHIKV reservoirs [26, 27], and locally-transmitted infections have already occurred in e.g. 
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Italy, France and the USA in 2007, 2010 and 2014 [28-30]. During the outbreak in Italy 
over 200 confirmed cases were reported [28]. 
In the Makonde language Chikungunya means “that which bends up”, which refers to 
the posture of people suffering from the disease due to the severe and persisting poly-
arthralgia that characterizes the disease [8]. Other symptoms include a short episode of 
high fever, myalgia, headache and rash. Asymptomatic infections range from 3-25% [31-
34]. Therapy is limited to supportive care as antiviral treatments and vaccines for CHIKV 
are still being developed [35, 36]. The development of antiviral therapies and vaccines 
is hampered by the rapidly occurring resistance, caused by the generally high mutation 
rate in RNA viruses [37-40]. 
Alphavirus genome organization and expression
CHIKV has a single stranded +RNA genome of 12kb and belongs to the alphavirus genus 
of the Togavirus family [41]. The alphavirus genome contains two large open reading 
frames (ORFs) that are translated into polyproteins. The genome also serves as the 
mRNA template for translation of the nonstructural proteins nsP1-4 that are encoded by 
the first ORF. Translation of nsP4 is dependent on read-through of an opal stop codon 
at the end of the nsP3-coding region [42]. The polyprotein is proteolytically processed 
by a protease domain residing in nsP2 [43, 44]. The structural polyprotein is encoded by 
the second ORF and is expressed from a subgenomic mRNA. The structural polyprotein 
is processed into the capsid (C) protein, the envelope proteins E1, E2 and E3, and the 
6k ion channel protein by a protease domain in C and host proteases in the exocytic 
pathway [45, 46]. A third small ORF is embedded within the sequence encoding 6k and 
is translated after a –1 ribosomal frameshift resulting in the synthesis of a transframe 
(TF) protein that shares the N-terminal sequence with 6k and with the C-terminal amino 
acids encoded by the -1 ORF [47]. 
Alphavirus replicative cycle in mammalian cells
The alphavirus nucleocapsid contains a single copy of genomic RNA and is enveloped in 
a lipid bilayer derived from the host plasma membrane. This bilayer contains glycosyl-
ated E1 and E2 heterodimers that are assembled into 80 trimeric spikes [48]. It is still 
unknown which cellular receptor(s) is required for CHIKV attachment to the host cell. 
Alphavirus cell entry is initiated by interaction of E2 with cellular proteins. Generally, 
alphavirus entry is dependent on clathrin-mediated endocytosis and E1-mediated fu-
sion with endosomal membranes [49]. After fusion, the nucleocapsid is released into the 
cytoplasm and is almost immediately uncoated to release the viral RNA for translation of 
the nonstructural polyprotein [50]. 
The nonstructural polyprotein is processed by nsP2 in a sequential manner. The nsP3/
nsP4 junction is cleaved first, followed by the nsP1/nsP2 junction and finally the nsP2/
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nsP3 junction. This sequential processing regulates the activity of RNA synthesis by the 
replication and transcription complex (RTC) consisting of the nonstructural proteins 
[51, 52]. The precursor P123 and nsP4 form a complex that synthesizes -strands exclu-
sively, while the nsP1/nsP2 cleavage converts the complex into one that also synthesizes 
+strands. After the nsP2/nsP3 junction has been cleaved, the complex can only synthe-
size +strand genomes and the 26S subgenomic mRNA [53]. Viral replication takes place 
in spherules at the plasma membrane and in cytoplasmic vacuoles that are derived from 
modified lysosomal and endosomal membranes [54, 55].
nsP1 has guanyl transferase and guanine-7-methyltransferase enzymatic activities 
required for capping of viral genomes and subgenomic mRNAs [56-58]. This protein 
is membrane-associated and is thought to anchor the RTC to the modified membrane 
structures [59]. Besides the protease activity that resides in a C-terminal domain, nsP2 
also has RNA helicase [60] and RNA triphosphatase/nucleoside triphosphatase activities 
[61, 62] residing in the N-terminal part of the protein. nsP2 is also responsible for the 
transcriptional and translational shut-off of the host cell during alphavirus infection [63]. 
nsP2 localizes to cytoplasmic foci and the nucleus [64, 65]. The exact functions of nsP3 
still remain unclear but the protein is required for RNA synthesis [43, 66] and the macro 
domain of CHIKV nsP3 has ADP-ribose 1”-phosphate phosphatase and RNA binding 
activity [67]. During infection nsP3 localizes to cytoplasmic foci where it might inhibit 
stress granule formation [65, 68, 69]. nsP4 is the RNA dependent RNA polymerase (RdRp) 
that synthesizes both + and –stranded RNA [43, 70]. This protein might also have terminal 
adenylyltransferase (TATase) activity which could be involved in the maintenance of the 
poly(A)tail [71]. Compared to the other nsPs, nsP4 is very short lived due to ubiquitin-
mediated degradation, which is one of the ways by which the nsP4 concentration is 
regulated during infection [72].
Processing of the alphavirus structural polyprotein C-E3-E2-6k-E1 starts by release of C 
through autoproteolysis [45, 73]. Subsequently, a signal sequence in the new N-terminus 
of the polyprotein initiates translocation of pE2 (the E3-E2 precursor [74]) across the en-
doplasmatic reticulum (ER) membrane [75]. A hydrophobic stretch near the C-terminus 
of E2 anchors the protein in the ER membrane [76]. The insertion signals for 6k and E1 are 
located after the E2 anchor sequence and in the C-terminal domain of 6k, respectively. 
The E2-6k and 6k-E1 junctions are cleaved by signalases in the ER lumen after insertion 
[46]. In the ER lumen and during transport through the Golgi apparatus pE2 and E1 
become glycosylated and palmitoylated [77-79]. pE2 and E1 form a heterodimer in the 
ER and during transport of the pE2-E1 complex through the trans Golgi complex to the 
plasma membrane pE2 is cleaved into E3 and E2 by furin, a host protease [80, 81]. CHIKV 
E3 is not incorporated into virions [82]. The alphavirus genomic RNA contains a packag-
ing signal that is recognized by C, which results in the subsequent oligomerization of 
capsid proteins to generate the nucleocapsid [83, 84]. Budding occurs at the plasma 
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figure 1: Alphavirus replicative cycle. 1. Alphavirus particles consist of a nucleocapsid that is enveloped 
in a host plasma membrane-derived lipid bilayer. Alphavirus entry is initiated by binding of the E2 glyco-
protein to cellular membrane proteins. 2. Alphavirus particles generally enter the cell through clathrin-me-
diated endocytosis. 3. The E1 glycoprotein mediates fusion with endosomal membranes. The nucleocapsid 
is released into the cytosol and uncoated to release the +RNA genome. 4. The nonstructural ORF of the ge-
nome is translated by cellular ribosomes into two polyproteins. Translation of nsP4 depends on stop codon 
readthrough. 5. nsP2 proteolytically processes the nonstructural polyproteins into the individual subunits. 
The nsPs assemble into replication and transcription complexes (RTCs) at the plasma membrane and on 
cytoplasmic vacuoles that are derived from modified lysosomal and endosomal membranes. 6. During ge-
nome replication, nsP4, the RNA-dependent RNA polymerase (RdRp) first synthesizes minus strands which 
are later used as templates to synthesize new + strand genomes. 7. – strands are used to transcribe + strand 
subgenomic mRNAs. 8. The structural ORF is translated from the +strand subgenomic mRNA to produce 
the structural polyprotein. 9. Processing of the structural polyprotein starts by release of C through auto-
proteolysis. The remaining polyprotein is translocated across the endoplasmatic reticulum (ER) membrane. 
The E2-6k and 6k-E1 junctions are cleaved by signalases in the ER lumen. 10. pE2 and E1 form a heterodimer 
and are glycosylated and palmitoylated in the ER lumen and during transport through the Golgi apparatus. 
11. During transport through the trans Golgi complex to the plasma membrane pE2 is cleaved into E3 and 
E2 by furin. At the plasma membrane E2 and E1 are incorporated into new virions. 12. The alphavirus ge-
nomic RNA contains a packaging signal that is recognized by C, which results in oligomerization of capsid 
proteins to generate the nucleocapsid. 13. Budding occurs at the plasma membrane through interaction 
of the nucleocapsid with the cytoplasmic domain of E2. 
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membrane through interaction of the nucleocapsid with the cytoplasmic domain of E2 
[85]. A schematic representation of the alphavirus replicative cycle in mammalian cells 
is depicted in Figure 1. 
Chikungunya virus-host interactions
CHIKV is, like all viruses, very dependent on host factors during its replicative cycle. As-
suming cell entry of CHIKV occurs in a similar fashion as for other alphaviruses, it requires 
binding of virus particles to host receptors [86, 87]. An active endocytic pathway, includ-
ing endosomal acidification, is required for fusion of the viral and host membranes and 
release of the nucleocapsid into the cytosol [88]. Uncoating of the nucleocapsid requires 
interaction with the large ribosomal subunit [89]. Translation of viral mRNA requires the 
cellular translational machinery since viruses do not encode their own ribosomes [90]. 
RTCs are associated with modified membrane structures [54] and several host factors 
have been reported to be recruited to these nsP-containing complexes [65, 91-94]. Viral 
proteins can be phosphorylated and glycosylated by cellular enzymes [77-79, 95, 96]. 
During budding the nucleocapsid becomes enwrapped in a host-derived membrane 
envelope [97]. Several steps in the replication cycle require the presence of host mem-
brane lipids [98]. Alphaviruses inhibit host transcription and translation and suppress 
(innate) immune responses to promote efficient replication and translation of viral 
genomes [99, 100]. 
A better understanding of these complex interactions between a virus and its host 
can facilitate the development of antiviral therapies. Instead of targeting viral enzymes, 
host factors may also be targeted to inhibit viral replication. With this strategy resistance 
is expected to occur less frequently, since cellular antiviral drug targets are unlikely to 
mutate during infection [101, 102]. 
Several different methods have been used to study CHIKV-host interactions in both 
mammalian and insect hosts. RNA interference (RNAi) screens [103], transcriptomics 
[104-106], yeast two-hybrid assays [91, 107], co-immunoprecipitation with viral proteins 
[108], computational methods [109, 110] and proteomics [111-120]. In these studies a 
great number of (potential) interaction partners of viral proteins and cellular processes 
that are affected by CHIKV infections have been identified. Several CHIKV proteomics 
studies have been performed so far, in which infected cells, infected mice and patient 
sera were analyzed. However, a large-scale quantitative proteomics study in which 
several time points post infection during the first round of replication on synchronously 
infected cells was still missing. Additionally, a systematic analysis of the posttransla-
tional modifications on host proteins during CHIKV infection has never been performed. 
The aim of the research in this thesis was to track changes in host protein abundance 
and phosphorylation status during CHIKV infection in well-characterized cells during a 
single round of replication before cytopathic effects become apparent. 
16 A + RNA virus diptych
QuANTiTATivE PRoTEomiCs 
In this first part of my thesis mass spectrometry-based quantitative proteomics was used 
to study the consequences of CHIKV infection in mammalian cells. Proteomics is the 
systematic study of the total set of proteins produced from the genome present in the 
cell at a given time point [121]. Proteomics is a hypothesis-generating approach and is 
often used as a starting point to identify proteins and pathways that might be involved 
in a certain process (such as viral infection). To determine the exact role of identified 
host factors it is usually necessary to do follow-up experiments. With quantitative 
proteomics the changes in protein abundance in the cell during viral infection can be 
studied. Relative changes in host protein abundance can provide novel insights into 
which host proteins and pathways are important during viral infection. An increase in 
the abundance of certain proteins can, for example, indicate activation of an innate 
immune pathway, while a decrease could indicate that the virus targets this protein for 
degradation [122-125]. 
In this thesis, the stable isotope labeling by amino acids in cell culture (SILAC) method 
(Figure 2) was used to study the full spectrum of host proteins during CHIKV infection. 
Cells are grown in media lacking certain essential amino acids, which are supplemented 
with non-radioactive, isotopically labeled forms of these amino acids [126]. In the heavy 
state, several 12C and/or 14N atoms are replaced with 13C and 15N isotopes to increase the 
mass of the amino acid. Cells are grown in SILAC media for at least five cell-doublings to 
allow >96% incorporation of the heavy amino acids. When labeled arginine and lysine 
are used in combination with trypsin digestion, all peptides, except for the C-terminal 
one, will contain at least one labeled amino acid [127]. There is no chemical difference 
between the heavy isotope-labeled amino acids and their natural counterparts and as 
a result cell growth and behavior in the light and heavy isotope-labeled conditions is 
the same. Light- and heavy-labeled peptides co-elute from the high performance liquid 
chromatography (HPLC) column and are analyzed together in the mass spectrometer 
[126]. Consequently, the relative quantification of peptide and protein ratios with SILAC 
is very accurate [128]. 
An advantage of SILAC over other quantitative proteomics methods such as iTRAQ 
[129], ICAT [130], dimethyl labeling [131] or label-free approaches [132-139] is that ex-
perimental and control samples can be mixed directly after harvesting, so before further 
sample processing, because every protein in the sample has already been labeled. This 
reduces the amount of variability between experimental and control conditions caused 
by sample handling [126] and increases reproducibility [140]. 
SILAC is most often applied in cell culture but has also been used successfully to label 
complete animals such as mouse [141], fly [142] and zebrafish [143]. 
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Quantification of post translational modifications
Most proteins undergo post-translational modifications (PTMs). These modifications 
play an important role in regulating biological processes and add another layer of com-
plexity to the proteome. PTMs allow the cell to respond rapidly to extra- and intracel-
lular stimuli by changing protein activity, subcellular localization, binding partners and 
stability [144-146]. Notably, the function of a certain protein can change significantly 
due to the addition of a specific PTM, while the abundance of that protein does not 
change at all. Over 400 different PTMs have been described, the most common being 
phosphorylation, acetylation, N-linked glycosylation and amidation [147]. A single 
protein can often be modified by distinct PTMs at the same or multiple residues and 
crosstalk between different PTMs generates an even more complex proteome [146, 148]. 
The analysis of PTMs poses several technical challenges. Modifications are frequently 
transient, which makes the timing of sampling during an experiment crucial. The abun-
Light state Heavy state
Arg0, Lys0 Arg10, Lys8
Combine
Trypsin digestion
Quantification by Mass Spectrometry














+ 8 or 10 Da
figure 2: siLAC labeling strategy. Cells are grown in media containing stable isotope-encoded amino 
acids until the amino acids have been fully incorporated into the cells. After the experiment (e.g. a viral in-
fection) has been performed, the light and heavy samples are mixed and further processed as a single sam-
ple. Peptides originating from the light and heavy experimental conditions can be distinguished through 
their mass difference by mass spectrometry and the relative intensities are used to determine whether the 
abundance of a protein did not change, was downregulated or upregulated as a result of the experimental 
treatment. 
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dance of modified proteins is often very low compared to their unmodified counterparts, 
which makes it essential to enrich for modified proteins or peptides prior to analysis 
[149]. Modified peptides can be lost during sample preparation, either due to instability 
of the modification or because modified peptides preferentially adsorb to metal or plas-
tics [150, 151]. The identification and quantification of a modified site is often based on a 
single peptide, while multiple peptide identifications are used when protein abundance 
is quantified. This makes PTM quantification less accurate than the quantification of 
relative protein abundance. The software search engine that is used to identify peptides 
and proteins from mass spectrometry data, tests each possible arrangement of amino 
acids with and without the variable modifications of interest (such as phosphorylation) 
to find the best peptide match in the database that is used for the search. The addition of 
each extra variable modification during the search greatly increases search complexity 
and generates more false assignments [151, 152]. For peptides that contain multiple 
residues that could contain the modification it is not always possible to identify the 
exact modified site [152]. When a change in modified peptide abundance is observed, 
it is important to verify that the total protein abundance did not change as well [151].
In this thesis, SILAC was used to study changes in host protein phosphorylation during 
CHIKV infection. One third of eukaryotic proteins is estimated to become phosphory-
lated [153]. Proteins are phosphorylated by the transfer of a phosphoryl group from ATP 
or GTP to either a side chain of a serine or threonine residue by protein serine/threonine 
kinases or to a tyrosine residue by protein tyrosine kinases [153]. Humans express ±520 
kinases of which around 90 are tyrosine kinases [154, 155]. Protein phosphorylation is 
a reversible modification and can be removed by protein phosphatases. The human 
genome contains genes for 107 protein tyrosine phosphatases [156] and around 30 
protein serine/threonine phosphatases [157]. The distribution of phosphotyrosine, 
phosphothreonine and phosphoserine sites in the cell is ± 2%, 12%, and 86% [158]. 
Several features of phosphorylated peptides aid their identification by mass spec-
trometry. The addition of HPO3 results in an increase in amino acid residue mass of 80 
Da. Sites on phosphopeptides can be identified from mass shifts in fragment ions gener-
ated by MS/MS [151]. Peptides containing phosphotyrosine can often be identified by a 
fragment ion of 216 Da which derives from peptide bond cleavage on either side of the 
phosphotyrosine residue [151, 159]. Additionally, peptides containing phosphoserine 





In this first part of my thesis, changes in the host cellular proteome following CHIKV 
infection were studied to better understand the interplay between viral replication and 
host cell infrastructure and metabolism. Chapter 2 describes a SILAC-based quantita-
tive proteomics study to analyze temporal changes in the proteome of CHIKV-infected 
cells. This study revealed that changes in protein abundance during CHIKV infection 
are relatively small and that most of the proteins that showed significantly changed 
abundance were downregulated. Four proteins that were significantly downregulated 
during CHIKV infection, Rnd3, DDX56, UbcH10 and Plk1, were overexpressed from plas-
mids in host cells and this inhibited CHIKV infection. Chapter 3 describes a SILAC-based 
quantitative phosphoproteomics study of CHIKV-infected cells. Eukaryotic elongation 
factor 2 (eEF2) was identified as a factor that becomes phosphorylated in various cell 
lines early during infection with CHIKV, Semliki forest virus (SFV) or Sindbis virus (SINV). 
Infection with coxsackie virus B3, a picornavirus, also triggered eEF2 phosphorylation. 
eEF2 phosphorylation might reflect part of the antiviral response of the cell, but it is 
not activated via one of the ‘classical’ pathways that are generally involved in the innate 
immune response to virus infections. In chapter 4 the findings of part 1 are summarized. 

Chapter 2
Temporal SILAC-based quantitative 
proteomics identifies host factors 
involved in chikungunya virus 
replication
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AbsTRACT
Chikungunya virus (CHIKV) is an arthropod-borne reemerging human pathogen that 
generally causes a severe persisting arthritis. Since 2005, the virus has infected millions 
of people during outbreaks in Africa, Indian Ocean Islands, Asia, and South/Central 
America. Many steps of the replication and expression of CHIKV’s 12-kb RNA genome 
are highly dependent on cellular factors, which thus constitute potential therapeutic 
targets. SILAC and LC-MS/MS were used to define the temporal dynamics of the cel-
lular response to infection. Using samples harvested at 8, 10, and 12 h post infection, 
over 4700 proteins were identified and per time point 2800-3500 proteins could be 
quantified in both biological replicates. At 8, 10, and 12 h post infection, 13, 38, and 
106 proteins, respectively, were differentially expressed. The majority of these proteins 
showed decreased abundance. Most subunits of the RNA polymerase II complex were 
progressively degraded, which likely contributes to the transcriptional host shut-off 
observed during CHIKV infection. Overexpression of four proteins that were significantly 
downregulated (Rho family GTPase 3 (Rnd3), DEAD box helicase 56 (DDX56), polo-like 
kinase 1 (Plk1), and ubiquitin-conjugating enzyme E2C (UbcH10) reduced susceptibility 
of cells to CHIKV infection, suggesting that infection-induced downregulation of these 
proteins is beneficial for CHIKV replication. All MS data have been deposited in the Pro-





Chikungunya virus (CHIKV) is an arthropod-borne RNA virus and its transmission to 
humans by mosquitoes generally leads to a short episode of high fever, rash and joint 
pains. The arthritis can be debilitating and may last for many months [14]. The virus 
was first isolated during an outbreak in Tanzania in 1952/1953 and large outbreaks 
used to be rare until the virus reemerged in 2005-2006 on the east coast of Africa and 
several Indian Ocean islands. Since then it has spread across the Asian continent, caus-
ing several large outbreaks that affected millions of people [14]. Hundreds of infected 
travelers have returned to Europe and locally transmitted infections have occurred in 
Italy and France in 2007, 2010, and 2014 [28, 29]. In the autumn of 2013, the virus was 
introduced to the Caribbean island of Saint Martin, which – for the first time – led to a 
massive outbreak in the Caribbean and South/Central America [17]. By November 2014, 
the number of estimated cases in the Americas already exceeded 900,000. and in July 
2014 the first locally transmitted infections in the USA were reported [30]. 
CHIKV belongs to the alphavirus genus of the togavirus family and has a 12 kb single-
stranded positive polarity (+) RNA genome that contains two open reading frames 
(ORFs). The first ORF of the genome is directly translated into a large polyprotein that 
is proteolytically processed into the nonstructural proteins (nsP) 1 to 4 by a protease 
residing in nsP2 [41, 76]. The four nsPs, probably together with host proteins, form a 
replication complex that first synthesizes a negative-stranded (-) RNA. Next, this –RNA 
serves as the template for the synthesis of genomic RNA and a subgenomic RNA. The 
latter is translated into a polyprotein that is proteolytically processed into the structural 
proteins C (capsid), envelope glycoproteins E1, E2 and E3 and the 6K ion channel protein 
by the joint action of a protease domain in C and host proteases in the exocytic pathway 
[41, 76]. For a schematic overview of CHIKV genome organization and expression, see 
Figure S1. Due to its small genome size, CHIKV is dependent on host factors during many 
steps of its replication cycle. For example, cellular receptors are required for CHIKV entry, 
ribosomes are required for translation of the viral mRNA, cellular membrane-derived 
spherules form a platform for viral RNA synthesis, and the secretory pathway is required 
for the maturation of the viral glycoproteins and virion biogenesis [76]. In addition to 
exploiting cellular resources, CHIKV suppresses cellular transcription, translation and 
(innate) immune responses to facilitate efficient virus replication [99, 100].
Currently, there is no licensed vaccine or antiviral treatment on the market to prevent 
or treat CHIKV infection [35]. Efforts to develop antiviral drugs have traditionally focused 
on viral targets (e.g. replicative enzymes), but drug resistance often emerges due to the 
high mutation rate of RNA viruses. Consequently, there is a growing interest in targeting 
host factors involved in viral replication as an alternative strategy, since host genes are 
unlikely to mutate during antiviral therapy [101, 102]. 
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To gain more insight into the complex interaction between CHIKV and its host we set 
out to study temporal changes in the cellular proteome during CHIKV infection through 
stable isotope labeling by amino acids in cell culture (SILAC) and subsequent LC-MS/MS 
analysis [126]. This was done from the moment that CHIKV +RNA became clearly detect-
able (8 h p.i.) until the moment that viral RNA and protein levels reached their maximum 
(10-12 h p.i.), but before serious cytopathic effects were observed.
Quantitative proteomics strategies have been used previously to study the effects of 
CHIKV infection in cell culture, mice and patient serum (for a recent review see [160]). 
2D-DGE and 2D-DIGE approaches [112, 113, 115, 119] identified between 15 and 51 
differentially-expressed proteins. A GeLC-MS/MS approach identified 1455 proteins, of 
which 90 were significantly downregulated [111]. Another study identified 3505 proteins 
of which only 514 were present in all samples and none of these were differentially ex-
pressed [120]. An iTRAQ approach resulted in the identification of 569 proteins of which 
63 were differentially expressed [116]. A combination of 2D-DIGE and iTRAQ resulted in 
the identification of 177 differentially-expressed proteins out of a total of 2686 identified 
proteins [114]. Advantages of our approach over these previously published studies are 
that we analyzed synchronously infected cells during the first round of replication in a 
well-characterized system and tracked changes in abundance over time. This approach 
resulted in the identification of over 4700 cellular proteins, of which 13, 38 and 106 
were differentially expressed at 8, 10 and 12 hours post infection (h p.i.), respectively. 
The majority of these proteins were downregulated. Peptides derived from ten of the 
twelve subunits of the RNA polymerase II complex were identified and 7 of these were 
significantly degraded by 12 h p.i., likely contributing to the well-known CHIKV-induced 
shut-off of cellular transcription [99, 161]. Overexpression (prior to infection) of four 
host factors found to be significantly downregulated during CHIKV-infection (Rho fam-
ily GTPase 3 (Rnd3), DEAD (Asp-Glu-Ala-Asp) box helicase 56 (DDX56), polo-like kinase 
1 (Plk1), and ubiquitin-conjugation enzyme E2C (UbcH10)) reduced the percentage of 
cells that could be productively infected with the virus. This suggests that the infection-
induced downregulation of these and presumably also other host proteins is not merely 
“collateral damage”, but is beneficial for CHIKV replication.
mATERiALs ANd mEThods
Cells
The previously described 293/ACE2 cell line [162] was obtained from dr. Shinji Makino 
(UTMB, Texas). These cells were chosen as they could be efficiently transfected with 
plasmids and infected with CHIKV (and other viruses), while adhering better to tissue 
culture plastics than standard HEK293 cells. This cell line was originally described to be 
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derived from human HEK293 cells, but cloning and sequencing of genes from 293/ACE2 
cells for overexpression studies that were done after we had completed our proteomics 
studies, suggested this was not the case. BLAST analysis [163] of the sequences of 
cDNAs of a variety of host factors obtained from 293/ACE2 cells revealed that these 
had greater similarity to sequences from several non-human primates, like Papio anubis 
(olive baboon) and Macaca mulatta (rhesus macaque), than to those of Homo sapiens. 
Subsequent analysis of the cytidine monophospho-N-acetylneuraminic acid hydroxy-
lase gene also revealed the absence of a Homo sapiens-specific 92-bp deletion [164]. 
Therefore, we now assume that the parental cells used to produce the 293/ACE2 cell 
line were actually of nonhuman primate origin. Cells were cultured in DMEM (Lonza, 
Switzerland), 10% FCS (PAA, Austria), 2 mM L-glutamine, 100 IU/ml penicillin and 100 μg/
ml streptomycin at 37 °C and 5% CO2. 
Plasmids and oligonucleotides
cDNA was made from total cellular RNA using random hexamers (Promega, Madison, WI, 
USA, C118A) and RevertAid H Minus M-MuLV RT (Fermentas, Lithuania).
pCMV-FLAG-Rnd3 was constructed by amplifying the human Rnd3 gene from MRC-5 
cell cDNA (all oligonucleotide sequences are listed in Table S1) using oligonucleotides 
RND3-fw and RND3-rev and cloning it into pCMV-Tag2 (Stratagene, United States). 
pCDNA3-DDX56-FLAG was constructed by amplifying the DDX56 gene from 293/ACE2 
cDNA using oligonucleotides DDX56-fw1 and DDX56-rev1 and cloning it into pCDNA3.0 
(Life Technologies Europe, The Netherlands) after a second PCR with oligonucleotides 
DDX56-fw2 and DDX56–rev2 . 
pCMV-FLAG-Plk1-WT and pCMV-FLAG-Plk1-KM (kinase domain mutant) [165] were 
a kind gift from dr. Hyungshin Yim (Hanyang University, Korea). pCMV-FLAG-Plk1-FAA 
(polo-box domain mutant) was constructed by site-directed mutagenesis of pCMV-
FLAG-plk1-WT using oligonucleotides FAA-QC1 and FAA-QC2 to introduce W414F and 
V415A, followed by the introduction of the L427A mutation using oligonucleotides FAA-
QC3 and FAA-QC4. These Polo-box domain mutations were previously described [165]. 
pCDNA3-FLAG-UbcH10 [166] was a kind gift from prof. Akira Nakagawara (Chiba 
Cancer Centre, Japan). All constructs were verified by sequencing. 
pCMV-FLAG-Ub [167] expresses FLAG-tagged ubiquitin. 
siLAC labeling & ChiKv infection
293/ACE2 cells were cultured in SILAC DMEM (PAA, Austria), 10% dialyzed FBS (Gibco, UK), 
0.280 mM arginine, 0.398 mM lysine, 0.5 mM proline, 10 mM HEPES, 2 mM L-glutamine 
and 100 IU penicillin and 100 μg/ml streptomycin for > 5 cell doublings to ensure com-
plete incorporation of the labeled amino acids. Arginine to proline conversion was not 
observed under these labeling conditions. The SILAC light medium was supplemented 
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with Arg 12C6 14N4 and Lys 12C6 14N2 (Sigma, The Netherlands), the SILAC heavy medium 
was supplemented with Arg 13C6 15N4 and Lys 13C6 15N2 (Cambridge Isotope Laboratories, 
Massachusetts, USA). 
SILAC-labeled cells were seeded in 10 cm2 dishes 1 day before infection with CHIKV 
strain LS3 at a multiplicity of infection (MOI) of 5, as previously described [168]. At 1 h p.i. 
the inoculum was removed and replaced with SILAC DMEM, 2% FBS, 0.280 mM arginine, 
0.398 mM lysine, 0.5 mM proline, 25 mM HEPES, 2 mM L-glutamine, 100 IU/ml penicillin 
and 100 μg/ml streptomycin. Infected and mock-infected cells were lysed at 8, 10 and 12 
h p.i. in 4% SDS, 0.1 M Tris pH 7.6, followed by incubation at 96 °C for 10 min to ensure 
complete inactivation of the virus. The experiment was performed in duplicate with a 
label swap (Figure 1A). 
A B
C
figure 1: siLAC experiment (A) Experimental set-up of the SILAC-based proteomics analysis of virus-
induced changes in the cellular proteome during the course of CHIKV infection. At each time point post 
infection 2 biological replicates were used, in which the SILAC label was swapped between mock-infected 
and infected samples. Infected and mock-infected cells were lysed and equal amounts of protein were 
mixed and subsequently digested into peptides using the FASP procedure. Peptides were separated into 12 
fractions using IEF and analyzed using LC-MS/MS. (B) Number of identified proteins at each time point post 
infection. The total number of identified proteins with ≥2 razor peptides of which ≥1 unique was 4763. The 
number of identified proteins with ≥ 2 evidence counts for each biological replicate and the total number 
of proteins that were identified in both replicates with ≥ 2 evidence counts at each time point post infection 
are shown. For follow-up analysis only protein groups with a variance <0.25 were selected. (C) Proteome-
wide quantification at 8, 10 and 12 hours post CHIKV infection. Average normalized log2 protein ratios are 
plotted against the log10 of summed peptide intensities. Each dot represents a protein group. Red dots 
indicate protein groups of which the abundance differed significantly between infected and mock-infected 
control cells (Benjamini-Hochberg FDR of 0.05). 
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Protein digestion and iEf
Equal amounts (200 μg) of mock- and CHIKV-infected lysates were mixed, followed 
by the addition of DTT to a final concentration of 0.1 M and 5 min incubation at 70 
ºC. Protein digestion was performed using the Filter Aided Sample Preparation (FASP) 
method [169] and 100 μg protein was loaded per 0.5-ml 30 kDa Microcon filter devices 
(Millipore, Massachusetts, USA). Filter devices were washed twice with 8 M urea, 0.1 M 
Tris pH 8.5 and cysteines were alkylated with 50 mM iodoacetamide in the same buffer. 
Samples were washed 3 times with 8 M urea, 0.1 M Tris pH 8 and proteins were digested 
by overnight incubation at room temperature (RT) in the same buffer with 1 μg endo 
Lys-C (Wako Pure Chemical Industries, Japan). The sample was diluted fourfold with 50 
mM ammonium bicarbonate pH 8.4 containing 1 μg trypsin (Worthington Chemical 
Corporation, New Jersey, USA) and digested for 4 h at RT. Peptides were collected by 
centrifugation, acidified by addition of TFA to 1% and desalted using SPE. Peptides were 
separated into 12 fractions on 13-cm Immobiline DryStrips pH 3-10 (GE Healthcare, UK) 
in a 3100 Offgel Fractionator (Agilent Technologies, California, USA) that was run up to 
20 kVh [170, 171]. Peptide fractions were desalted using SPE, frozen in liquid nitrogen 
and lyophilized in a CHRIST RVC 2-18. 
mass spectrometry 
Lyophilized peptide fractions were dissolved in 95/3/0.1 (v/v/v) water/ACN/formic acid. 
The samples were analyzed by nanoflow LC-MS. The 1100 HPLC system (Agilent Technol-
ogies, California, USA) operating in split-flow configuration as described by Meiring et 
al [172] was coupled on line to a 7-tesla LTQ-FT Ultra MS (Thermo, Massachusetts, USA). 
HPLC columns were made in house. The samples were trapped on a 15-mm ReproSil-Pur 
C18, 3-µm pre-column (inner diameter 100-µm) and eluted to a 20-cm ReproSil-Pur C18, 
3-µm analytical column (inner diameter 50-µm) by a 2.5 h 0-50% solvent B (10/90/0.1 
v/v/v water/ACN/formic acid) gradient. The eluent was emitted via a customized nano-
electrospray probe into the mass spectrometer performing in data-dependent mode, 
automatically switching between MS and MS/MS mode. Full scan MS spectra were 
acquired in the FT-ICR. The top 5 most intense ions were fragmented with collision-
induced dissociation in the linear ion trap. The data were acquired with Xcalibur, version 
2.0 SR2 (Thermo, Massachusetts, USA). Each fraction was measured twice. 
data analysis
Raw data files were analyzed with MaxQuant 1.2.2.5 [173] using the Andromeda search 
engine [174], databases used for the main search were ipi.HUMAN.v3.72 (86,392 entries) 
and a custom-made database containing the protein sequences of CHIKV-LS3 (11 
entries) using the GenBank sequence (accession KC149888) [168]. A smaller database, 
human.first.search (15,612 entries) containing a subset of human protein sequences was 
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used for the first search. A concatenated reversed database (KR special amino acids) 
was used to reach a FDR of 0.01 and a list of common contaminants was included in 
the search. FDR at the peptide level was also 0.01. Enzyme specificity for the search was 
Trypsin/P. Variable modifications included in the search were oxidation (M) and acetyla-
tion (protein N-term) and carbamidomethyl (C) was included as a fixed modification. 
Up to 2 missed cleavages and a maximum of 5 modifications per peptide were allowed. 
Mass tolerance for precursor ions was 7 ppm and for fragment ions 0.5 Da. MaxQuant 
results were further analyzed with Perseus version 1.2.0.17, Microsoft Excel 2010 and 
GraphPad Prism version 5. 
Contaminants, protein groups identified with the concatenated reversed database 
and protein groups that were only identified by site were removed from further analysis. 
Proteins that were identified with ≥2 razor peptides, of which ≥1 unique peptides were 
included for further analysis. For each time point only proteins with a ratio count ≥2 for 
both biological replicates were selected. Normalized ratios from one of the biological 
replicates were inverted to ensure all ratios were displayed as infected/mock. Normal-
ized ratios were log2 transformed and averages and variances were calculated. Proteins 
with a variance <0.25 were included in the analysis. The list of excluded proteins was 
manually inspected and some of these proteins were still included in the analysis when 
a large change was observed in both replicates in the same direction but with relatively 
large variation. The Significance B function in Perseus 1.2.0.17 was used separately for 
each time point, both sided, with Benjamini-Hochberg FDR 0.05 to determine which 
protein groups displayed significantly changed abundance during CHIKV infection. 
To estimate the percentage of protein originating from CHIKV, the total intensity of all 
identified CHIKV proteins was divided by the total intensity of all protein groups (includ-
ing CHIKV proteins) identified per biological replicate. This was also done separately for 
the nonstructural and structural polyprotein. 
Previously published protein half-lives [175] were used to predict log2 protein ratios 
for a hypothetical situation in which a block in protein translation occurs at 8 h p.i. These 
theoretical changes in protein abundance were compared to the observed protein deg-
radation rates. Proteins were only selected for follow-up if their observed degradation 
was faster than published. 
Homo sapiens, Macaca mulatta, Papio anubis, Pan troglodytes, Gorilla gorilla and Pongo 
abelii protein sequences of Rnd3, DDX56, UbcH10 and Plk1 were aligned using Geneious 
7.1.5 [176] to determine cross species sequence conservation of the peptides identified 
during LC-MS/MS.
Western blot Analysis
CHIKV- or mock-infected 293/ACE2 cells in 10 cm2 dishes were washed with PBS and 
then lysed in 0.5 ml of 4× Laemmli sample buffer (100 mM Tris-HCl, pH 6.8, 40% glycerol, 
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8% SDS, 40 mM DTT, 0,04 mg/ml bromophenol blue). Proteins were separated by SDS-
PAGE in a 10% polyacrylamide gel and were transferred to Hybond LFP-membranes (GE 
Healthcare, UK) by semi-dry blotting with a Transblot SD semi-dry transfer cell (BioRad, 
California, USA). Membranes were blocked with 1% casein in PBST and incubated o/n 
with rabbit antisera against CHIKV nsP1 [168], nsP2 [177], nsP3 [178], C, kind gifts from 
prof. Andres Merits (University of Tartu, Estonia), CHIKV E1, E2 [179], mouse monoclonal 
antibody H68.4 against the transferrin receptor (Invitrogen) or mouse monoclonal anti-
body against β-actin (Sigma) diluted in PBST with 1% casein. Biotin-conjugated swine-
a-rabbit (DAKO) or goat-a-mouse (DAKO), and Cy3-conjugated mouse-a-biotin (Jackson, 
Pennsylvania, USA) diluted in PBST with 0.5% casein were used for fluorescent detection 
with a Typhoon-9410 scanner (GE Healthcare, UK).
immunofluorescence microscopy
293/ACE2 cells grown on coverslips were fixed o/n in 3% paraformaldehyde (PFA) in 
PBS. Quenching was done with 10 mM Glycine in PBS and cells were permeabilized with 
0.1% Triton X-100 in PBS for 10 min. Coverslips were incubated for 1 h with CHIKV E2 
antiserum [179] and mouse monoclonal antibody J2 against dsRNA (English & Scientific 
Consulting, Hungary) diluted in PBS with 0.5% BSA. Primary antibodies were detected 
with donkey-a-rabbit-Cy3 (Jackson, Pennsylvania, USA) and goat-a-mouse-Alexa488 
(Jackson, Pennsylvania, USA). Nuclei were stained with Hoechst-33342. Coverslips were 
mounted with Prolong (Invitrogen) and examined using a Zeiss Axioskop2 fluorescence 
microscope with Axiocam HRc camera and AxioVision software (Zeiss, Germany).
fACs
One day prior to transfection with 0.5 μg plasmid and 2.5 μl Lipofectamine2000 (Life 
Technologies Europe, The Netherlands) in antibiotics-free medium, 7.5 x 104 293/ACE2 
cells were seeded in 12-well clusters. At 4 hours post transfection (h p.t.) the medium 
was replaced by antibiotics-containing medium. At 10 h p.t. cells were either mock in-
fected or infected with CHIKV-LS3-GFP [168] (Figure S1A) or GFP-expressing adenovirus 
HAdV-GFP/LUC [180] at an MOI of 5. At 10 h p.i. cells were harvested by trypsinization 
and fixed o/n at 4 °C in 3% PFA in PBS. Cells were washed twice with 1% FCS in PBS and 
once with 0.1% Saponin, 0.5% BSA, and 0.02% NaN3 in PBS. Cells were permeabilized 
for 10 min on ice with 0.1% Saponin, 0.5% BSA, and 0.02% NaN3 in PBS and stained 
on ice for 30 min with anti-FLAG-APC (APC anti-DYKDDDDK tag, clone L5, Biolegend, 
California, USA) diluted in the same buffer. Cells were washed 3 times in 0.5% BSA in PBS 
and stored at 4 °C in 1% FCS, 1% PFA in PBS until they were analyzed using a FACSCalibur 
(BD Biosciences, California, USA) and CellQuestPro software (BD Biosciences, California, 
USA). Intact single cells were gated. Contour plots were made using CellQuestPro with 
the following settings: log density 50%, smoothing 2, 1% threshold. Each contour 
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plot contains approximately 1 x 104 cell events. Each plot was divided into quadrants 
to differentiate between non-transfected, uninfected cells (lower left quadrant (LL)), 
non-transfected, infected cells (lower right quadrant (LR)), transfected, uninfected cells 
(upper left quadrant (UL)) and transfected, infected cells (upper right quadrant (UR)).To 
determine the effect of overexpression of host factors on the virus-driven expression of 
a GFP reporter gene, for each plot the percentage of transfected cells that also became 
infected (“double positive”) was calculated as follows: UR/(UL+UR)*100. This number 
was compared to the percentage of non-transfected cells that became infected within 
the same sample, which was calculated as: LR/(LL+LR)*100. 
REsuLTs
Proteomics
Quality of proteomics dataset
To analyze changes in the cellular proteome in response to CHIKV infection we have 
performed a time course experiment in which we compared cell lysates of infected 
and mock infected SILAC-labeled mammalian cells harvested at 8, 10 and 12 h p.i. To 
minimize background signal from uninfected cells, an MOI of 5 was chosen to ensure 
that >99% of cells became infected. A CHIKV-induced cytopathic effect in 293/ACE2 cells 
became visible by microscopy around 14 h p.i., and, therefore, 12 h p.i. was chosen as 
the latest time point for proteomic analysis, to avoid a high proportion of false positive 
hits, e.g. through proteins that leaked out of these cells. At 8 h p.i. the changes in the 
proteome were limited and we, therefore, did not analyze earlier samples, but focused 
on samples with a high expression of viral proteins and viral RNA. At each time point, 
CHIKV proteins were identified by mass spectrometry (Table S2). To estimate how much 
of the total protein in infected cells was of viral origin, the sum of the intensities of all 
protein groups that originated from CHIKV was divided by the sum of all intensities for 
a given biological replicate (Table S3). CHIKV proteins accounted for roughly 0.6% to 
1.1% of total protein, depending on the time-point analyzed. Based on the peptides 
analyzed, we estimated that about 70-80% of CHIKV protein in the cell originates from 
the structural polyprotein. 
Successful CHIKV infection of the SILAC-labeled cells was also confirmed by western 
blot (WB) and immunofluorescence microscopy (IFA) (Figure 2A). At 4 h p.i., a weak 
labeling for double-stranded RNA (dsRNA), a marker for viral replication, was observed 
in a small number of cells, while at 8 h p.i. nearly all cells stained positive for dsRNA 
and the viral envelope protein E2 (Figure 2A). This confirmed that virtually all cells were 
CHIKV-infected under our experimental conditions. Viral proteins nsP1 and E2 were also 
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detected by WB at 6 h p.i. and their abundance increased during the course of infection 
(Figure 2B). 
A total number of 4763 protein groups was identified with ≥2 razor peptides of which 
at least 1 peptide was unique. In each biological replicate 3000-4000 protein groups 
were quantified with ≥2 evidence counts and at each time point 2800-3550 protein 
groups were quantified in both biological replicates (Figure 1B and Table S2). 
Proteins displaying significantly changed abundance during CHIKV infection
The relative abundance of the majority of the identified proteins did not change during 
the course of infection. At 8 h p.i., the abundance of only 13 proteins had significantly 
changed with a Benjamini-Hochberg FDR of 0.05. At 10 and 12 h p.i., this number had 
increased to 38 and 106 proteins, respectively (Figure 1B and C and Table S4). The major-
figure 2: immunofluorescence microscopy and Western blot analysis of ChiKv-infected siLAC-la-
beled cells at different time points post infection. (A) Cells were immunolabeled for dsRNA (green) and 
the CHIKV E2 protein (red), and nuclear DNA (blue) was stained with Hoechst-33342. Scale bar corresponds 
to 50 µm. (B) Protein lysates were separated by SDS-PAGE and viral proteins nsP1 and E2 were detected by 
Western blotting. The precursors E3-E2 and E3-E2-6k-E1 could also be detected with the E2 antibody. The 
transferrin receptor was used as a loading control.
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ity of proteins with a significantly changed abundance showed a decrease during the 
course of CHIKV infection. 
Nine proteins were found to be significantly downregulated at all investigated time 
points (Table 1) and for most of these there was a clear correlation between their de-
creasing abundance and the progression of the infection. One of these proteins, Rpb1, 
is a subunit of the RNA polymerase II complex (POLR2). Six other subunits from this 
complex were also significantly downregulated at 12 hpi (Table 2). 
Virus-specific downregulation versus normal turn-over of downregulated proteins
Alphaviruses, including CHIKV, are known to induce a host translational shut-off [100]. 
In CHIKV-infected 293/ACE2 cells this process starts between 8 and 9 h p.i. [168]. There-
fore, a decrease in the abundance of any host protein might merely be the result of its 
normal turn-over (degradation in the absence of synthesis). For a subset of proteins the 
observed degradation rate was compared to their predicted decay based on published 
half-lives in uninfected cells [175]. Indeed, several proteins were identified that showed 
no relative change in abundance at 8 h p.i., while their abundance had decreased 
significantly by 10 and/or 12 h p.i. (Figure S2A) with a degradation rate that was close 
to the predicted one. These downregulated proteins were not selected for follow-up 
analysis. Other proteins were specifically downregulated as a result of the infection, as 
their abundance decreased much more rapidly than predicted (Figure S2B). 
Effect of overexpression of host proteins that were downregulated during 
ChiKv infection
Four significantly downregulated proteins, Rnd3, DDX56, Plk1 and UbcH10, were chosen 
for follow-up experiments to more extensively assess their role in CHIKV replication. 
Rnd3 and UbcH10 showed significant decreased abundance at all three time points that 
were studied (Table 1). DDX56 showed significant decreased abundance at 10 (log2 ratio 
-0.71) and 12 h p.i. (log2 ratio -0.64) and Plk1 at 12 h p.i. (log2 ratio -1.01) (Table S4). 
Plasmids expressing FLAG-tagged versions of these four proteins were transfected into 
293/ACE2 cells that were subsequently infected with a GFP-expressing CHIKV reporter 
virus (Figure S1A). This virus was previously characterized and showed a growth pheno-
type similar to the parent CHIKV strain without the reporter [168]. The abundance of the 
FLAG-tagged host factor and GFP reporter protein was analyzed by FACS. FLAG-tagged 
ubiquitin (Ub) was used as a negative control. Abundance of this protein did not change 
during CHIKV infection as log2 ratios for this protein were -0.10, -0.23 and -0.33 at 8, 10 
and 12 h p.i., respectively, which was expected based on its half-life of 11h [175]. A GFP-
expressing adenovirus was used as an additional negative control, as we anticipated 
only a very limited overlap between the host factors involved in the replication of this 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































figure 3: (over)expression of different fLAG-tagged host factors, followed by infection with a GfP-
expressing ChiKv at 10 h p.t. at an moi of 5. At 10 h p.i., the cells were fixed, permeabilized and stained 
with anti-FLAG-APC. APC staining and GFP expression were quantified by FACS. (A) FACS contour plots. The 
mock plot displays non-transfected cells that were not infected. In all other plots cells were infected with 
reporter virus CHIKV-LS3-GFP. pCDNA3.0 was used as an empty vector control and FLAG-Ub as a negative 
control. Each plot contains approximately 10,000 events. The x-axis shows the level of GFP expression, the 
y-axis shows the intensity of APC staining. The numbers in the upper right of each panel indicate the per-
centage of cells in each quadrant. Contour plots of control cells that were transfected with FLAG-tagged 
host factors, but were not infected with CHIKV can be found in Figure S4. (B) Summary of FACS data ob-
tained with CHIKV-infected cells transfected with plasmids to overexpress FLAG-tagged host factors. The 
number of events that was recorded in each quadrant during FACS analysis is shown. The percentage of 
CHIKV infected cells was calculated using the total number of transfected cells and total number of non-
transfected cells. The fold reduction in number of infected cells is shown in the last column. TF, Transfected, 
NTF, nontransfected, Inf, infected.
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Transfection of cells in general had a (nonspecific) negative effect on the susceptibil-
ity of cells to CHIKV infection, as only 50.6% of cells transfected with an empty vector 
became infected with CHIKV, compared to 87.2% of nontransfected cells (Figure 3). This 
(nonspecific) effect on susceptibility was not observed when cells were infected with 
the adenovirus (Figure S3). Overexpression of the negative control FLAG-Ub had no 
effect on the number of GFP-positive cells during either CHIKV (Figure 3) or adenovirus 
(Figure S3) infection.
Overexpression of FLAG-Rnd3 and DDX56-FLAG inhibited CHIKV replication, result-
ing in a 2.8- and 2.3-fold reduction in the number of GFP-positive cells, respectively. 
Overexpression of FLAG-Plk1-WT and FLAG-UbcH10 had a more modest effect, resulting 
in a 1.7- and 1.3-fold reduction in the number of GFP-expressing cells, respectively. Mu-
tations in the kinase domain and Polo-box domain of Plk1 did not change the effect that 
overexpression of this protein had on CHIKV infection (Figure 3 and Figure S4). The FACS 
analysis revealed that especially cells expressing high levels of the FLAG-tagged host 
proteins were less likely to become infected with CHIKV. The replication of adenovirus, 
determined by quantifying GFP reporter abundance, was not affected by the overexpres-
sion of FLAG-Plk1-WT, FLAG-UbcH10 and DDX56-FLAG. Compared to nontransfected 
cells in the same sample, FLAG-Rnd3 overexpression did reduce the infection rate of 
adenovirus-infected cells by 1.5 fold, and there was a correlation between the level of 
FLAG-Rnd3 abundance and the reduction in GFP reporter abundance (Figure S3). 
disCussioN
minimal changes in the cellular proteome in response to ChiKv infection
To obtain more insight into the complex interactions between CHIKV and its host cell, 
we have applied SILAC-based quantitative proteomics to analyze changes in abundance 
in the cellular proteome during the stages of infection with high viral RNA and protein 
expression. At 8 h p.i. almost 3000 proteins could be quantified and, surprisingly, the 
cellular proteome had remained largely unchanged. Mass spectrometry and WB analysis 
revealed that cells at this time point already contained substantial quantities of viral 
protein (0.6% of total protein) and microscopy showed that almost all cells had been 
successfully infected. This demonstrated that the limited response of the cells at this 
time point was not due to a low percentage of infected cells or slow progression of the 
infection. The number of affected proteins increased from only 13 at 8 h p.i. to 106 at 12 
h p.i. Strikingly, the majority of these proteins was downregulated and the abundance 
of none of the upregulated proteins increased by more than 2-fold. 
The innate immune response is rapidly activated upon detection of dsRNA in the 
cytoplasm [181] and we thus expected to observe upregulation of at least some in-
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nate immunity-related proteins, but this was not the case. However, it was previously 
shown that CHIKV infection leads to a strong transcriptional upregulation of interferon 
regulatory factor 3 (IRF3)-dependent genes, such as interferon-β and Viperin in hu-
man fibroblasts, while this increase in mRNA levels did not result in increased protein 
abundance [182]. This suggests that CHIKV very efficiently evades or blocks the innate 
immune response and our data support these earlier observations. The report by White 
et al. and our current study emphasize the importance of directly measuring protein 
abundance instead of mRNA levels in virus-infected cells, as changes in the latter might 
not translate into altered protein levels. Alphaviruses are known to induce a host trans-
lational shut-off [100] and CHIKV-LS3 does so in 293/ACE2 cells from 8 h p.i. onward 
[168]. By considering a block of translation starting at 8 h p.i., predicting the decay of 
a protein in the following hours based on its published half-life, and comparing this 
to its real decrease in abundance, we could distinguish between proteins that merely 
decreased in abundance due to normal turnover and those that were degraded faster 
than predicted during CHIKV infection. Many other viruses also cause a host shut-off, 
and our study shows that it is important to take this into consideration when analyzing 
proteomics data to avoid follow-up research on false positive hits.
During the follow-up studies we discovered that the 293/ACE2 cell line was not of hu-
man but of non-human primate origin, most likely from an Old-World monkey related to 
Papio anubis and Macaca mulatta. The M. mulatta genome has been sequenced and this 
revealed that 89% of human-macaque orthologs differ at the amino acid level and the 
average human gene differs by 12 nonsynonymous and 22 synonymous substitutions 
from its macaque ortholog [183]. Since a single amino acid change in a peptide already 
prevents matching to the corresponding protein sequence in the search database, this 
could theoretically have lowered the number of identified proteins resulting from our 
search against a human proteome database. To exclude this, a second search against 
the uniprot M. mulatta database (69,931 entries, reviewed:358 (Swiss-Prot), unreviewed: 
69,573 (TrEMBL); data not shown) was performed. This resulted in a similar number of 
identifications (4818) and proteins with significantly changed abundance (9, 42, 91, at 
8, 10 and 12 h p.i., respectively), the majority of those being the same as in the original 
search against the human database. An advantage of using a human proteome data-
base for the search, however, is that it is much better annotated than the non-human 
primate databases and results in less identifications of uncharacterized proteins. For the 
four proteins that were selected for our overexpression studies we additionally aligned 
sequences from Homo sapiens, Macaca mulatta, Papio anubis, Pan troglodytes, Gorilla 
gorilla and Pongo abelii (Figure S5). Mapping of the peptides that were identified with 
LC-MS/MS to these alignments indicated that each of these proteins was identified with 
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at least 4 peptides that are 100% conserved across these six species. From these findings 
we conclude that the initial identifications and quantifications are valid. 
downregulation of host proteins is beneficial for ChiKv infection 
Although the overall effect of CHIKV infection on the cellular proteome was rather 
limited, several proteins were specifically downregulated. This could be mediated by the 
virus or might be a (antiviral) response of the cell. Four of these downregulated proteins 
were chosen for follow-up studies and the effect of their overexpression on CHIKV infec-
tion was analyzed. Figure S6 summarizes the possible roles these proteins play during 
CHIKV infection. 
Rnd3
Of the four host factors, overexpression of FLAG-RND3 had the strongest negative effect 
on CHIKV-LS3-GFP infection, leading to 2.8-fold reduction in the number of GFP positive 
cells, compared to the non-transfected cells in the same sample. Rnd3 was also one of 
the most downregulated proteins during CHIKV infection. Expression of Rnd3 appears 
to be unfavorable for a broader range of viruses, as its overexpression also reduced 
adenovirus infection. The protein belongs to a subfamily of Rho GTPases that constitu-
tively bind GTP. Its activity does not depend on a GDP/GTP switch, but is regulated by 
expression, localization and phosphorylation [184]. Many cellular functions have been 
ascribed to Rnd3 and the protein could inhibit CHIKV infection in several ways. 
Rnd3 might limit CHIKV through its effect on the cytoskeleton since it is an important 
antagonist of RhoA induced stress fibers [184] and alphavirus replication complexes 
interact with cytoskeleton filaments [55, 185].
Another function of Rnd3 is the regulation of cap-dependent translation of mRNAs 
with highly structured 5’untranslated regions (UTRs) [186]. Rnd3 prevents the phos-
phorylation of 4E binding proteins (4E-BP1), which limits the release of bound eukary-
otic initiation factor 4E (eIF4E). Low availability of eIF4E affects the activity of the eIF4F 
translation initiation complex, resulting in the translation of mainly mRNAs with 5’ UTRs 
containing little secondary structure. Consequently, Rnd3 would inhibit the translation 
of mRNAs with complex structured 5’ UTRs. +RNA virus genomes, including that of 
CHIKV, generally have highly structured 5’ UTRs and therefore Rnd3-mediated inhibi-
tion of translation of such mRNAs could be responsible for its negative effect on CHIKV 
replication. Degradation of Rnd3 during CHIKV infection might be a strategy by which 
the virus ensures efficient translation of its genome.
DDX56
Overexpression of DDX56-FLAG led to a 2.3-fold reduction in the percentage of CHIKV-
infected cells, but had no effect on adenovirus infection, suggesting this was not due 
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to e.g. a general effect on cellular homeostasis. DDX56 is a nucleolar ATP-dependent 
helicase from the DEAD-box family and is involved in ribosome biogenesis [187, 188]. 
During CHIKV infection, DDX56 appears to have an antiviral role, as its overexpression 
decreased the number of infected cells. DDX56 degradation during infection might be 
induced by CHIKV nsP2 or C since a fraction of these proteins localizes to the nucleolus 
through nucleolar import signals [76, 108]. 
DDX56 has previously been shown to be a proviral host factor for West Nile virus 
(WNV) and human immunodeficiency virus type 1 (HIV-1) [189-191]. During WNV 
infection DDX56 relocalizes from the nucleolus to the cytosol where it interacts with 
WNV capsid protein and its helicase domain is essential for the assembly of infectious 
virions [189, 190]. DDX56 is one of several DEAD-box helicases that interact with the 
HIV-1 Rev protein and synergistically enhance Rev-dependent HIV-1 RNA export from 
the nucleus to the cytoplasm. DDX56 promotes relocalization of Rev from the nucleolus 
to the nucleus [191]. 
Plk1
Compared to Rnd3 and DDX56, overexpression of FLAG-Plk1-WT had only a modest ef-
fect on CHIKV-driven GFP reporter protein expression, but still reduced the percentage 
of infected cells by 1.7-fold. Overexpression of this protein had no effect on adenovirus 
infection. In an attempt to pinpoint which of the known domains is responsible for the 
antiviral effect of (overexpressed) Plk1, we analyzed the effect of a kinase defective and 
a polo-box domain Plk1 mutant. Overexpression of these variants had the same nega-
tive effect on CHIKV replication as WT Plk1, suggesting that the kinase- and polo-box 
domain are not responsible for the antiviral properties of this protein. 
Plk1 was previously described as a host factor for other viruses and was therefore 
selected for follow-up studies [192-195]. It is a serine/threonine mitotic kinase that 
is expressed during the S, G2 and M phase of the cell cycle and is a key regulator of 
several steps during mitosis [196]. The C-terminal polo-box domain of Plk1 targets the 
N-terminal kinase domain to specific targets and subcellular locations through binding 
of phosphorylated residues on a specific motif [196]. Plk1 has also been described as a 
regulator of interferon induction by mitochondrial antiviral signaling protein (MAVS), 
which plays a crucial role in the signal transduction that leads to induction of interferon 
β in response to viral infection. Overexpression of Plk1 has been shown to inhibit the 
induction of interferon β [197] and therefore overexpression of Plk1 could be expected 
to have a proviral effect. However, during CHIKV infection this was not the case, conceiv-
ably because CHIKV employs alternative mechanisms to evade the interferon response, 
e.g. through inhibition of JAK-STAT signaling by nsP2 [198]. 
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UbcH10
UbcH10 was chosen for follow-up studies because it was also significantly downregu-
lated during infection with equine arteritis virus, an unrelated +RNA virus (unpublished 
data). However, overexpression of FLAG-UbcH10 had a limited impact on CHIKV infec-
tion, leading to a 1.3-fold reduction of the number of CHIKV-infected cells. UbcH10 is 
the E2 ubiquitin-conjugating enzyme of the anaphase-promoting complex (APC), an E3 
ubiquitin ligase responsible for the ubiquitination of cyclins [199]. It is an essential factor 
for cell cycle progression and plays a role at several cell cycle checkpoints [200]. Its effect 
on CHIKV replication might be indirect and through its general effect on the cell (cycle), 
although it did not affect adenovirus infection. 
PoLR2 complex is specifically downregulated during ChiKv infection
We observed that several subunits of the POLR2 complex were downregulated dur-
ing CHIKV infection. This confirmed the results of a previous study that showed that 
nsP2 of CHIKV, Sindbis virus and Semliki Forest virus induced degradation of Rpb1, the 
catalytic subunit of the POLR2 complex, through a proteasome-dependent pathway. 
This degradation results in a host transcriptional shut-off, which likely serves to inhibit 
cellular antiviral responses [63]. We identified 10 of the 12 subunits of the POLR2 com-
plex and observed the progressive downregulation of most of the components during 
CHIKV infection (Table 2). By 12 h p.i., 7 subunits (Rpb1-3, Rpb5 and Rpb9-11) had been 
significantly downregulated (1.5- to 3.4-fold). The whole complex appears to be a target 
for degradation during CHIKV infection. Degradation of Rpb1 occurs most rapidly and 
is, therefore, most likely the first subunit to be degraded, closely followed by Rpb5 and 
Rpb9. The loss of Rpb2, Rpb10 and Rpb11 started at 10 h p.i., followed by that of Rpb3 
and Rpb12 at 12 h p.i. Whether these proteins are directly targeted by the virus or are 
degraded because Rpb1 is lacking is not clear at the moment. We have previously shown 
that the host transcriptional shut-off triggered by CHIKV-LS3 in 293/ACE2 cells can be 
observed as early as 6 h p.i. and increases until there is almost no host transcription left 
at 12 h p.i. [168]. These findings are supported by the progressive degradation of the 
POLR2 subunits observed here. Rpb 5, 6, 8, 10 and 12 are also part of the POLR1 complex, 
which synthesizes ribosomal RNA, and the POLR3 complex, which produces tRNAs [201]. 
Consequently, the downregulation of these subunits might result in a very broad effect 
on cellular transcription and (indirectly on) translation. 
Comparison with previously published ChiKv proteomics data sets
Previously conducted proteomics studies showed a very limited overlap in the lists of 
proteins with significantly changed abundance during CHIKV infection [111-116, 119, 
120]. This is most likely due to differences in the experimental systems (mice, patient 
serum, cell culture), experimental conditions (virus strain, MOI, time post infection), and 
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the methods (database, software, statistics) used to analyze the data. The in vivo infec-
tion studies (e.g. with mice or serum) are based on relatively heterogeneous biological 
material (various cell types, infected and non-infected cells) and are complicated by the 
fact that not only the direct effects of CHIKV infection are observed, but also all kinds of 
indirect effects such as tissue damage and the response of uninfected cells to cytokines 
produced elsewhere in the infected organism. In addition, the applied proteomics 
techniques might be a factor in the limited overlap between the different studies. For 
example, in the study that combined iTRAQ and 2D-DIGE, the two datasets only had 
a few proteins in common, despite the fact that they were generated using the same 
biological samples [114]. The low number of identifications generated with the 2D-DIGE 
approach (32 proteins) was probably the main contributor to this limited overlap. 
A comparison of our results with previously reported datasets identified a few proteins 
that were also differentially expressed in other studies. Synthenin-1 was down regulated 
2-fold at 12 h p.i. in our study and was 5-fold downregulated 2 days post infection in a 
human microglial cell line in the study by Abere et al.[111]. CD63 and HTRA1 were both 
downregulated, while HYRC and DNAJC13 were both upregulated in our study and in 
the study by Wikan et al., while agrin was downregulated in our study but upregulated 
in their study [120]. HKQ and LAMB1 were downregulated in our study and 2 days post 
infection in the study by Frasier et al., while SNW1 was downregulated in our study 
but up regulated in their study [114]. In line with our results, three other studies also 
observed that the majority of significantly changed proteins were downregulated [111, 
114, 119].
We set out to analyze the direct effects of CHIKV-infection on cells by specifically 
analyzing synchronously infected cells during the first round of replication in a well-
defined and characterized system. We used a SILAC-based time course so we could track 
abundance during the course of infection. This increases the chance of identifying dif-
ferentially expressed proteins and decreases the chance of finding false positives, which 
are unlikely to be the same at multiple time points. A similar approach was recently 
used to study temporal changes during CMV infection [202]. An additional advantage 
of our time course study is that kinetics of the differentially regulated proteins could be 
compared to published half-lives. Several of the other studies analyzed samples at much 
later time points post infection, probably long after the onset of the translational shut-
off. Therefore, the downregulation of many of the proteins identified in these studies 
might have merely been the result of normal turnover (in the absence of translation). 
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CoNCLusioN
The data presented in this study show that the immediate impact of CHIKV infection on 
host cell protein abundance is rather limited. This might be because the cellular response 
to the infection is limited at the level of protein abundance, or because it is effectively 
suppressed by CHIKV, e.g. through the virus-induced translational and transcriptional 
shut-off, rendering the cell unable to upregulate protein expression. The previously 
described CHIKV nsP2-induced degradation of an RNA polymerase subunit [63] and the 
downregulation of most components of the POLR2 complex that we observed in our 
study, likely contribute importantly to the host transcriptional shut-off and suggests 
that also other proteome changes that we describe are relevant. 
The majority of the differentially expressed proteins were downregulated during the 
infection, likely to manipulate the intracellular environment in a way that is beneficial 
for CHIKV replication. In line with this assumption, we discovered that overexpression 
of four of these downregulated proteins had a negative effect on the ability of CHIKV 
to establish a productive infection in these cells. How these four proteins affect CHIKV 
replication, directly or indirectly, and whether they are specifically targeted for degrada-
tion by CHIKV, as previously described for Rpb1 [63], remain interesting questions for 
future studies. 
Although CHIKV infection only led to a limited cellular response at the level of protein 
abundance, it remains very well possible that the cell responds to infection in ways that 
cannot be detected with a quantitative proteomics approach that only studies changes 
in total protein abundance. For example, this approach will not detect changes in 
subcellular localization or PTMs, such as phosphorylation, that can occur rapidly during 
(antiviral) signaling. Our findings advance the understanding of the response to CHIKV 
infection at the cellular level and this information might be used in future studies aimed 
at developing ‘host-directed’ antiviral strategies. 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Con-
sortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository 
[203] with the dataset identifier PXD001330.
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supporting information Table s1: List of oligonucleotides
supporting information Table s2: Excel table with protein groups identified during the siLAC time 
course. Contaminants, proteins identified with the concatenated reversed database, proteins that were 
only identified by site and proteins that were identified with <2 peptides were removed. Protein groups 
that were used for further analysis (variance <0.25) were placed in different sheets for each time point. 
Identified CHIKV proteins were placed in a separate sheet. This table can be downloaded on the website of 
the journal: http: //onlinelibrary.wiley.com/doi/10.1002/pmic.201400581/suppinfo. 
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28 h p.i. 10 h p.i. 12 h p.i.
replicate 1 replicate 2 replicate 1 replicate 2 replicate 1 replicate 2
Nonstructural polyprotein 
(%)
0.10 0.24 0.34 0.23 0.16 0.19
Structural polyprotein (%) 0.32 0.55 0.92 0.73 0.74 0.54
Total CHIKV protein (%) 0.43 0.79 1.26 0.95 0.90 0.72
Average total CHIKV 
protein (%)
0.61 1.11 0.81
supporting information Table s3: Relative protein intensity in percentages originating from ChiKv 
proteins. To estimate what percentage of the total protein in infected cells was of viral origin, the sum of 
the intensities of all protein groups that originated from the CHIKV nonstructural polyprotein, structural 
polyprotein and total CHIKV protein was divided by the sum of all intensities for a given biological replicate. 
The average of the total amount of CHIKV protein in the 2 biological replicates at each time point is also 
shown. The amount of structural proteins was about 2 to 4-fold higher than that of the of the nsPs at the 
various time points post infection.
supporting information Table s4: Excel table with the proteins that showed significantly different abun-
dance during CHIKV infection. Each time point is placed in a different sheet. This table can be downloaded 
on the website of the journal: http: //onlinelibrary.wiley.com/doi/10.1002/pmic.201400581/suppinfo.




supporting information figure s1: schematic overview of ChiKv genome organization and protein 
expression. (A) Schematic representations of CHIKV constructs used in this paper. CHIKV has a single-
stranded positive polarity RNA genome that encodes for two polyproteins. The genome is 5’ capped and 
has a 3’ poly-A tail. The CHIKV-LS3-GFP genome contains a second subgenomic promotor from which GFP is 
expressed. (B) Schematic overview of viral protein expression. Upon entering the cell the CHIKV genome is 
directly translated by cellular ribosomes into the nonstructural polyprotein. The RNA dependent RNA poly-
merase nsP4 is only expressed upon translational readthrough of the stop codon between nsP3 and nsP4. 
The protease domain in nsP2 processes the polyprotein into the different subunits. The viral replication 
complex transcribes minus (-) strands from the +RNA genome. These are used as templates to transcribe 
new CHIKV genomes. A subgenomic promotor on the –strand is used to transcribe a subgenomic RNA 
that is translated into the structural polyprotein, which is proteolytically processed into individual subunits 
by the protease domain in C and host proteases. (C) Schematic overview of the accumulation of negative 
strand, genomic RNA, subgenomic RNA, nonstructural and structural proteins and the release of infectious 
virions, during the replication of CHIKV in 293/ACE2 cells. In addition the progression of the transcriptional 
and translational host shut-off are shown. Plots are based on data from Scholte et al. (RNA, viral titers, host 
shut-off) [168], and this paper (protein; see panel D and Supplemental Table 3). Arrows indicate the time 
points that were analyzed in our proteomics experiment. (D) Western blot analysis of samples from CHIKV-
LS3 infected 293/ACE2 cells showing the expression of nsP1, nsP2, nsP3, C, E1, E3-E2 and E2 from 2-12 h p.i. 
Mock-infected cells were included as controls to demonstrate the specificity of the antibodies used. 




















































































supporting information figure s2: Comparison of observed and predicted log2 ratios over time of 
6 proteins that were hardly affected at 8 h p.i. but were significantly downregulated later during 
ChiKv infection. The predicted change in relative abundance was calculated using published half-lives 
(indicated in each graph) [175] and assuming virus-induced host translational shut-off starts 8 h p.i. (A) Pro-
teins of which the observed decay was very similar to the predicted curve. (B) Proteins that were degraded 
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Non-transfected 1 13 2538 7870 10422 75.6 n/a n/a
Empty vector 2 22 2767 7561 10352 73.2 n/a n/a
FLAG-Ub 953 2506 1821 5119 10399 73.8 72.4 1.0
FLAG-Rnd3 1321 1112 2270 5719 10422 71.6 45.7 1.6
DDX56-FLAG 439 1229 2267 6425 10360 73.9 73.7 1.0
FLAG-UbcH10 430 1706 1761 6500 10397 78.7 79.9 1.0
FLAG-Plk1-WT 849 2110 1776 5607 10342 75.9 71.3 1.1
FLAG-Plk1-KM 769 1962 1841 5773 10345 75.8 71.8 1.1
FLAG-Plk1-FAA 763 1876 1929 5791 10359 75.0 71.1 1.1
supporting information figure s3: (over)expression of different fLAG-tagged host factors, followed 
by infection with a GfP-expressing Adenov at 10 h p.t. and an moi of 5. At 10 h p.i., the cells were 
fixed, permeabilized and stained with anti-FLAG-APC. APC staining and GFP expression were quantified by 
FACS. (A) The first scatter plot shows side- and forward scatter and the gate that was used to select cells to 
display in contour plots. The contour plots show a-FLAG-APC staining and GFP expression. For each host 
factor a mock- and adenovirus-infected plot is shown. pCDNA3.0 was used as an empty vector control and 
FLAG-Ub as a negative control. Each plot contains approximately 10,000 events. The x-axis shows the level 
of GFP expression, the y-axis shows the intensity of APC staining. The numbers in the upper right of each 
panel indicate the percentage of cells in each quadrant. (B) Summary of FACS data. The number of events 
that was recorded in each quadrant during FACS analysis is shown. The percentage of adenovirus-infected 
cells was calculated using the total number of transfected cells and the total number of non-transfected 
cells. The fold reduction in number of infected cells is shown in the last column. TF= Transfected, NTF= non-
transfected, Inf= infected.





































supporting information figure s4: fACs contour plots of transfected uninfected control cells. 293/
ACE2 cells were transfected with fLAG-tagged host factors and at 10 h p.t. mock-infected. Cells were 
fixed 10 h later, permeabilized and stained with anti-FLAG-APC. APC staining and GFP expression were 
measured by FACS. The first plot shows side- and forward scatter and the gate that was used to select cells 
to display in the contour plots. Each plot contains approximately 10,000 events. X-axis shows GFP expres-




supporting information figure s5: sequence alignments of the proteins that were used in the follow-
up experiments of our proteomics study. Alignments were made for each of the four proteins that were 
selected for follow-up (overexpression) studies, using sequences from Homo sapiens, Macaca mulatta, Papio 
anubis, Pan troglodytes, Gorilla gorilla and Pongo abelii. Alignments were made with Geneious 7.1.5 [176]. 
The uniprot identifier for each sequence that was used for the alignment is shown after the species name. 
The level of sequence identity is shown in the bar above the sequence. The peptides identified in the LC-
MS/MS analysis are indicated with bars underneath the sequence. (A) Rnd3, (B) DDX56, (C) UbcH10, (D) Plk1. 
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supporting information figure s6: schematic overview of possible functions of significantly down-
regulated proteins during ChiKv infection. The POLR2 complex is required for host transcription and 
degradation of its subunits results in a decrease in host transcription. The POLR1 and POLR3 complexes are 
involved in tRNA synthesis and rRNA synthesis, respectively, and degradation of their subunits affects host 
translation. Rnd3 is an antagonist of RhoA induced stress fibers and the protein might affect CHIKV entry 
or the replication and transcription complex (RTC). Rnd3 also inhibits translation of mRNAs with highly 
structured 5’UTRs and could affect translation of CHIKV genomes through this function. Overexpression of 
DDX56 inhibits CHIKV infection but how it affects replication is still unclear. The effect of overexpression of 
UbcH10 on CHIKV infection was minimal and it is still unknown how inhibition would take place. Plk1 has 
several functions in regulation of the cell cycle and interferon-β production. Since mutations in the kinase- 
and polobox-domain of this protein had no effect on the inhibitory effect that overexpression of Plk1 had 
on CHIKV infection it might inhibit CHIKV through yet another function.
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AbsTRACT
Chikungunya virus (CHIKV) is a reemerging alphavirus that causes a high fever, rash and 
severe persisting arthralgia. Since 2005, millions of people have been infected during 
outbreaks in Africa, Asia, and recently also in South/Central America. CHIKV is highly de-
pendent on cellular factors during many steps of its replication cycle. Here stable isotope 
labeling with amino acids in cell culture (SILAC) and liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) were used to assess temporal changes in the cellular 
phosphoproteome in response to CHIKV infection. Almost 3000 unique phosphoryla-
tion sites were identified and per time point the phosphorylation status of 800–1200 
sites was quantified. At 2, 8, and 12 h p.i., we measured significant modulation of 10, 
71, and 136 phosphorylation sites, respectively. The largest change in phosphorylation 
status was measured on residue T56 of eukaryotic elongation factor 2 (eEF2), which 
showed a >50-fold increase at 8 and 12 h p.i. while an increase in phosphorylation could 
already be detected by 2 h p.i. Infection with other alphaviruses (Semliki Forest virus 
and Sindbis virus) and a picornavirus triggered a similar strong eEF2 phosphorylation, 
which could not be prevented by inhibition of PKA or AMPK or by activation of mTORC1, 
known regulators of eEF2 phosphorylation. Activation of the RIG-I-mediated innate im-
mune response was also not responsible for eEF2 phosphorylation. Transfection with a 
CHIKV replicon RNA also induced a strong eEF2 phosphorylation, which demonstrated 
that neither the viral entry process nor the expression of CHIKV structural proteins were 
responsible. We hypothesize that the increase in phosphorylation of eEF2 is triggered 
by a specific feature of the genome (e.g. RNA structure) or of (alpha)virus genome RNA 
translation or transcription and may constitute a novel cellular antiviral/stress response 




Chikungunya virus (CHIKV) is a reemerging human pathogen that has affected the lives 
of millions over the past decade. It has a 12-kb RNA genome of positive polarity and 
belongs to the alphavirus genus of the togavirus family [15]. CHIKV is an arthropod-
borne virus and can be transmitted by mosquitos from the Aedes species [26]. Clinical 
symptoms include a high fever, rash and severe persisting polyarthralgia [14]. The virus 
was first discovered in 1952 in Tanzania [8] and for a long time mainly caused outbreaks 
of a limited magnitude. In 2005-2006, however, the virus reemerged in an epidemic 
form on the east coast of Africa and several Indian ocean islands, infecting millions of 
people as it spread across the Asian continent [204]. In the autumn of 2013, the virus 
reached the Caribbean island of Saint-Martin, which was the start of a massive outbreak 
in the Caribbean and South/Central America [205]. Within a year more than 1 million 
suspected cases were reported [206]. In the past decade, hundreds of infected travel-
ers have returned to non-endemic countries and as a result small locally-transmitted 
outbreaks have already occurred in e.g. Italy, France, and the USA [20, 29, 30, 207]. 
The CHIKV replicative cycle depends on a wide range of interactions with the host, 
while the infection is also expected to trigger a variety of antiviral and stress responses. 
To gain more insight into the changes that occur in the host cell during the course of 
infection, we have previously performed a temporal quantitative proteomics analysis 
of CHIKV-infected cells [208]. Surprisingly, this study revealed that overall changes 
in protein abundance were minimal and that the majority of significantly changed 
proteins showed decreased abundance during infection. An important reason for the 
lack of protein upregulation during CHIKV infection is the host translational shut-off 
induced by alphaviruses, which renders the cell unable to respond to the infection at 
the level of protein synthesis after a certain time point [100]. However, cellular responses 
to infection might also involve modulation of the activity of proteins and pathways, e.g. 
by changes in the localization and post-translational modifications (PTM) of proteins, 
such as phosphorylation and ubiquitination. Compared to changes in protein expres-
sion levels, these processes, in general, occur on a different time scale and allow much 
more rapid responses than those that depend on the induction of protein synthesis. 
Such PTM-based responses would not be detected by the commonly used quantitative 
proteomics approaches that only analyze changes in protein abundance. For example, 
a protein could relocate to a different organelle resulting in an altered function, while 
the total abundance of this protein could remain unchanged. A change in its PTM status 
could also alter a protein’s function, activity, interaction partners, or stability without 
affecting its abundance [145, 146, 209]. Especially PTMs can quickly (de)activate signal-
ing pathways, leading to major changes within the cell [158]. Considering the limited 
changes in protein abundance in CHIKV-infected cells that we observed previously, we 
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hypothesized that the cell may mainly respond to infection at the level of PTMs. We, 
therefore, set out to study changes in host protein phosphorylation status during CHIKV 
infection, because the regulation of protein function through phosphorylation is one of 
the most widespread regulatory mechanisms in eukaryotes [209]. A temporal quantita-
tive phosphoproteomics approach using stable isotope labeling by amino acids in cell 
culture (SILAC) [126] was used, and to our knowledge, this is the first in-depth analysis 
of the temporal changes in host protein phosphorylation status during alphavirus infec-
tion. 
We have quantified changes in phosphorylation status of 2988 phosphorylation sites 
on 1038 phosphoproteins, of which 167 unique sites on 113 proteins were modulated 
significantly on at least one of the time points analyzed. In 110 instances a significant 
increase in phosphorylation was measured, whereas a significant decrease was ob-
served in 107 instances. The largest change was measured on residue T56 of eukaryotic 
elongation factor 2 (eEF2). Phosphorylation of this threonine residue increased more 
than 50-fold after CHIKV infection, an observation that was also made early after 
infection with two other alphaviruses and a picornavirus. During translation eEF2 is 
required for the translocation step of peptide-chain elongation and phosphorylation of 
T56 blocks protein synthesis in the elongation phase [221]. siRNA knockdown of eEF2 
resulted in decreased expression of CHIKV proteins, suggesting that the presence of 
(non-phosphorylated) eEF2 is important for CHIKV replication. Our study provides a first 
glimpse into the phosphorylation-based regulation of cellular protein function follow-
ing CHIKV infection and provides a starting point for the more detailed exploration of 
host processes that restrict or promote alphavirus replication. 
mATERiAL & mEThods
Cells and viruses 
MRC-5 cells were cultured in EMEM (Lonza), 10% fetal calf serum (FCS) (PAA), 2 mM L-
Glutamine, and 1% non-essential amino acids (NEAA) (GE Healthcare) at 37°C and 5% 
CO2. Vero E6 cells were cultured in DMEM (Lonza) containing 8% FCS. 293/ACE2 cells 
[162] were cultured in DMEM (Lonza) containing 10% FCS and 2 mM L-Glutamine. 
BHK-21 cells were cultured in BHK-21 medium (Glasgow MEM; Invitrogen), containing 
5% FCS, 10% tryptose phosphate broth, and 10 mM HEPES, pH 7.4. All culture media 
contained 100 IU/ml penicillin and 100 ug/ml streptomycin unless otherwise specified. 
All cells were grown at 37°C and 5% CO2.
Infections with CHIKV LS3 and LS3-GFP were performed essentially as described previ-
ously [168]. The construction of a Chikungunya replicon that was derived from CHIKV 
LS3 by replacing the structural genes with a puromycin resistance/foot-and-mouth 
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disease virus 2A oligopeptide/green fluorescent protein (PAC-2A-GFP) reporter gene 
will be published elsewhere (details available upon request). The sequence of the 2A 
oligopeptide contains an amino acid motif that prevents formation of the peptide bond 
between glycine and the final proline of the sequence which allows expression of mul-
tiple proteins from a single ORF [210, 211]. 
Vero E6 cells were infected with the Sindbis virus (SINV) HR-strain or Semliki Forest 
virus (SFV) strain SFV4 [212] at a multiplicity of infection (MOI) of 5. Vero E6 cells were 
infected with a GFP-expressing recombinant human adenovirus (HAdV-GFP/LUC; [180]) 
at an MOI of 5 and with a GFP-expressing recombinant coxsackie B3 virus (CVB3) (a kind 
gift from prof. dr. Frank van Kuppeveld, Utrecht University) at an MOI of 1. BHK-21 cells 
were infected with the equine arteritis virus (EAV) Bucyrus strain at MOI 5 at 39.5°C es-
sentially as described previously [213]. 
siLAC labeling
MRC-5 cells were cultured in SILAC DMEM (PAA) containing 10% dialyzed Fetal Bovine 
Serum (FBS) (Gibco), 0.280 mM arginine, 0.384 mM lysine, 0.5 mM proline, 10 mM HEPES, 
2 mM L-Glutamine and 1% NEAA for >5 cell doublings to ensure complete incorporation 
of labeled amino acids. Arginine to proline conversion was not observed under these 
conditions. The ‘light SILAC labeling’ was performed using Arg 12C6 14N4 and Lys 12C6 
14N2, whereas the ‘heavy SILAC sample’ was labeled with Arg 13C6 15N4 and Lys 13C6 15N2 
(Cambridge Isotope Laboratories). 
ChiKv infection of siLAC labeled cells 
SILAC-labeled MRC-5 cells were seeded in 75-cm2 flasks 1 day before infection with 
CHIKV-LS3 [168] at MOI 5. One hour post infection (h p.i.), the inoculum was removed 
and replaced with SILAC DMEM containing 2% dialyzed FBS, 0.280 mM arginine, 0.384 
mM lysine, 0.5 mM proline, 25 mM HEPES, 2 mM L-Glutamine and 1% NEAA. At 2, 8, 
and 12 h p.i., infected and mock-infected cells were harvested for phosphoproteomics 
analysis by lysis in 4% SDS, 0.1M Tris pH 7.6, followed by heating to 96°C for 10 min. At 
12 h p.i., protein lysates for western blot (WB) analysis were harvested in 4× Laemmli 
sample buffer (LSB) (100 mM Tris-HCl, pH 6.8, 40% glycerol, 8% SDS, 40 mM DTT, 0.04 
mg/ml bromophenol blue) and cells grown on coverslips were fixed in 3% PFA in PBS . 
The experiment was performed in duplicate with a label swap (Figure 1A).























figure 1: siLAC experiment. (A) Experimental set-up of the SILAC-based phosphoproteomics study of 
virus-induced changes in the host proteome during the course of CHIKV infection. B) At each time point 
two biological replicates were used, in which a SILAC label-swap was performed between infected and 
mock-infected samples. Infected and mock-infected cells were lysed at 2, 8 and 12 h p.i. and equal amounts 
of protein were mixed and subsequently digested into peptides using the filter-aided sample preparation 
procedure. The samples were enriched for phosphopeptides using the HAMMOC procedure and analyzed 
by LC-MS/MS. (B) Number of identified phosphorylation sites at each time point p.i. The number of identi-
fied phosphorylation sites for each biological replicate and the total number of phosphorylation sites that 
were identified in both replicates at each time point p.i. are shown. For follow-up analysis only phosphor-
ylation sites with a variance <0.25 were selected. (C) Immunofluoresence microscopy analysis of SILAC-
labeled CHIKV-infected cells at 12 h p.i. Cells were immunolabeled for dsRNA (green) and the CHIKV E2 
protein (red), and nuclear DNA (blue) was stained with Hoechst-33342. (D) Proteome-wide quantification of 
phosphorylation sites at 2 (dots), 8 (squares), and 12 (triangles) h post-CHIKV infection. Average normalized 
log2 ratios are plotted against the log10 of peptide intensities. Each mark represents a protein group. Red 
marks indicate phosphorylation sites that were significantly modulated (Benjamini-Hochberg FDR of 0.05).




The protein concentration of the SILAC cell lysates was determined using the bicin 
chonicic acid assay (Pierce). Digestion of the proteins was performed using the Filter 
Aided Sample Preparation (FASP) method [169], for which equal amounts (900 µg) of 
mock and infected lysates were mixed and DTT was added to a final concentration of 50 
mM, followed by a 5-min incubation at 70°C. Samples were loaded on two 15-ml 30 kDa 
Microcon filter devices (Millipore), which were washed twice with 8 M urea, 0.1 M Tris 
pH 8.5, while cysteines were alkylated with 50 mM iodoacetamide in the same buffer. 
Samples were washed 3 times with 8 M urea, 0.1 M Tris pH 8. Proteins were digested 
overnight at room temperature using 20 ug endoLysC (Wako Pure Chemical Industries) 
per filter device in the same buffer. The sample was diluted fourfold with 50mM ammo-
nium bicarbonate pH 8.4 containing 20 ug trypsin (Worthington Chemical Corporation), 
and digested for 4h at room temperature. Peptides were collected by centrifugation, 
acidified to a final percentage of 1% TFA, and desalted using solid phase extraction. Pep-
tides were eluted in 20/80/0.1 milliQ/acetonitrile (ACN) (Actu-All Chemicals)/trifluoric 
acid (TFA) (Sigma-Aldrich) (v/v/v). 
Phosphopeptide enrichment 
The samples were enriched for phosphopeptides by Hydroxy Acid Modified Metal Oxide 
Chromatography (HAMMOC) [214]. Per 500 ug peptide digest a 200 ul tip with an Octyl 
C8 membrane (Empore) and 2.5 mg Titansphere TiO2 10 µm (GL Sciences) were used. The 
tips were preconditioned with 20/80/0.1 milliQ/ACN/TFA (v/v/v) (solution A) and equili-
brated with 300 mg/ml DL Lactic acid (Fluka Analytical) in solution A. Peptide samples 
were mixed 1:1 with 300 mg/ml DL Lactic acid in solution A and loaded on the tips. The 
tips were washed with 300 mg/ml DL Lactic acid in solution A and solution A. 100 ul 20% 
phosphoric acid (Sigma-Aldrich) was put in collection tubes and phosphopeptides were 
eluted with 50 ul 0.5% piperidine (Actu-All Chemicals) followed by 50 ul 5% piperidine. 
Peptides were desalted on 200 ul tips with an SDB-XC membrane (Empore). Tips were 
preconditioned with solution A and equilibrated with 0.1% TFA. Samples were loaded on 
the tips and the tips were washed with 0.1 %TFA. Peptides were eluted with solution A 
and lyophilized in a CHRIST RVC-2-18 CDplus. 
mass spectrometry
Phosphopeptide-enriched samples were analyzed via on-line C18-nano-HPLC-MS 
with a system consisting of an Easy nLC 1000 gradient HPLC system (Thermo, Bremen, 
Germany), and a Q-Exactive mass spectrometer (Thermo). Fractions were injected onto 
a homemade precolumn (100 μm × 15 mm; Reprosil-Pur C18-AQ 3 μm, Dr. Maisch, Am-
merbuch, Germany) and eluted via a homemade analytical nano-HPLC column (15 cm 
× 50 μm; Reprosil-Pur C18-AQ 3 um). The gradient was run from 0% to 30% solvent B 
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(10/90/0.1 water/ACN/FA v/v/v) in 120 min. The nano-HPLC column was drawn to a tip of 
~5 μm and acted as the electrospray needle of the MS source. The Q-Exactive mass spec-
trometer was operated in top10-mode. Parameters were resolution 70,500 at an AGC 
target value of 3,000,000, maximum fill time of 250 ms (full scan), and resolution 17,500 
at an AGC target value of 200,000/maximum fill time of 80 ms for MS/MS at an intensity 
threshold of 2,500. Apex trigger was set to 1 to 15 seconds, and allowed charges were 
2-6. Each sample was analyzed in duplo. 
data analysis
Raw data files were analyzed using Maxquant 1.4.0.3 [173] using the Andromeda search 
engine [174]. Databases used for the main search were UNIPROT/KB_Human (88,665 
entries) and a custom-made database containing the protein sequences of CHIKV-LS3 
(11 entries) using the GenBank sequence (accession KC149888) [168]. For the first search 
a smaller database, human.first.search (15,612 entries) containing a subset of human 
protein sequences was used. A list of common contaminants was included in the search. 
To reach a false discovery rate (FDR) of 0.01 a concatenated reversed database (KR spe-
cial amino acids) was used, FDR at the peptide level was also 0.01. Enzyme specificity 
was Trypsin/P. Variable modifications included in the search were oxidation (M), acetyla-
tion (protein N-term) and phospho (STY), whereas carbamidomethyl (C) was included 
as a fixed modification. Up to 3 missed cleavages and a maximum of 5 modifications 
per peptide were allowed. The minimum score for modified peptides was set to 40 and 
the minimum delta score for modified peptides was set to 17. Match between runs was 
turned on with a matching time window of 1 minute. MaxQuant results were further 
analyzed with Perseus version 1.2.0.17 and Microsoft Excel 2010 and GraphPad Prism 
version 5. 
From the list of identified phosphorylation sites, contaminants and peptides identi-
fied with the concatenated reversed database were removed before further analysis. 
Normalized ratios from one of the biological replicates were inverted to ensure all ratios 
were displayed as infected/mock. Normalized ratios were log2 transformed and aver-
ages and variances were calculated for each experiment. Phosphorylation sites with a 
variance <0.25 were included in the analysis. The list of excluded sites was manually 
inspected and some of these were still included in the analysis when a large change 
was observed in both replicates in the same direction but with relatively large variation. 
Significance B with a Benjamini-Hochberg FDR of 0.05 (both-sided) was calculated in 
Perseus 1.2.0.17 separately for each time point to determine which phosphorylation 
sites were significantly modulated during CHIKV infection.
String 10 was used to determine enrichment with medium confidence for protein-




Western blot (WB) analysis was performed essentially as described previously [208]. 
Primary antibodies used were rabbit antisera against CHIKV nsP1 [168], CHIKV capsid 
protein, SFV capsid protein (both kind gifts from prof. Andres Merits, University of Tartu, 
Estonia), rabbit polyclonal against eEF2 #2332, mouse monoclonal against STAT-1 (9H2) 
#9176 (both Cell Signaling Technology), mouse monoclonal H68.4 against the transfer-
rin receptor (Invitrogen), or mouse monoclonal against b-actin (A5316; Sigma) diluted in 
1% casein in phosphate buffered saline containing 0.1% Tween-20 (PBST). Rabbit poly-
clonal phospho-eEF2 (Thr56) #2331 (Cell Signaling Technology) was diluted in 1% BSA in 
tris buffered saline containing 0.1% Tween-20 (TBST). Biotin-conjugated swine-a-rabbit 
diluted 1:2000 (DAKO) or goat-a-mouse (DAKO) diluted 1:1000, and Cy3-conjugated 
mouse-a-biotin diluted 1:2500 (Jackson) were used for fluorescent detection with a 
Typhoon-9410 scanner (GE Healthcare).
immunofluorescence microscopy
Immunofluorescence microscopy (IFA) was performed essentially as described previ-
ously [208]. Primary antibodies used were rabbit polyclonal against CHIKV E2 [179] and 
mouse monoclonal antibody J2 against dsRNA (English & Scientific Consulting) diluted 
in 0.5% BSA in PBS. Primary antibodies were detected with donkey-a-rabbit-Cy3 or goat-
a-mouse-Alexa488 (Jackson). Nuclei were stained with Hoechst33342. Coverslips were 
mounted with Prolong (Invitrogen) and examined using a Zeiss Axioskop2 fluorescence 
microscope with Axiocam HRc camera and AxioVision software.
siRNA-mediated knockdown of eEf2
eEF2 protein levels were knocked down in Vero E6 and MRC-5 cells using ON-TARGETplus 
siRNA SMARTpool against human eEF2 (1938; Thermo Scientific) at a final concentration 
of 25 nM and 2 ul Dharmafect1 in 1 ml per 3.8 cm2 well. A pool of non-targeting (scram-
bled) siRNAs (NTP; cat. nr. D-001810-10; Dharmacon) was used as a negative control. The 
cells were grown in medium without antibiotics 1 day prior to siRNA transfection until 1 
day p.t. At 2 days p.t., cells were infected with CHIKV LS3 at an MOI of 1 and 16 h p.i. cells 
were harvested in 4× LSB. Protein levels for eEF2, CHIKV nsP1, CHIKV capsid and actin 
were determined by WB analysis. 
modulating eEf2 phosphorylation with compounds
The AMPK inhibitor dorsomorphin (Sigma-Aldrich) and the PKA inhibitor KT5720 (Ab-
cam) were dissolved in anhydrous DMSO (Sigma-Aldrich). mTORC1 activator L-Leucine 
(Sigma-Aldrich) was dissolved in DMEM. Vero E6 cells were pretreated with compound 
for 1 h prior to infection with SFV at an MOI of 5 in the presence of the same concentra-
tion of compound. As a control no compound and 0.1% DMSO were used. Cells were 
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harvested at 5 h p.i. in 4× LSB and protein levels for peEF2, SFV capsid and actin were 
determined by WB analysis.
Treatment of cells with 5’pppRNA 
The in vitro synthesis of 5’pppRNA representing sequences from the 5’ and 3’ untranslated 
regions of the vesicular stomatitis virus (VSV) genome was described previously [216]. 
MRC-5 cells were transfected with 0.1, 1, or 10 ng/ml 5’pppRNA or control RNA (same 
sequence but lacking the 5’ppp moiety; Integrated DNA Technologies Inc., IA, USA) 1 h 
prior to infection or mock infection with CHIKV-LS3-GFP at MOI 0.1, as described previ-
ously [216]. At 24 h p.i., cells were lysed in 4× LSB and protein levels for pEEF2, STAT-1, 
and actin were determined by WB analysis. 
Replicon RNA transfection
BHK-21 cells were transfected by electroporation using 4x106 cells in 400 ul PBS and 4 
ug of in vitro transcribed capped or uncapped CHIKV replicon RNA per cuvette. After 
2 pulses with an Eurogentec Easyjet Plus instrument set at 850 V and 25 µF, cells were 
taken up in pre-warmed medium and seeded at a density of 6x105 cells/10cm2 dish and 
incubated at 37°C. Cells were harvested 6, 8, and 10 h p.i. in 4× LSB for WB analysis or in 
20 mM Tris-HCl (pH 7.4), 100 mM LiCl, 2 mM EDTA, 5 mM DTT, 5% (w/v) lithium dodecyl 
sulfate, and 100 mg/ml proteinase K for in-gel hybridization analysis. 
RNA isolation, denaturing agarose electrophoresis and in-gel hybridization
Total RNA was isolated from cells lysed in 20 mM Tris-HCl (pH 7.4), 100 mM LiCl, 2 mM 
EDTA, 5 mM DTT, 5% (w/v) lithium dodecyl sulfate, and 100 mg/ml proteinase K as de-
scribed previously [168]. RNA was separated in 1.5% denaturing formaldehyde-agarose 
gels using the MOPS buffer system as described previously [217]. RNA molecules were 
detected by direct hybridization of the dried gel with 32P-labeled oligonucleotides 
essentially as described previously [218]. CHIKV positive- or negative-stranded RNAs 
were visualized as described previously [168] using probe CHIKV-hyb4 (5’-TGTGGGTTC-
GGAGAATCGTGGAAGAGTT-3’) or probe CHIKV-hyb2 (5’-AACCCATCATGGATCCTGTGTAC-
GTGGA-3’), which are complementary to the 3’ end of the genome (detects genome and 
subgenomic mRNA) and anti-genome (detects negative-stranded RNA), respectively. 
18S ribosomal RNA (loading control) was detected with the oligonucleotide probe 5’-AT-
GCCCCCGGCCGTCCCTCT-3’. Hybridized gels were exposed to Storage Phosphor screens 




To identify proteins of which the phosphorylation status is modified during CHIKV infec-
tion, we performed a SILAC time course experiment in which protein lysates of mock- and 
CHIKV-infected MRC-5 cells were compared. Samples harvested at 2, 8 and 12 h p.i. were 
enriched for phosphopeptides, followed by LC-MS/MS analysis and phosphorylation site 
quantification (Figure 1A). Our earlier study [208] demonstrated that until 8 h p.i. there 
were minimal changes in the host proteome at the level of protein abundance, but we 
expected that changes in phosphorylation status could occur much more rapidly and, 
therefore, decided to also analyze samples taken at 2 h p.i. to monitor early responses to 
CHIKV infection. At 8 h p.i. the viral proteins are clearly detectable by WB analysis in this 
cell line (Figure 2A) and by 12 h p.i. high levels of viral protein and RNA are present but 
cytopathic effects are not yet observed. 
figure 2: Alphavirus infection triggers early phosphorylation of eEf2 on T56. (A) WB analysis of CHIKV 
MOI 5 infected MRC-5, 293/ACE2 and Vero E6 cells at different time points post infection. Protein lysates 
were separated by SDS-PAGE and viral protein nsP1 and peEF2 (T56) were detected by WB. Actin was used 
as a loading control. (B) WB analysis of SINV and SFV MOI 5 infected Vero E6 cells at different time points 
post infection. Protein lysates were separated by SDS-PAGE and viral protein C, eEF2 and peEF2 (T56) were 
detected by WB. Actin was used as a loading control. (C) WB analysis of a GFP-expressing CVB3 MOI 1 in-
fected VeroE6 cells at different h p.i. Protein lysates were separated by SDS-PAGE and GFP (marker for viral 
protein synthesis) and peEF2 (T56) were detected by WB analysis. Actin was used as a loading control. (D) 
WB analysis of EAV MOI 5 infected BHK-21 cells and GFP-expressing AdenoV infected Vero E6 cells at differ-
ent time points p.i. Protein lysates were separated by SDS-PAGE and viral protein nsP2 or GFP, and peEF2 
(T56) were detected by WB analysis. Actin was used as a loading control.
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General proteomics results
Successful CHIKV infection of SILAC-labeled cells was confirmed by immunofluorescence 
microscopy at 12 h p.i. All cells stained positive for double-stranded RNA (a marker for 
viral replication) and E2, one of the CHIKV structural proteins (Figure 1B). 
In total, 2988 phosphorylation sites were identified on 1060 unique proteins (Table 
S1). Per time point 800-1200 peptides containing phosphorylation sites were quantified 
in both biological replicates. (Figure 1C and D). 
Phosphorylated CHIKV peptides were also identified. Two phosphorylation sites were 
identified on the capsid protein (C), two on envelope protein E2 and four on nonstruc-
tural protein nsP3. (Table S1)
During CHIKV infection 167 unique phosphorylation sites on 113 host proteins were 
modulated significantly on at least one time point with a Benjamini-Hochberg FDR of 
0.05. Several sites were significantly modulated at multiple time points (Figure 1D and 
Table S2). 
At 2 h p.i., changes in phosphorylation status were minimal, although 10 sites were 
significantly modulated, with four of these also being significantly modulated at the 
two later time points: T56 on eEF2 (Log2 ratio 0.70), S430 on Vimentin (Log2 ratio 0.48), 
and T185 and Y187 on MAPK (Log2 ratio -0.48 and 0.29, respectively). At 8 h p.i., the 
phosphorylation status of 71 sites had changed significantly and at 12 h p.i. this number 
increased to 136 sites. 42 sites were significantly modulated at both 8 and 12 h p.i. (Table 
S2). Both increases (110 occurrences) and decreases (107 occurrences) in phosphoryla-
Protein Accession 
number
Peptide sequence modified 
residue(s) #
Log2 ratio
2 h p.i. 8 h p.i. 12 h p.i.
EEF2 P13639 _AGETRFT(ph)DTR_ T56 0.70 * 5.85 * 3.81 *
_AGETRFT(ph)DT(ph)RKDEQER_ T56, T58 NaN 7.08 * NaN
HSPB1 P04792 _ALS(ph)RQLS(ph)SGVSEIR_ S78, S82 0.05 0.35 2.31 *
LARP1 Q6PKG0 _S(ph)LPTTVPES(ph)PNYR_ S769, S774 -0.02 -1.37 * -2.11 *
MTDH E5RJU9 _SETSWES(ph)PK_ S568 -0.06 -2.02 * -3.12 *
NES P48681 _S(ph)LGEEIQESLK_ S548 NaN 1.03 * 2.27 *
_SLRS(ph)LEEQDQETLR_ S746 NaN NaN 2.85 *
NUP50 Q9UKX7-2 _VAAETQS(ph)PSLFGSTK_ S221 NaN 1.30 2.34 *
PRRC2C Q9Y520-2 _AFGSGIDIKPGT(ph)PPIAGR_ T2673 -0.14 -1.62 -2.45 *
RALY Q9UKM9-2 _TRDDGDEEGLLTHS(ph)EEELEHS(ph)
QDTDADDGALQ_
S288, S295 -0.27 -2.17 -2.37 *
SH3KBP1 B7Z6E8 _ANS(ph)PSLFGTEGKPK_ S587 NaN 2.35 * 2.57 *
Table 1: Peptides that contain a phosphorylation site that changed phosphorylation status >4 fold 
on at least one of the time points analyzed. (ph) indicates the preceding amino acid residue was modi-
fied by phosphorylation. # Amino acid residue number according to PhosphoSitePlus [283]. *Significantly 
changed phosphorylation status at this time point with Benjamini-Hochberg FDR 0.05. NaN: peptide was 
not identified at this time point. 
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tion were observed. On 11 peptides we identified sites with a larger than 4-fold change 
in phosphorylation status on at least one of the time points studied (Table 1). 
The 113 proteins that contained phosphorylation sites that were significantly modu-
lated were analyzed with medium confidence using String 10 [215]. The dataset was 
enriched for protein-protein interactions with a p-value of 2.22e-16. This set of proteins 
were also strongly enriched for the Gene Onthology (GO) [219, 220] molecular functions 
poly(A)-binding RNA binding (Bonferroni corrected p-value 1.10*10-20) and RNA binding 
protein (Bonferroni corrected p-value 1.48*10-19), the GO biological processes intracel-
lular transport (Bonferroni corrected p-value 7.66*10-4) and the GO cellular component 
adherens junction (Bonferroni corrected p-value 7.48*10-20) and cell-substrate adherens 
junction (Bonferroni corrected p-value 1.12*10^-19) (Table S3). 
eEf2 becomes strongly phosphorylated during alphavirus infection
The protein that showed the largest increase in phosphorylation, i.e. a >50 fold increase 
at 8 and 12 h p.i., was eEF2. This protein became phosphorylated on T56 and T58 
(Figure 1D). Because of this strong effect, it was selected for follow-up analysis. Phos-
phorylation of eEF2 on T56 during CHIKV infection was confirmed with WB on samples 
from independent time course infection experiments in MRC-5, Vero E6, and 293/ACE2 
cells. In the proteomics experiment, a significant increase in phosphorylation (Log2 ratio 
0.70) was already observed at 2 h p.i. Also in Vero E6 cells strong phosphorylation at this 
residue could be detected early in infection (at 4 h p.i) by WB analysis. (Figure 2A). 
Other proteins involved in translation, eEF1D, ribosomal protein S6 (rps6), ribosomal 
protein, large, P1 (rplp1) and rplp2, also contain phosphorylation sites that were signifi-
cantly modulated during CHIKV infection suggesting that the slowing down of transla-
tion might have a broader basis than only through inhibition of eEF2. 
Phosphorylation of eEF2 in Vero E6 cells was also observed during infection with two 
other alphaviruses, Sindbis virus (SINV) and Semliki Forest virus (SFV) (Figure 2B). We 
subsequently also tested three unrelated viruses, a GFP expressing CVB3 (+RNA virus, 
picornavirus family), EAV (+RNA virus, arterivirus family, order Nidovirales) and a GFP-
expressing HAdV (dsDNA virus, adenovirus family). Infection with CVB3 resulted in early 
eEF2 phosphorylation (Figure 2C) but infections with EAV and HAdV did not (Figure 2D).
eEF2 is a GTPase that is required for the translocation step of peptide-chain elongation 
during translation. Its activity is regulated by the eEF2 kinase (eEF2K) that phosphory-
lates two threonine residues in an ordered process with T56 phosphorylation preceding 
T58 phosphorylation [221], but phosphorylation on T56 is already sufficient to inactivate 
eEF2 [222]. In our study, we only identified phosphorylated T58 on a peptide that was 
also phosphorylated on T56 (Table 1). 
To obtain more insight into the role of eEF2 during CHIKV infection, the effect of 
siRNA-mediated depletion of eEF2 on CHIKV LS3-GFP replication in MRC-5 and Vero E6 
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cells was analyzed (Figure 3). The siRNA-mediated knockdown had no significant effect 
on cell viability, while the synthesis of CHIKV proteins was reduced, although this was a 
modest effect.
Preliminary studies into the mechanism that triggers eEf2 phosphorylation
Modulating pathways involved in regulating eEF2 activity 
eEF2 phosphorylation is modulated by several pathways, including the AMPK, PKA, 
mTORC1 and MAP kinase pathways [225]. To investigate which cellular pathways could 
be responsible for eEF2 phosphorylation, and to understand how this PTM affects 
CHIKV replication, several inhibitors and agonists were used. Activation of PKA results 
in activation of eEF2K [223, 224]. However, inhibition of PKA with KT5720 only mildly 
inhibited phosphorylation of eEF2 on T56 during CHIKV infection and had no effect on 
the synthesis of capsid protein (Figure 4). Activation of AMPK can result in increased 
phosphorylation of eEF2 [225]. However, inhibition of AMPK with dorsomorphin 
increased phosphorylation on eEF2 T56 during CHIKV infection but did not appear to 
have an effect on capsid protein expression (Figure 4). Inhibition of mTORC1 promotes 
translation elongation [225]. However, activation of mTORC1 with L-Leucine increased 
eEF2 phosphorylation during CHIKV infection and at the same time reduced the amount 
of capsid protein accumulating in CHIKV-infected cells (Figure 4). These preliminary 
compound studies suggest that the pathways that were tested so far are not involved in 
the induction of eEF2 phosphorylation, but additional studies including more positive 
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figure 3: siRNA-mediated knockdown of eEf2 inhibits viral protein synthesis. Vero E6and MRC-5 cells 
were transfected with 25 nM siRNA targeting eEF2, a non-targeting pool of control siRNAs or no siRNA. 2 
days post infection the cells were infected with CHIKV LS3 MOI 1 and protein lysates were harvested at 16 
h p.i. Proteins were separated by SDS-PAGE and viral proteins nsP1 and C, eEF2 were detected by WB. Actin 







































































































































































































































































































































70 A + RNA virus diptych
Innate immune response
We next hypothesized that phosphorylation of eEF2 might be part of an innate immune 
response that is triggered by PAMPs, e.g. via the detection by the RIG-I/MDA5-MAVS 
pathways. To test this possibility, RIG-I was activated by transfection of a non-cytotoxic 
dose of 5’ triphoshorylated RNA (5’pppRNA) representing sequences from the 5’and 3’ 
untranslated regions of the VSV genome into MRC-5 cells, which has been shown to 
induce a good antiviral response against CHIKV infection [216]. This treatment did not 
induce phosphorylation of eEF2 T56, while it did lead to the induction of STAT1 synthe-
sis, indicating that the 5’pppRNA triggered an innate immune response in these cells. 
In cells that were infected with CHIKV one hour after transfection of 5’pppRNA, eEF2 
phosphorylation was prevented in a dose-dependent manner, likely because CHIKV 
replication was inhibited in these cells by the 5’pppRNA treatment (Figure 5). 
No involvement of CHIKV structural proteins and virus entry
To determine whether any of the structural proteins play a role in triggering eEF2 
phosphorylation, BHK-21 cells were transfected with a CHIKV RNA replicon lacking 
expression of all structural proteins and eEF2 phosphorylation was analyzed by WB 
(Figure 6A). Also in the absence of the structural proteins the CHIKV replicon triggered 
eEF2 phosphorylation. Uncapped replicon RNA was transfected as a control since it will 
not be translated and not be replicated and this construct did not induce phosphoryla-
tion. Since entry was bypassed by direct electroporation of the RNA into the cytosol, 
we conclude that the entry process did not trigger phosphorylation either. An increase 
in genome, subgenomic mRNA (sgRNA) and negative-stranded RNA could be detected 
actin
STAT1
-       0.1     1       10     0.1       1     10 
cntrl RNA 5’pppRNA cntrl RNA 5’pppRNA
CHIKVUninfected
peEF2 (T56)
-       0.1     1       10     0.1       1     10 
figure 5: RiG-i activation does not trigger eEf2 phosphorylation. MRC-5 cells were transfected with 
0.1, 1 or 10 ng/ml 5’pppRNA or a control RNA 1 hour prior to infection with CHIKV-LS3-GFP at an MOI of 0.1. 
Protein lysates were harvested 24 h p.i. and separated by SDS-PAGE. STAT1 and peEF2 (T56) were detected 
by WB analysis. Actin was used as a loading control. 
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for the capped replicon but the uncapped RNA was most likely quickly degraded after 
electroporation as it could not be detected at 6 h p.t. (Figure 6B). 
disCussioN
Proteomics techniques to analyze changes in host protein abundance have already 
been applied to many different viruses. These changes are often relatively slow and 
many viruses cause a host transcriptional and/or translational shut-off that prevents the 
synthesis of new proteins after a certain time point. To gain more insight in signaling 
pathways that are triggered or inhibited during CHIKV infection, we have performed 
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capped RNA uncapped RNA
- strand RNA
figure 6: Transfection of a capped ChiKv replicon triggers eEf2 phosphorylation. BHK-21 cells were 
electroporated with in vitro transcribed capped or uncapped CHIKV LS3 replicon RNA. Protein lysates were 
harvested and RNA was isolated at 6, 8 and 10 h p.i. (A) Protein lysates were separated by SDS-PAGE and 
viral protein nsP1 and peEF2 (T56) were detected by WB. Actin was used as a loading control. (B) RNA was 
isolated and separated on a denaturing formaldehyde-agarose gel. Positive- and negative strands of CHIKV 
RNA were detected by in-gel hybridization with radioactively labeled oligonucleotides complementary to 
the 3’ end of either negative- or positive-strand CHIKV RNA. The cellular 18S ribosomal RNA was used as a 
loading control.
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number of phosphorylation sites on cellular proteins at 2, 8 and 12 h p.i. In our previous 
study, we studied protein abundance and only observed minimal changes at 8 h p.i. 
[208], but changes in phosphorylation status can occur very rapidly and may also be 
triggered during the earliest stages of viral replication, which is why we also included 
the 2 h p.i. time point in the current study.
Numerous proteins showed regulation of phosphorylation status during CHIKV infec-
tion. Several of these factors were previously implicated in viral infection, although not 
always through their phosphorylation status. For example, SH3KBP1 (S587; Log2 ratio 
2.35 and 2.65 at 8 and 12 h p.i. in our study) interacts with the ORF3 protein of hepatitis 
E virus which results in prolongation of endomembrane growth factor signaling and 
promotes cell survival during infection [226]. SH3KBP1 was also shown to inhibit herpes 
simplex virus replication [227]. Hyper-phosphorylation of nuclear pore proteins (Nups) 
induced by the leader protein inhibits nucleocytoplasmic trafficking during picornavirus 
infection [228, 229]. Although Nup50 (S221; Log2 ratio 2.34 at 12 h p.i. in our study) was 
not implicated in picornavirus infection, Nup153 (S687; Log2 ratio 0.64 and 1.24 at 8 and 
12 h p.i. in our study) was [228-231]. 
For several proteins interactions with one of the alphavirus proteins have been de-
scribed. For vimentin several sites significantly changed phosphorylation status during 
CHIKV infection and this protein was reported to be an interaction partner of nsP2 and 
nsP3 in a yeast two-hybrid assay [91]. However, another study, which used immunopre-
cipitation, reported that the interaction between these proteins was due to aspecific 
binding [94] so the changes in phosphorylation status on vimentin may also prove to be 
irrelevant to the CHIKV infection. Also Ybx1 (S165; Log2 ratio -1.03 and -1.17 at 8 and 12 h 
p.i. in our study) and hnRNPK (S116; Log2 ratio 0.31 at 8 h p.i. in our study) were reported 
to interact with nsP2 and nsP3 in the yeast two-hybrid assay [91]. 
eEF2 showed the largest change in phosphorylation status during CHIKV infection. 
The increase in phosphorylation could already be detected by 2 h p.i. and is thus an early 
event during infection. eEF2 is required for successful virus replication since knockdown 
resulted in a (modest) decrease in viral protein synthesis. Interestingly, several other pro-
teins involved in translation, eEF1D, rps6, rplp1 and rplp2, showed significant changes in 
phosphorylation as well during CHIKV infection suggesting that the inhibition of protein 
synthesis might have a broader basis than only through inactivation of eEF2. The sites 
on rplp1 (S101 and S104) and rplp2 (S102 and S105) are part of the elongation factor 
binding site of the large ribosomal subunit and phosphorylation of these proteins is 
necessary for ribosome activity [232, 233] and at 8 h p.i. phosphorylation on these sites 
was significantly decreased (Log2 ratio -0.75). The phosphorylated form of rplp2 was 
also shown to interact with eEF2 [232]. For rps6, an interaction with nsP2 of Venezuelan 
equine encephalitis virus (VEEV), SINV, and SFV has been reported [234]. This study 
reported a decrease in phosphorylation for rps6 during alphavirus infection. After 2 h 
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p.i., there might have been a decrease (S235 and S236; Log2 ratio -0.62) during CHIKV 
infection, but the peptide was only identified in one of the biological replicates. At later 
time points we observed an increase (Log2 ratio 1.02 and 0.96 at 8 and 12 h p.i.). For 
several elongation factors, including eEF1D, a role as cofactor during virus replication 
has been described (Li et al., 2013).
The strong induction of eEF2 phosphorylation was also observed during infections 
with two other alphaviruses, SFV and SINV, and picornavirus CVB3, and was previously 
reported to occur during Rift Valley Fever virus (RVFV) infection [235], suggesting that 
the mechanism triggering phosphorylation during viral infection may be more uni-
versal. However, phosphorylation was not triggered during infections with two other 
viruses, EAV and HAdV. It will be interesting to determine whether more viruses from 
different virus families trigger eEF2 phosphorylation as this may help to determine what 
the trigger is for phosphorylation induction. In the four phosphoproteomics studies 
that have been published, using cells infected with human immunodeficiency virus 
(HIV)-1, Sendai Virus, porcine reproductive and respiratory syndrome virus (PRRSV), and 
influenza A virus, the peptide containing eEF2 T56 was not identified so it is possible that 
phosphorylation was also not induced during infections with these viruses [236-239]. 
For PRRSV this is not surprising, since it is an arterivirus related to EAV. In the HIV-1 study, 
samples were already analyzed at 1 min p.i. which was most likely too early to observe 
an increase in eEF2 phosphorylation [239]. 
Regulation of eEf2 activity
eEF2 is a GTPase that is required for the translocation of the nascent polypeptide chain 
from the P and A site to the E and P site of the translating ribosome [240]. eEF2 can be 
modified on multiple residues, of which phosphorylation on T56 is physiologically the 
most important. Phosphorylation on this residue results in a structural change in eEF2 
that reduces its affinity for the ribosome. This arrests protein translation at the translo-
cation step of elongation [241]. During CHIKV infection, eEF2 became phosphorylated 
on T56 and T58. Both T56 and T58 are phosphorylated by eEF2 kinase (eEF2K) and T56 
phosphorylation always precedes phosphorylation of T58 [221, 242]. In our experiment 
we only identified T58 phosphorylation on a peptide that was also modified on T56, 
which is in line with earlier findings. eEF2K belongs to a small group of atypical α-kinases 
and eEF2 is its only known substrate [225]. eEF2K activity is Ca2+/calmodulin dependent 
[243, 244] and the kinase is additionally positively and negatively regulated by phos-
phorylation at several sites [225]. We did not identify any of these sites in our proteomics 
analysis. Besides an increase in Ca2+ levels, two other pathways positively regulate 
eEF2K activity. Cyclic AMP (cAMP) is a catabolic signal that inhibits protein synthesis 
by stimulating cAMP-dependent protein kinase (PKA). Phosphorylation of eEF2K on 
S500 by PKA makes it partially Ca2+/calmodulin independent [223, 224]. AMP-activated 
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protein kinase (AMPK), a cellular energy sensor [245], also stimulates eEF2K activity, 
although it is still unclear whether AMPK regulates eEF2K directly through phosphoryla-
tion or indirectly through the inhibition of mammalian target of rapamycin complex 1 
(mTORC1) signaling [225]. It is also possible that AMPK directly phosphorylates eEF2 
to decrease protein synthesis [246]. mTORC1 negatively regulates eEF2K activity by 
inducing phosphorylation on S78, S359 and S366 and as a result promotes translation 
elongation [225]. There is also some evidence that eEF2K is phosphorylated on S366 and 
as a result is inactivated in response to MAP kinase pathways, SAPK/p38δ and MEK/ERK, 
either directly or through downstream effectors [247-249]. Low pH values also activate 
eEF2K which might inhibit protein synthesis during tissue acidosis [250]. Phosphoryla-
tion of eEF2 is reversible and dephosphorylation is done by protein phosphatase 2 A 
(PP2A) [251]. A schematic overview of the various pathways involved in modulating 
eEF2 activity is depicted in Figure 7. 
Nutrient sensing as an antiviral mechanism
One of our hypotheses was that eEF2 becomes phosphorylated during alphavirus infec-
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figure 7: schematic overview of different pathways involved in regulating eEf2 phosphorylation. 
An increase in the cytosolic Ca2+ concentration activates eEF2K. Activation of PKA by an increased con-
centration of cAMP activates eEF2K and can be inhibited by KT5720. Activation of AMPK by an increase 
in the AMP:ATP ratio activates eEF2K and AMPK possibly also directly phosphorylates eEF2. AMPK can be 
inhibited by Dorsomorphin. eEF2K can be inhibited by mTORC1, the MEK/ERK pathway and SAPK/p38 MAP 
kinases. eEF2 T56 phosphorylation is reversible through dephosphorylation by PP2A.
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innate immune responses through sensing of pathogen-associated molecular patterns 
(PAMPs) by pathogen recognition receptors such as Toll-like receptors (TLRs), RIG-I like 
receptors (RLRs), nucleotide-binding and oligomerization domain (NOD)-like recep-
tors (NLRs) and DNA-dependent activator of IRFs (DAIs) [181, 252-254]. The activation 
of these innate sensors can induce rapid immune responses. Our data suggests that 
phosphorylation of eEF2 during alphavirus infection is not mediated through RIG-I since 
transfection of 5’pppRNA did not induce phosphorylation on T56. However, next to 
sensing of viral products such as dsRNA, nutrient sensing in metabolic stress pathways 
also plays a role in the innate immune response to viruses [255]. During nutrient depri-
vation, several pathways are activated to conserve cellular resources [256, 257]. Protein 
synthesis consumes a large part of the cellular energy and is one of the processes that 
is inhibited to save energy. There are several energy sensors that could mediate an 
increase in eEF2 phosphorylation. 
During cellular stress an increase in the AMP:ATP ratio activates the AMPK pathway. 
Activation of AMPK results in the general inhibition of ATP-consuming (anabolic) pro-
cesses, including protein synthesis, and the activation of ATP-generating (catabolic) 
processes. AMPK has already been described as an antiviral sensor [258]. In our CHIKV 
infection experiment, phosphorylation on S108 of the beta subunit of the AMPK com-
plex (PRKAB1) was significantly increased at 8 and 12 h p.i. (log2 ratio 0.95 and 0.69) 
and phosphorylation on this residue is known to stimulate AMPK activity [259]. Other 
phosphorylation sites were not identified for this complex. Despite the likely increase 
in AMPK activity during alphavirus infection, our data indicate that phosphorylation of 
eEF2 during alphavirus infection is not mediated via AMPK activation alone. Inhibition of 
AMPK with dorsomorphin, an AMPK inhibitor even resulted in a small increase in phos-
phorylation during SFV infection and had no effect on translation of viral capsid protein. 
It has been shown that eEF2 becomes phosphorylated during RVFV infection, a –ssRNA 
virus of the bunyavirus family. In this study phosphorylation on eEF2 still occurred in 
AMPK knockout cells and was thus also independent of AMPK activation [235], although 
at this point we cannot prove that the mechanism of phosphorylation induction in these 
diverse viruses is triggered by the same stimulus. 
Intracellular cyclic AMP (cAMP) is sensed by PKA. An increase in cAMP during alphavi-
rus infection could result in increased activation of eEF2K. Inhibition of PKA with KT5720 
resulted in a small decrease in eEF2 phosphorylation during SFV infection but if PKA is 
involved in triggering the increase in eEF2 phosphorylation it is most likely not the only 
pathway that is involved since inhibition of PKA should then have resulted in a stronger 
inhibition of phosphorylation. 
The amino acid availability is rate-limiting in protein synthesis. mTORC1 functions as 
a nutrient sensor and its promotion of translation is directed by the intracellular amino 
acid supply [260]. mTORC1 inhibition due to a decrease in intracellular L-leucine levels 
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could result in an increase in phosphorylation of eEF2 [261]. However, stimulation of 
mTORC1 with L-leucine did not prevent phosphorylation of eEF2 during SFV infection. 
The highest concentrations even resulted in a small increase in phosphorylation and in-
hibited SFV as the amount of capsid that was produced during infection was decreased. 
The preliminary compound studies suggest that the pathways that were tested so 
far do not appear to be involved in inducing eEF2 phosphorylation during alphavirus 
infection. The very early triggering of eEF2 phosphorylation may also argue against an 
energy sensor as the initiator because the level of replication and translation of viral 
genomes is not yet so high after 2 h p.i. that it is expected to deplete nutrient pools. The 
small effect that inhibition of PKA with KT5720 had on eEF2 phosphorylation suggests 
that this pathway may enhance the stimulation later during infection, when energy 
resources do become exhausted by massive replication and translation of viral RNAs, 
but that the initial trigger is another stimulus. Additional studies which include more 
controls are required because at this point we cannot prove that the compounds truly 
inhibited or activated the pathways that they were supposed to target in our experi-
ments. The inclusion of known inducers of eEF2 phosphorylation through these path-
ways, out of the context of alphavirus infection, should help us to determine whether 
inhibition was truly successful. We have not yet tested all the pathways that could be 
responsible for eEF2 phosphorylation as it is also possible that one of the MAP kinase 
pathways is involved, but this requires additional studies. Our data suggests that activa-
tion of MAPK1 and MAPK3 is probably minimal during CHIKV infection. Phosphorylation 
of Y187 on MAPK1 and Y204 on MAPK3 increased significantly during CHIKV infection, 
but phosphorylation of T185 on MAPK1decreased and the status of T202 on MAPK3 
did not change. Phosphorylation on both residues is required for full activation of the 
kinases [262]. 
No involvement of structural proteins 
The alphavirus 6k protein is cotranslationally translocated across the ER membrane 
and has been reported to trigger depletion of reticular calcium stores, resulting in an 
increase in cytosolic Ca2+ levels [263]. Since eEF2K activity is Ca2+/Calmodulin depen-
dent this led us to hypothesize that expression of 6k during alphavirus infection causes 
an increase in cytosolic calcium levels which results in eEF2K activation to slow down 
translation. However, transfection of a replicon that lacks all structural proteins into 
BHK-21 cells still induced high levels of eEF2 phosphorylation, so none of the structural 
proteins is responsible for triggering eEF2 phosphorylation. The early induction of eEF2 
phosphorylation also argues against the involvement of 6k, since at 2 h p.i. the abun-
dance of viral proteins in the cells is still very low and most likely not enough to cause 
massive depletion of calcium stores.
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other mechanisms that could trigger eEf2 phosphorylation
The transfection of viral RNA into cells circumvents clathrin-mediated endocytosis. 
Since the transfected replicon RNA was still able to induce strong eEF2 phosphoryla-
tion, it is not likely that one of the steps during CHIKV entry is responsible for triggering 
phosphorylation. Perhaps RNA structures in the viral genome are sensed in the cytosol 
and this triggers an innate immune response that slows down protein synthesis. Inhibi-
tion of CHIKV replication by pretreatment with 5’pppRNA of cells prior to infection also 
prevented the induction of eEF2 phosphorylation suggesting that the presence of a 
certain level of e.g. viral RNA or protein is required before phosphorylation is induced. In 
different cell lines infected with CHIKV, infection does not progress at the same rate. In 
Vero E6 cells, in which viral proteins could be detected with WB by 4 h p.i., the induction 
of phosphorylation could also be observed at that time point. In MRC-5 cells, in which 
infection progresses slower, viral proteins could not be detected until 8 h p.i. while only 
a small amount of phosphorylated eEF2 could be detected at 6 h p.i. This also suggests 
that a certain level of e.g. viral RNA or protein has to be reached before the induction of 
phosphorylation is fully triggered. 
It was recently reported that eEF2 is required for the Gag-mediated block of stress 
granule assembly during HIV-1 infection [264]. Although this paper suggests that eEF2 
phosphorylation might decrease during HIV-1 infection, this stress granule connection 
might be interesting to explore for CHIKV as well since CHIKV also exhibits complex 
interactions with stress granules and some of their components, such as the G3BPs [65]. 
An increase of cytosolic Ca2+ early during alphavirus infection could trigger activa-
tion of eEF2K, but there is conflicting evidence as to whether alphaviruses induce an 
increase in cytosolic calcium levels during infection [265, 266]. 
eEf2 abundance does not change during alphavirus infection
Other groups have reported a decrease in eEF2 abundance during CHIKV infection [111, 
112, 119]. However, in our previous proteomics study the abundance of eEF2 did not 
change [208] and we have not been able to reproduce this finding in our WB analysis 
at the time points that we studied either. In the other studies, samples were analyzed 
at much later time points in infection (24 h p.i. or later) than we used and eEF2 might 
be degraded during this stage of infection. This might not be an eEF2-specific property, 
however, since alphaviruses induce a host translational shut-off [100]. Two of the studies 
that quantified a decrease in eEF2 levels used 2D-DIGE and most likely the large increase 
of phosphorylated eEF2 during CHIKV infection significantly decreased the amount 
of eEF2 in the spot containing the unmodified form of eEF2, which could explain the 
observed decrease in abundance in these studies [112, 119]. 
It has been shown that ribosomes and eEF2 co-localize with aggregation sites of the 
C protein during SINV infection [267]. eEF2 was also identified as one of the interaction 
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partners of SINV nsP3 during infection with a nsP3-GFP expressing SINV mutant [94]. In 
these studies the phosphorylation status of eEF2 was not determined, but it would be 
interesting to determine whether these interactions occur with the modified or unmodi-
fied form of eEF2. 
CoNCLusioN
In our previous proteomics analysis of CHIKV-infected cells, there were only minimal 
changes in protein abundance and most of the proteins that did show a significantly 
changed abundance were downregulated [208]. The current study shows that more and 
larger changes occur on the level of phosphorylation and that both increased phos-
phorylation and dephosphorylation can be observed. Our data suggest that, at least 
for alphaviruses, cellular responses to viral infection may mainly occur on the level of 
PTMs and it would certainly be interesting to study other PTMs in this context. However, 
it continues to be important to analyze changes in total protein abundance as well, 
since a two-fold change in protein abundance can also result in a two-fold change in 
phosphorylation status, which would falsely indicate that the phosphorylation status is 
regulated while it is in fact the protein abundance. 
Our study revealed that early during infection with several alphaviruses and a 
picornavirus, eEF2 becomes phosphorylated. The phosphorylation status of sites of 
other proteins involved in translation also changed significantly during CHIKV infec-
tion and possibly also contribute to translation inhibition. The phosphorylation of 
eEF2 is unfavorable for CHIKV replication as a reduction in the eEF2 levels resulted in 
a decreased expression of CHIKV proteins. The trigger for eEF2 phosphorylation during 
CHIKV infection is not yet known, but it does not appear to be mediated through one of 
the energy-sensing pathways, RIG-I signaling, alphavirus structural proteins or the viral 
entry process. We hypothesize that the increase in eEF2 phosphorylation is triggered by 
a special/unique feature of the viral genome (e.g. RNA structure) or by the translation 
or transcription of (alpha)virus RNA as a novel antiviral/stress response that slows down 
translation. 
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supporting information Table s1: Complete list of identified phosphorylation sites, the first sheet con-
tains all sites identified in host proteins, the second sheet contains the sites identified in CHIKV proteins. In 
case this research has not yet been published this table can be requested from the author. 
supporting information Table s3: Go terms that the list with unique phosphoproteins that contained 
phosphorylation sites that were significantly modulated during ChiKv infection was enriched for. 
Go_id molecular 
function
Term NumberofGenes p-value p-value_fdr p-value_
bonferroni
GO:0044822 poly(A) RNA binding 42 2.81E-24 1.11E-20 1.11E-20
GO:0003723 RNA binding 44 3.76E-23 7.4E-20 1.48E-19
GO:0003779 actin binding 12 1.97E-07 0.000258 0.000775
GO:0003676 nucleic acid binding 39 2.66E-07 0.000262 0.00105
GO:0005515 protein binding 76 5.75E-07 0.000452 0.00226
GO:0008092 cytoskeletal protein binding 15 2.62E-06 0.00172 0.0103
Go_id biological 
processes
Term NumberofGenes p-value p-value_fdr p-value_
bonferroni
GO:0046907 intracellular transport 23 5.70E-08 7.66E-04 7.66E-04
GO:0051641 cellular localization 28 5.11E-07 2.81E-03 6.88E-03
GO:0051649 establishment of localization in cell 25 6.90E-07 2.81E-03 9.29E-03
GO:0007010 cytoskeleton organization 16 8.84E-07 2.81E-03 1.19E-02
GO:0071840 cellular component organization or 
biogenesis
45 1.04E-06 2.81E-03 1.40E-02
GO:0008380 RNA splicing 11 1.44E-06 3.23E-03 1.94E-02
GO:0007167 enzyme linked receptor protein 
signaling pathway
17 2.02E-06 3.63E-03 2.71E-02
GO:0033036 macromolecule localization 26 2.16E-06 3.63E-03 2.90E-02
GO:0006996 organelle organization 31 3.49E-06 4.93E-03 4.70E-02
GO:0016043 cellular component organization 43 3.70E-06 4.93E-03 4.98E-02
Go_id Cellular 
Component
Term NumberofGenes p-value p-value_fdr p-value_
bonferroni
GO:0005925 focal adhesion 27 4.95E-23 3.75E-20 7.84E-20
GO:0005924 cell-substrate adherens junction 27 7.09E-23 3.75E-20 1.12E-19
supporting information Table s2: Lists with phosphorylation sites that were significantly modulated dur-
ing CHIKV infection. Each time point is put in a separate sheet. In case this research has not yet been pub-
lished this table can be requested from the author.
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supporting information Table s3 (continued)
Go_id Cellular 
Component
Term NumberofGenes p-value p-value_fdr p-value_
bonferroni
GO:0030055 cell-substrate junction 27 7.09E-23 3.75E-20 1.12E-19
GO:0005912 adherens junction 27 2.40E-21 9.49E-19 3.80E-18
GO:0070161 anchoring junction 27 6.31E-21 2.00E-18 9.99E-18
GO:0030054 cell junction 31 4.69E-15 1.24E-12 7.42E-12
GO:0015629 actin cytoskeleton 17 1.59E-11 3.60E-09 2.52E-08
GO:0044422 organelle part 68 1.33E-09 2.63E-07 2.11E-06
GO:0044446 intracellular organelle part 67 1.51E-09 2.66E-07 2.39E-06
GO:0043228 non-membrane-bounded organelle 42 2.13E-09 3.07E-07 3.38E-06
GO:0043232 intracellular non-membrane-
bounded organelle
42 2.13E-09 3.07E-07 3.38E-06
GO:0044428 nuclear part 44 9.81E-09 1.29E-06 1.55E-05
GO:0031988 membrane-bounded vesicle 42 1.72E-08 2.09E-06 2.72E-05
GO:0005829 cytosol 38 4.07E-08 4.60E-06 6.44E-05
GO:0031981 nuclear lumen 40 1.32E-07 1.39E-05 2.09E-04
GO:0043230 extracellular organelle 36 2.26E-07 1.89E-05 3.59E-04
GO:0070062 extracellular exosome 36 2.26E-07 1.89E-05 3.59E-04
GO:0065010 extracellular membrane-bounded 
organelle
36 2.26E-07 1.89E-05 3.59E-04
GO:0031982 vesicle 40 3.47E-07 2.75E-05 5.50E-04
GO:0005856 cytoskeleton 26 4.92E-07 3.71E-05 7.80E-04
GO:0032991 macromolecular complex 43 5.22E-07 3.76E-05 8.26E-04
GO:0005654 nucleoplasm 35 5.80E-07 3.99E-05 9.18E-04
GO:0005634 nucleus 56 7.48E-07 4.94E-05 1.18E-03
GO:0042641 actomyosin 6 1.31E-06 8.28E-05 2.07E-03
GO:0070013 intracellular organelle lumen 42 1.72E-06 1.05E-04 2.73E-03
GO:0043233 organelle lumen 42 2.54E-06 1.49E-04 4.03E-03
GO:0031974 membrane-enclosed lumen 42 3.55E-06 2.01E-04 5.63E-03
GO:0043227 membrane-bounded organelle 76 3.91E-06 2.14E-04 6.19E-03
GO:0044421 extracellular region part 38 4.85E-06 2.56E-04 7.69E-03
GO:0043234 protein complex 37 7.66E-06 3.92E-04 1.21E-02
GO:0005911 cell-cell junction 10 1.34E-05 6.63E-04 2.12E-02
GO:0016020 membrane 59 2.24E-05 1.08E-03 3.55E-02
GO:0005737 cytoplasm 68 2.55E-05 1.19E-03 4.05E-02




supporting information figure s1: sTRiNG network with medium confidence of the 113 phospho-
proteins that contained phosphorylation sites that were significantly modified during ChiKv infec-
tion. The dataset was enriched for protein-protein interactions with a p-value of 2.22e-16
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Chapter 2 and 3 of this thesis described two quantitative proteomics studies of CHIKV-
infected cells. In chapter 2 the changes in host protein abundance following CHIKV infec-
tion were determined, while chapter 3 identified proteins of which the phosphorylation 
status changed during infection. This chapter summarizes these findings, places them in 
a broader context and discusses the reproducibility of proteomics studies. 
Changes in protein abundance and phosphorylation status during ChiKv 
infection
As described in chapter 2, the changes in protein abundance in CHIKV-infected cells 
during the course of infection were rather limited, especially prior to the onset of host 
translational shut-off. Not only the number of proteins showing a significantly changed 
abundance was limited, but also the extent of change was quite small (<2 fold) for 
most proteins. Despite the lack of stronger effects, this study yielded interesting results. 
The majority of the proteins for which a significant change was observed showed a 
decreasing abundance after CHIKV infection (figure 1, chapter 2). For many proteins 
this decrease was probably the result of their normal turn-over, i.e. natural degradation 
in the absence of translation due to the virus-induced host shut-off that starts around 
8 h p.i. However, certain proteins are most likely specifically targeted by the virus for 
degradation. The best example is the RNA polymerase II (POLR2) complex of which most 
subunits were progressively degraded during CHIKV infection (Table 2, chapter 2). This 
is in line with a previous study that found that the Rpb1 subunit, which is the catalytic 
subunit of the POLR2 complex, is targeted for degradation by nsP2 [63]. The same could 
be true for Rnd3, DDX56 and Plk1, three of the proteins chosen for follow-up research. 
CHIKV replication was reduced in cells overexpressing these proteins, suggesting that 
their presence is not beneficial for the virus (figure 3, chapter 2). The decreasing abun-
dance of these proteins might be explained by the viral manipulation of the intracellular 
environment to create optimal conditions for replication, or could even be part of a 
specific strategy to evade antiviral responses.
Based on the results in chapter 2, one could argue that a proteomics study studying 
only changes in protein abundance may not be the best approach to identify host fac-
tors that respond to viral infection in the case of viruses that kill their host cell relatively 
quickly. During the relatively short course of the infection, the time frame for induction 
of changes in protein abundance is simply not large enough, especially when the virus 
induces a transcriptional and/or translational host shut-off. For viruses that cause a per-
sistent infection, meaning that cells can be monitored over the course of several days, 
this strategy seems a better option [202]. 
The low number of changes observed during CHIKV infection suggested that the cel-
lular response to infection during the first cycle of replication does not affect protein 
abundance. The much more abundant and larger changes that were observed at the 
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level of phosphorylation status, described in chapter 3, proved this assumption to be 
correct. Several phosphorylation sites showed large (>4 fold) increases or decreases 
in phosphorylation during CHIKV infection, especially at 8 and 12 h p.i. Phosphoryla-
tion on one site, T56 on eEF2, even increased >50 fold at 8 and 12 h p.i., and already 
showed a significant increase in phosphorylation at 2 h p.i. Therefore, the role of eEF2 
in the infection with CHIKV and other viruses was studied in more detail. At this point 
it remains unknown what the trigger is for the induction of eEF2 phosphorylation dur-
ing alphavirus infection. However, it does not appear to rely on pathogen-associated 
molecular pattern (PAMP) recognition (figure 5, chapter 3) or energy sensing pathways 
(figure 4, chapter 3), although additional studies are required to completely exclude 
their involvement. The presence of the viral structural proteins is not required and 
merely the presence of a small amount of viral (uncapped) RNA is not enough to induce 
phosphorylation (figure 6, chapter 3). Perhaps the RNA structures in the viral UTRs are 
sensed. The reduction of available eEF2 appears to restrict alphavirus replication since 
siRNA-mediated knockdown of eEF2 reduced translation of viral proteins, although this 
was a minor effect. 
The induction of eEF2 phosphorylation slows down translation, which is unfavorable 
for a replicating virus, and this might be a general antiviral response. However, while this 
strong induction of eEF2 phosphorylation in response to infection was also observed 
with two other alphaviruses and a picornavirus (figure 2b and C, chapter 3), and was 
previously reported to occur during infection with rift valley fever virus (RVFV), a –RNA 
virus from the bunyavirus family [235], two other viruses, equine arteritis virus (EAV), 
a +RNA virus from the arterivirus family and human adenovirus, a dsDNA virus, did 
not induce a measurable increase in eEF2 phosphorylation (figure 2d, chapter 3). It 
will be interesting to determine whether viruses from other families also induce eEF2 
phosphorylation as this may help to determine what the trigger is. The large increase 
in phosphorylation of eEF2 residue T56 upon alphavirus infection is induced early, as a 
1.6-fold increase could already be observed as early as 2 h p.i. in CHIKV-infected MRC-5 
cells in the proteomics analysis. This relatively small increase proved to be relevant since 
phosphorylation levels strongly increased as infection progressed. The western blot 
analysis was not equally sensitive as phosphorylated eEF2 could only be detected at 6 h 
p.i. in these cells (figure 2A, chapter 3). This is an important caveat, since western blot 
analysis is often used to confirm mass spectrometry findings. However, in case of a phos-
phorylation site with a low occupancy at the start of the experiment, a relatively small 
increase in phosphorylation may be hard to detect with phospho-specific antibodies. It 
proved helpful to analyze different time points as the 2 h p.i. mass spectrometry analysis 
indicated that the induction of eEF2 phosphorylation started several hours prior to what 
we would have been able to determine from the WB analysis. 
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The use of quantitative proteomics approaches to study virus-host interactions
Quantitative proteomics is used for different purposes in the study of virus-host interac-
tions [124]. It is often applied to study global changes during virus infection, either at 
a single time point or in a time course similar to what is described in this thesis. Some 
studies involve the overexpression of viral proteins, out of the context of a viral infec-
tion, to determine their impact on cellular protein expression [268, 269]. Proteomics 
studies have also been applied to study the recruitment or depletion of host proteins to/
in certain organelles during viral infection [93, 270-272]. The use of e.g. SILAC can help to 
filter out non-specific interactors when proteomics is used to identify novel interaction 
partners of viral proteins [273-275]. 
Of the proteomics studies on CHIKV-infected cells that are described in this thesis, the 
phosphoproteomics analysis (chapter 3) offers a different view into molecular events at 
the protein level during infection than the analysis of protein abundance (chapter 2). 
However, the findings from the study described in chapter 2 exclude that the observed 
changes in phosphorylation status in chapter 3 merely resulted from changes in protein 
abundance. The major advances in post-translational modification (PTM) enrichment 
methods, mass spectrometer sensitivity and more powerful software tools [276] will 
probably lead to an increase in studies on proteome-wide changes in PTMs during 
viral infection. So far, the number of proteome-wide studies that analyzed changes in 
PTM abundance on host proteins during viral infection is still limited. Only four other 
studies in which phosphorylation sites were quantified during viral infection have been 
published so far. The signaling events induced during human immunodeficiency virus 
(HIV)-1 entry of CD 4+ cells were studied by quantifying phosphorylation sites 1 min 
p.i. This revealed that abundance of 239 phosphorylation sites out of 1757 quanti-
fied sites already changed significantly upon binding of HIV-1 to the cell surface and 
possibly already modulates the cell to facilitate steps later in the life cycle [239]. For 
influenza A virus, 366 phosphorylation sites on cellular proteins were identified by 24 h 
p.i., with phosphorylation on 43 and 35 phosphoproteins being up- or downregulated, 
respectively, but the majority of these sites changed less than 2-fold [237]. Porcine 
reproductive and respiratory syndrome virus (PRRSV) WUH3-infected porcine alveolar 
macrophages (PAMs) were analyzed and of 2125 identified phosphorylation sites, 292 
and 373 sites had a significantly changed abundance at 12 and 36 h p.i., respectively. 
Most of these sites showed increased levels of phosphorylation [236]. Analysis of sendai 
virus (SeV) infected A549 cells resulted in the identification of 3947 phosphorylation 
sites, which revealed that mTOR signaling is needed for the host IFN response and viral 
protein synthesis during SeV infection [238].
Other modifications, such as ubiquitination and lysine acetylation, would also be 
interesting to study in the context of viral infection. Several virus families encode a 
deubiquitinating enzyme (DUB) that may serve to suppress the host innate immune 
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response [167, 277-279] and quantitative proteomics could be used to find out whether 
specific host cell proteins are targeted by these DUBs. For lysine acetylation it has already 
been shown that during borna disease virus (BDV) infection the cellular histone lysine 
acetylation levels are affected and such changes might also occur during infections with 
other viruses [280]. 
It will most likely also become more common to study multiple modifications at the 
same time, as it is becoming increasingly clear that there is cross-talk between different 
modifications that can modulate protein function. A certain PTM can, for example, signal 
the addition or removal of a modification on another residue or it could mask the recog-
nition site of a second PTM [146, 148, 281, 282]. One has to keep in mind, however, that 
it is not only important to make an inventory of PTM changes on proteins, but that for 
understanding their biological relevance it is also crucial to determine the exact func-
tion that a certain PTM or a combination of PTMs has on its activity. Only for a very small 
subset of the experimentally observed modifications [283] it is currently known what 
their function is, which hinders interpretation of study results. There are also limitations 
at the level of the currently available bioinformatics tools. For example, for pathway 
analyses it is currently only possible to use protein or gene names as input, while for 
the study of PTMs more specific output might be obtained if the modified site could be 
included, since modifications often determines the protein’s activity and function. 
Reproducibility of quantitative proteomics studies
During the past decade, hundreds of studies that used proteomics to study viruses were 
published. Remarkably, when the different quantitative proteomics studies of CHIKV-
infected cells or organisms are compared, there is little overlap between the datasets 
obtained in different labs (chapter 2) [111-114, 116, 119, 120, 208, 284]. Also for other 
viruses, such as influenza virus A H1N1 [285-287] or HIV-1 [288, 289], there is limited 
overlap in the lists of host proteins with significantly changed abundance when differ-
ent studies are compared. Sometimes proteins are even identified as upregulated in 
one study and downregulated in another. This lack of reproducibility is not unique to 
proteomics studies as it is also seen with e.g. RNA interference screens [290-292]. The 
reasons for the limited reproducibility of this type of experiments are explored below. 
One of the most important reasons for the limited overlap between various studies 
probably are the large differences in experimental set-up. Different cell lines and host 
organisms are used, which may obviously differ in their response to infection (or other 
stresses and stimuli), including, but not limited to, their ability to mount innate immune 
responses upon infection. Different virus isolates are used at different MOIs, which 
influences the dynamics of infection, especially when not every cell becomes infected 
at the same time. This might for example lead to secondary effects like the responses 
of non-infected cells to cytokines produced by infected neighboring cells. The timing 
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of sampling also greatly affects whether a certain protein is identified as displaying 
significantly changed abundance, e.g. it might be upregulated 10 h p.i. but not yet after 
6 h p.i. and no longer after 20 h p.i. Especially for PTMs, timing will most likely be crucial 
for many proteins since e.g. phosphorylation usually is a transient event and dephos-
phorylation can also occur within minutes [158]. The differences in the experimental 
set-up between the various CHIKV studies almost certainly contributed to the limited 
overlap that was found. For example, the three infected cell culture-based studies each 
used a different cell line and CHIKV strain. The MOI was either 0.1, 2.5 or 5 and cells were 
harvested within a day (8, 10 and 12 h p.i.), 24 h p.i. or 48 h p.i. [111, 119, 208]. For viruses 
such as CHIKV that induce a host transcriptional and translational shut-off, sampling late 
in infection almost certainly results in the identification of false positive hits, especially 
when the normal half-life of host proteins is not considered (quick non-specific decrease 
of proteins with a rapid turnover) (figure s2, chapter 2). 
Another aspect that has a serious impact on reproducibility is how many peptides and 
proteins were identified by mass spectrometry in a given experiment. This number is 
influenced by many factors. The instrument used for data acquisition already influences 
how many peptides are identified in a sample [293]. The proteomics method used also in-
fluences which proteins are identified [294, 295]. For example, with 2D-DIGE approaches 
usually a lower number of proteins is identified than when SILAC, iTRAQ or label-free 
methods are used. In 2D-DIGE studies often only the spots that clearly show a change 
in abundance are chosen for mass spectrometry analysis and as a result these studies 
do not provide any information about proteins that were present in the infected cell but 
did not change abundance or PTM statuswhich can make it difficult to confirm a finding 
from another study. For CHIKV, the best example of this problem is the study by Fraisier 
et al. which analyzed the same sample using 2D-DIGE and iTRAQ. In this study only a few 
proteins of the same sample were identified by both methods, which is likely due to the 
fact that only 32 protein spots were analyzed in the 2D-DIGE experiment [114]. Several 
of the CHIKV studies quantified less than 600 proteins [112, 113, 116, 119], which makes 
it less likely that common proteins with significantly changed abundance are identified, 
especially since most proteins do not show very large changes in abundance during 
CHIKV infection. The reproducibility of PTM analyses will be hampered even more by 
the identification of a limited number of peptides in a study, since PTM identification 
often depends on the detection of a single peptide while a protein is usually identified 
by multiple peptides. 
The apparent discrepancies between datasets can also be due to differences in analy-
sis methods, software and databases used. Analysis of the same raw data files with a 
different software package or using a different protein database can already result in 
differences in protein identifications, which also affects quantification [293, 294]. The 
method of quantification also determines how accurate peptide and protein ratios are. 
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In general, metabolic labeling methods such as SILAC generate more precise quantifica-
tions than chemical labeling or label-free quantification strategies, since samples are 
combined immediately after harvesting [140, 294-296]. 
Another aspect that strongly affects reproducibility is the method used for determin-
ing which peptides or proteins display significantly changed abundance. A major factor 
in the limited reproducibility most likely is the very large number of false-positive hits 
in many of the published data sets. While it is certainly tempting to have a long list 
of proteins or peptides that show significantly changed abundance, it is important to 
be strict when determining which proteins should be on this list. The cut-off is often 
arbitrary (e.g. >2-fold change), while it depends on how accurate the quantifications 
are whether this cut-off is strict enough [294]. When statistics methods are employed it 
is not always clear whether there was any correction applied for multiple testing, while 
this is certainly necessary when large datasets are analyzed [297]. Sometimes, inappro-
priate strategies are employed, such as the lack of identification of a peptide or protein 
in one of the conditions [120, 238]. In shotgun proteomics, peptide lists from technical 
replicates generally overlap only 35-60% and peptide lists from biological replicates 
even less [293]. When the lack of its identification is used as a measure to determine 
whether the abundance of a protein or peptide has changed significantly, a large degree 
of chance is added to which proteins or peptides end up in the list and will certainly yield 
less reproducible results. The lists with proteins with significantly changed abundance 
from the CHIKV studies probably contain many false positives. For example, in a study 
in which both 2D-DIGE and iTRAQ were used to analyze the same sample, none of the 
proteins in the list from the 2D-DIGE analysis changed abundance more than 2-fold. 
Such changes were most likely not large enough to be also significant with the iTRAQ 
method in case these proteins were also identified in that analysis [114], but this could 
not be confirmed because the authors only included lists with proteins that significantly 
changed abundance in the paper. 
Some issues are specifically related to certain techniques. Since the research described 
in chapter 2 and 3 is based on SILAC, some issues related to this technique are discussed 
in more detail. It was first described in 2003 that the use of arginine for SILAC labeling 
can result in an underestimation of the intensity of proline-containing peptides in the 
heavy-labeled sample because certain cell lines can convert arginine into proline [298]. 
It is simple, and important, to test whether a cell line exhibits this conversion before 
a large scale SILAC experiment is performed. Moreover, the conversion can easily be 
prevented by the addition of unlabeled proline and/or the reduction of the arginine 
concentration in the culture medium [299-301]. Another option is to correct computa-
tionally for this conversion after the mass spectrometry data has been acquired [302], 
but most software platforms used for analyzing proteomics data do not offer this option 
and it is best to avoid the conversion from happening in the first place. Even though 
Chapter 4 91
4
this conversion issue is well known, in many SILAC papers it is unclear whether the au-
thors tested their cell line for this problem prior to using it for experiments or whether 
they took any precautions to prevent it. For example, HeLa cells are known to convert 
arginine into proline [300, 303]. Despite this, there are still SILAC studies published in 
which HeLa cells were used in which, based on the composition of the culture medium, 
it is likely that conversion took place [270, 304, 305]. This may have affected protein 
ratios in these studies and could have made certain findings less reproducible. Another 
issue with SILAC studies is that a label-swap is often omitted, while it has been shown 
that this procedure can solve some experimental errors such as incomplete labeling or 
arginine-to proline conversion that can lead to incorrect identification of proteins with 
significantly changed abundance [306]. In the studies described in chapter 2 and 3 some 
proteins or peptides were, for example, upregulated in the infected sample when this 
sample was labeled with the light amino acids and downregulated with an equally large 
change when the infected sample was labeled with the heavy amino acids. If a label 
swap would not have been performed, these proteins would have ended up in the list of 
proteins with significantly changed abundance, making the results less reproducible by 
increasing the number of false-positive hits. Using a label swap increases accuracy of the 
average ratios of biological replicates and should be standard practice when performing 
SILAC studies. 
It would be very helpful to be able to compare the dataset from one proteomics study 
with those from other relevant studies, for example to determine whether a protein that 
is phosphorylated upon CHIKV infection is also modified in response to infection with 
other pathogens. It is currently rather hard to do so and sometimes it is even difficult 
to determine whether the protein was even identified in other studies. This is, among 
other issues, due to the fact that datasets are often represented in different ways with 
inconsistent annotation. It would be helpful if a standard approach for storing and an-
notating data could be implemented. For some studies only the lists with significantly 
up- and downregulated proteins are provided in the paper, while for a comparison 
between studies it is can also be relevant to know whether a certain protein was identi-
fied but perhaps did not change in abundance or PTM status. None of the other CHIKV 
studies supplied a complete list of identified proteins. For a quick comparison between 
different studies it would be advisable, and most convenient, when such lists of proteins 
or sites would be supplied as supplemental Excel tables, especially when they contain 
several thousands of entries, as these can be easily searched for proteins of interest and 
compared with other datasets. However, it is not uncommon to find them in PDF format. 
Although tables in PDF files can be converted into Excel tables, conversion is not always 
flawless which hinders proper searching and comparison.
Nowadays, proteomics journals usually require authors to deposit the raw and 
supporting data from proteomics studies in public data repositories such as PRIDE to 
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grant other scientists easy access [203]. For older studies or studies published in non-
proteomics journals this is usually not the case and as a result it is not possible to find 
datasets for most of these studies. For the CHIKV proteomics studies, only one other 
paper mentions depositing the data with PRIDE [114]. Re-analyzing data from another 
lab using the same, database, search engine and statistics methods can remove some of 
the aspects that cause variability between different studies. 
Conclusion 
Quantitative proteomics can aid in the identification of proteins and pathways that were 
previously not associated with viral infection due to the hypothesis-generating nature 
of the technique. Nevertheless, after its identification, it can be a challenge to determine 
the exact function a certain host protein exerts during the viral replication cycle. The 
increasing number of studies from different labs studying the same virus shows that it 
remains important to scrutinize the results as many factors can influence reproducibility. 
Overall, quantitative proteomics, and quantitative phosphoproteomics in particular, 
remain valuable tools for the analysis of virus-host interactions and will most likely be 
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CANoNiCAL TRANsLATioN iN EuKARYoTEs
Ribosomes convert messenger RNA (mRNA) nucleotide sequences into protein amino 
acid sequences; this process is called translation. Eukaryotic translation is a complex 
process that is highly regulated and involves many different factors. It can be subdivided 
into three phases; initiation, elongation and termination/ribosome recycling [307-311]. 
Translation initiation
The first step in translation initiation is the formation of a ternary complex (TC) that 
consists of initiator methionyl-transfer RNA (met-tRNAi) and the GTP-bound form of 
eukaryotic initiation factor 2 (eIF2). The TC assembles with the small (40S) ribosomal 
subunit and eIF1, 1A, 3 and 5 to form the 43S preinitiation complex (PIC). Initiation fac-
tors eIF4B, 4H and 4F (consisting of 4A, 4E and 4G) bind the 5’ end of the mRNA that in 
eukaryotes contains a 7-methylguanosine (m7G) cap [309, 312]. Eukaryotic translation is 
dependent on this 5’ cap [313]. The 3’ end of the mRNA is bound by the poly(A)-binding 
protein (PAPB). The 5’ and 3’ ends of the mRNA are brought together through the inter-
action of eIF4G with both eIF4E and PAPB, resulting in a circular activated messenger 
ribonucleoprotein (mRNP). The PIC is then recruited to the activated mRNP at the 5’ end 
of the mRNA [309, 312]. After the PIC has been loaded onto the 5’ end, it starts to scan 
the mRNA in a linear base-by-base fashion until it encounters a start codon in a favorable 
sequence context (Kozak consensus sequence). In eukaryotes the start codon generally 
is AUG, although there are some exceptions to this rule [313]. Recognition of the start 
codon halts mRNA scanning by the PIC. The start codon is recognized through base-
pairing between the anticodon of Met-RNAi and the AUG codon in the peptidyl-tRNA 
(P)-site of the 40S subunit. This results in the dissociation of eIF1 from the ribosome 
which triggers full accommodation of the tRNA in the P-site [314] and conversion of eIF2 
to its GDP-bound state [315]. Release of GDP-bound eIF2 and most other initiation fac-
tors from the PIC and binding of GTP-bound eIF5B to the complex facilitate large (60S) 
subunit joining to form the 80S initiation complex (IC), after which eIF5B hydrolyzes 
and dissociates. The last subunit to leave the IC is eIF1A, although eIF3 possibly remains 
associated with the ribosome during elongation [309, 312]. A schematic representation 
of the translation initiation phase is depicted in Figure 1.
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figure 1: Translation initiation phase. A ternary complex (TC) consisting of initiator methionyl-transfer 
RNA (met-tRNA) and the GTP-bound form of eIF2 is formed. The TC assembles with the small (40S) ribo-
somal subunit and eIF1, 1A, 3 and 5 to form the 43S preinitiation complex (PIC). Initiation factors eIF4B, 4H 
and 4F (consisting of 4A, 4E and 4G) bind the 5’ end of a 7-methylguanosine capped mRNA. The 3’ end of 
the mRNA is bound by the poly(A)-binding protein (PABP) and the 3’ and 5’ ends of the mRNA are brought 
together, resulting in a circular activated messenger ribonucleoprotein (mRNP). The PIC is recruited to the 
activated mRNP at the 5’ end of the RNA and starts to scan until it encounters an AUG start codon. Start 
codon recognition halts mRNA scanning by the PIC. The start codon is recognized through base-pairing 
between the anticodon of the Met-tRNAi and the AUG codon in the ribosomal P-site. This results in dissocia-
tion of eIF1 and conversion of eIF2 to its GDP-bound state. Most of the initiation factors dissociate from the 
ribosome and GTP-bound eIF5B binds. The 60S ribosomal subunit joins to form the 80S initiation complex 
(IC) which results in eIF5B hydrolysis and dissociation. eIF1A is the last subunit to leave the IC, although it is 
possible that eIF3 remains associated during the elongation phase. 
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figure 2: Translation elongation phase. At the start of the elongation phase the 80S ribosome is posi-
tioned on the mRNA with the Met-tRNAi paired to the start condon in the P-site. The A-site contains the 
second codon of the ORF. Amino-acyl tRNAs are bound by eEF1A in a GTP-dependent manner and directed 
to the A-site. tRNA recognition results in GTP hydrolysis which releases the elongation factor. Peptide bond 
formation with the peptidyl-tRNA in the P-site occurs fast. Translocation to the E- and P-site requires bind-
ing of eEF2 and GTP. Conformation changes in eEF2 and Pi release following GTP hydrolysis allow move-
ment of tRNA and mRNA. eEF2 is released from the ribosome and the A-site becomes available for the next 
aminoacyl-tRNA. 
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figure 3: Translation termination/ribosome recycling phase. When one of the stop codons enters the 
ribosomal A-site, a ternary complex of eRF1 and eRF3 with GTP binds. GTP hydrolysis by eRF3 causes eRF1 
to trigger hydrolysis of the polypeptidyl-tRNA in the peptidyl transferase site (PTC) which releases the na-
scent polypeptide. The 80S ribosome remains associated with the mRNA, the deacetylated tRNAs and eRF1. 
ABCE1 binds the complex with promotes 60S subunit dissociation. Release of tRNA and 40S subunit is medi-




The ribosome has three tRNA binding sites, the acceptor (A)-site for aminoacyl-tRNA, 
the P-site for peptidyl-tRNA and the exit (E)-site for deacylated tRNA [316]. At the start of 
elongation, the 80S ribosome is positioned on the mRNA with the Met-tRNAi anticodon 
base-paired to the start codon in the P-site. The A-site contains the second codon of 
the ORF. Amino-acyl tRNAs are bound by eukaryotic elongation factor 1A (eEF1A) in 
a GTP-dependent fashion and are directed to the A-site of the ribosome. tRNA codon 
recognition results in GTP hydrolysis by eEF1A, which releases the elongation factor and 
enables accommodation of the amino-acyl tRNA into the A-site [307, 308]. Peptide bond 
formation with the peptidyl-tRNA in the P-site occurs fast as the peptidyl transferase 
center (PTC) in the large ribosomal subunit positions the substrates for catalysis [317]. 
After peptide bond formation the two ribosomal subunits rotate so that the acceptor 
ends of the tRNAs are placed in the E- and P-sites while the anticodon loops remain in 
the P- and A-sites [318]. Translocation to the E and P-sites requires binding of eEF2 (a 
GTPase) and GTP. Conformational changes in eEF2 and Pi release following GTP hydroly-
sis allow movement of tRNA and mRNA and locks the subunits in the posttranslocation 
state [240]. eEF2 is released from the ribosome and the A-site becomes available for 
binding of the next aminoacyl-tRNA [308]. A schematic representation of the translation 
elongation phase is depicted in Figure 2.
Translation termination/ribosome recycling
Termination of translation requires two release factors (RFs), eRF1 and eRF3, that form a 
ternary complex with GTP [319]. When one of the stop codons (UGA, UAG, UAA) enters 
the ribosomal A-site this complex binds, with eRF1 being responsible for codon recogni-
tion [320]. GTP hydrolysis by eRF3 causes eRF1 to trigger hydrolysis of the polypeptidyl-
tRNA in the PTC which results in release of the nascent polypeptide [311]. After release 
of the protein product, the 80S ribosome remains associated with the mRNA, the deacyl-
ated tRNA and eRF1. The ribosome dissociates into a free 60S subunit and a 40S subunit 
that is still associated with the mRNA and tRNA, a process promoted by the ATP-binding 
cassette protein ABCE1 [321]. Release of tRNA and mRNA from the 40S subunit can be 
mediated by eIF1A, eIF1 and eIF3 with its loosely associated eIF3j subunit. 40S subunits 
bound to eIF1A, eIF1 and eIF3 are reused to initiate translation [310, 311]. A schematic 
representation of the translation termination/ribosome recycling phase is depicted in 
Figure 3.
Non-canonical translation of RNA virus genomes 
Viruses do not encode their own ribosomes and, therefore, for their protein synthesis 
all viruses are completely dependent on the translational machinery of the host cell. 
Especially for RNA viruses, this poses a challenge since their genomes are usually short 
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and often consist of a single strand of RNA from which all replicative, accessory and 
structural proteins need to be expressed. Additionally, many RNA viruses replicate in the 
cytoplasm and as a result do not have access to cellular systems for mRNA capping and 
polyadenylation that reside in the nucleus. Some viruses solve this problem by encod-
ing their own capping enzymes or by snatching caps from cellular mRNAs [322]. Other 
viruses have evolved non-canonical translation strategies to circumvent the limitations 
of canonical 5’-end dependent eukaryotic translation, which allows synthesis of just a 
single protein from a single mRNA. Many +RNA viruses even employ more than one of 
these mechanisms to expand the possibilities for gene expression from their compact 
genomes [323-325]. The non-canonical translation strategies that are discussed below 
are depicted schematically in Figure 4. 
AAAAAAAAm7G AUG UAGcanonical translation
internal ribosomal entry site AAAAAAAAAUG UAGAUG
leaky scanning AAAAAAAAm7G AUG UAG
AUG UAG
non AUG initiation AAAAAAAAm7G AUG UAGCUG
ribosome shunting AAAAAAAAm7G AUG UAG AUG UAG
reinitiation AAAAAAAAm7G AUG UAG AUG UAG
stopcodon readthrough AAAAAAAAm7G AUG UAGUAG
stop-carry on AAAAAAAAm7G AUG UAG
ribosomal frameshifting AAAAAAAAm7G AUG UAG
figure 4: Non-canonical translation mechanisms. Eukaryotic canonical translation is shown at the top. 
ORFs are indicated as grey bars on the mRNA. The darker grey indicates the main route taken by translating 
ribosomes. Arrows at the start of the ORF indicate ribosome translation initiation. Horizontal arrows indi-




Several +RNA virus groups employ cap-independent translation via an internal ribo-
somal entry site (IRES). An RNA structure, usually located in the 5’-untranslated region 
(UTR) of the genome, replaces the cap and, depending on the type of IRES, some or all 
of the initiation factors [326], and serves as a binding site for ribosomes. Some viruses 
can initiate translation at multiple AUGs in the same or different reading frames from 
one IRES [327, 328]. Other viruses express two polyproteins from separate IRESes [329]. 
Leaky Scanning
In principle, ribosomes scan mRNAs in a linear fashion, starting at the 5’ end and initiat-
ing translation at the first AUG start codon they encounter. However, when the context 
for recognition of that AUG start codon is not optimal (GCCRCCaugG, R is A or G, -3 R and 
+4 G are most important for efficient initiation) ribosomes can continue scanning and 
initiate translation at a downstream AUG instead. If the upstream AUG occurs in a very 
weak context nearly all ribosomes will continue scanning, if it is only somewhat subop-
timal most ribosomes will initiate translation [330]. Leaky scanning is widely employed 
by viruses and allows the translation of two proteins from a single mRNA in the same or 
a different reading frame [323]. 
Initiation at non-AUG codons
In a strong context, near-cognate codons, such as CUG and ACG, can be recognized 
by the Met-tRNAi to initiate translation. Non-AUG initiation is often inefficient and, as 
a result, frequently occurs in combination with leaky scanning [330]. In viruses these 
combined mechanisms can enable the expression of 3 or 4 different proteins from a 
single strand of RNA [323]. 
Ribosome shunting
Ribosome shunting allows ribosomes to translate downstream ORFs in a 5’ cap-
dependent manner. The RNA usually contains a first short ORF followed by a stem-loop 
structure and a downstream main ORF. Translation of the first ORF is initiated at the start 
codon and terminates just before the stem-loop. It is thought that the small subunit of 
the ribosome retains certain initiation factors during translation of the first ORF. Ribo-
somes are then capable of bypassing the stem-loop and resume scanning at the landing 
site 3’ of the stem-loop [311, 331]. 
Reinitiation
Certain initiation factors (most likely eIF3 and eIF4G) remain briefly associated with the 
40S ribosomal subunit after joining of the 40S and 60S subunits. If translation of a short 
ORF is terminated before these factors are released, the 40S subunit can resume scan-
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ning after dissociation of the 60S subunit. The rescanning ribosome initially does not 
have an associated TC and successful reinitiation of translation depends on the distance 
between stop codon and reinitiation site and TC availability [311]. In mammalian systems 
it is very rare for translation reinitiation to occur after translation of a long ORF. Mam-
malian caliciviruses have bicistronic subgenomic mRNAs with a short overlap region of 
the two ORFs. Translation reinitiation at the second ORF is dependent on translation 
of the upstream ORF. It requires the presence of a sequence element upstream of the 
second initiation site that is called the “termination codon upstream ribosome-binding 
site” (TURBS) [332]. Motifs within the TURBS sequence hybridize with 18S rRNA [333]. 
The TURBS also interacts with eIF3 and 40S ribosomal subunits. It is thought that the 
interaction with the TURBS secures 40S subunits that have terminated translation of 
the upstream ORF to the mRNA. Subsequent recruitment of the TC results in translation 
initiation to express the downstream ORF [334]. 
Stop codon read-through
The occurrence of a stop codon signals translation termination and induces the release 
of the polypeptide from the ribosome. However, the efficiency of translation termina-
tion is influenced by the type of stop codon (UGA and UAG are more leaky than UAA) 
and its context. When stop codon read-through occurs the stop codon is decoded by a 
near-cognate or “suppressor” tRNA, and translation continues until the next stop codon 
enters the ribosomal A-site. The UGA and UAA codons can induce the incorporation of 
tryptophan, arginine or cysteine. The UAG codon can induce the incorporation of tyro-
sine, glutamine or leucine [335]. Read-through results in the synthesis of a C-terminally 
extended polypeptide. Read-through occurs at a defined frequency and many viruses 
use it to express their polymerase at a lower level than other replicative proteins or to 
produce an extended version of their coat protein [323, 335]. 
Stop-carry on
Many viruses translate proteins from a single ORF as a polyprotein that is subsequently 
cleaved into the individual protein products by host and/or viral proteases. Stop-carry 
on is an alternative to proteolytic cleavage that also allows the expression of multiple 
proteins from a single ORF with near to 100% efficiency. The amino acid motif D(V/I)
ExNPGP and the upstream amino acids that are present in the ribosome exit tunnel 
prevent formation of the peptide bond between glycine and the final proline. Instead, 
the nascent peptide is released from the ribosome after which the proline tRNA can bind 
the A-site and translation continues with proline as the N-terminal amino acid of the 




In certain contexts, ribosomes can shift 1 or 2 nucleotides and continue translation in a 
different reading frame, which is called programmed ribosomal frameshifting (PRF). –1 
PRF is widely used by +RNA viruses and allows them to produce proteins at a defined 
ratio or translate transframe proteins that share the N-terminal sequence [323]. A bipar-
tite signal in the mRNA determines the frameshifting efficiency. A slippery sequence 
X_XXY_YYZ (_ separates 0 frame codons, X is any 3 identical nucleotides, YYY is AAA or 
UUU, Z is A, C or U) on which the ribosome backs up 1 nucleotide and a downstream 
stimulatory element, in most cases either a pseudoknot or a very stable RNA stem-loop 
structure [336]. The distance between slippery sequence and downstream element (6-8 
nt) is also important [336]. It has been proposed that the resistance of the stimulatory 
RNA structure to unwinding induces tension in the mRNA. This causes ribosomes to 
pause at the slippery sequence with XXY in the P-site and YYZ in the A-site. Unpairing of 
mRNA and tRNA could release this tension, which then causes the ribosome to move to 
the –1 frame while still retaining base-pairing in the non-wobble positions [337, 338]. +1 
and –2 frameshifting mechanisms are less common and their efficiency is usually very 
low [323]. 
PRRsv
The work in this second part of my thesis focuses on porcine reproductive and respira-
tory syndrome virus (PRRSV), a single-stranded enveloped +RNA virus belonging to the 
family Arteriviridae of the order Nidovirales [339]. For the expression of its polycistronic 
genome PRRSV and other arteriviruses employ a combination of strategies, including 
multiple non-canonical translation mechanisms. 
PRRSV currently is one of the economically most important viruses in the swine indus-
try [340]. In the late 1980’s, distantly related PRRSVs, which are likely to be reclassified 
as separate viral species in the near future, simultaneously emerged in Europe [10] and 
the United States [11, 341]. The two current genotypes, type 1 (European) and type 2 
(North-American), probably share a common ancestor but diverged extensively, retain-
ing a nucleotide identity of only 60-70% [342, 343]. Within each genotype the nucleotide 
similarity is >80% [344]. 
order Nidovirales
The viruses belonging to the Nidovirales have a similar genome organization and 
expression strategy and their key replicative enzymes, including the RNA-dependent 
RNA polymerase (RdRp) and helicase, presumably share a common ancestor [345, 346]. 
The order Nidovirales currently contains four families, the Coronaviridae, Roniviridae, 
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Mesoniviridae and Arteriviridae [347, 348]. Its coronavirus branch includes several hu-
man pathogens, in particular four “established” human coronaviruses (HCoVs), which 
generally cause common colds [349], and highly pathogenic zoonotic agents like severe 
acute respiratory syndrome coronavirus (SARS-CoV) [2, 4] and Middle East respiratory 
syndrome coronavirus (MERS-CoV) [350]. 
The arterivirus family currently consists of four recognized species that infect mam-
mals: equine arteritis virus (EAV), lactate dehydrogenase-elevating virus (LDV) of mice, 
simian hemorrhagic fever virus (SHFV) and PRRSV [339]. The recently discovered wobbly 
possum disease virus (WPDV) will most likely be classified as an arterivirus [351] and 
several newly discovered monkey viruses appear to be distantly related to SHFV [352]. 
The PRRsv replicative cycle
The 13-16 kb arterivirus genome is encapsidated by the N protein and wrapped in a 
lipid envelope that is cell-derived and contains seven viral membrane proteins. The two 
major envelope proteins are the ORF5-encoded glycoprotein (GP5) and the membrane 
(M) protein. The five minor envelope proteins are GP2, GP3, GP4, envelope (E) protein 
and the ORF5a product [353-355]. For PRRSV all envelope proteins are required for the 
production of infectious virus particles [356, 357]. Cell entry occurs through clathrin-
mediated endocytosis. Following endosome acidification and membrane fusion, the 
viral nucleocapsid is released into the cytosol [358, 359]. It is still uncertain which of the 
viral envelope proteins mediates fusion but host receptors CD163 and CD169 are likely 
required for PRRSV internalization and uncoating [360]. 
Arterivirus genomes are poly-adenylated and presumed to have a 5’ cap. Upon cell 
entry the PRRSV replicase proteins are expressed from two 5’ ORFs (ORF1a and ORF1b) as 
two precursor polyproteins (pp1a and pp1ab) that are proteolytically processed into 14 
individual nonstructural proteins (nsps) by four viral proteases residing in nsp1α, nsp1β, 
nsp2 and nsp4 [361-364]. There is a small overlap between ORF1a and ORF1b and trans-
lation of pp1ab depends on a –1 PRF event that is directed by a “slippery sequence” and 
a downstream pseudoknot structure [342, 365]. The structural and accessory proteins 
are translated from the 3’ORFs 2-7 as a nested (Latin nidus = nest) set of 5’- and 3’-co-
terminal subgenomic mRNAs (sgmRNAs) [218, 366]. The termini of most of the ORFs 2a 
to 7 overlap with neighboring genes and several sets of proteins are translated from the 
same sgmRNA, presumably through leaky scanning [354, 366, 367]. 
The arteriviral replication and transcription complex (RTC) is associated with mem-
brane structures. These are complex networks of modified ER-derived structures in the 
perinuclear region of the cell that consist of double-membrane vesicles [368-370]. The 
RTC first synthesizes full-length and subgenome-length minus strand RNAs, which are 
used as templates for the synthesis of new genomes and the sgmRNAs, respectively 
[371]. Newly synthesized genomes become encapsidated by N protein [372]. Subse-
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quently, nucleocapsids are enwrapped by membranes from smooth ER and/or Golgi 
complex [373, 374]. Virions are then transported to the plasma membrane by the exo-
cytic pathway and released from the cell [375]. A schematic overview of the arterivirus 
replicative cycle is shown in figure 5. 
figure 5: overview of the arterivirus replicative cycle. Following entry by receptor-mediated endocy-
tosis and endosomal membrane fusion the nucleocapsid is released into the cytosol. Genome translation 
yields replicase polyproteins pp1a and pp1ab that are cleaved by internal proteinases. The viral nonstruc-
tural proteins assemble into a replication and transcription complex (RTC) that first engages in minus-strand 
RNA synthesis. Both full-length and subgenome-length minus strands are produced, the latter serving as 
templates for the synthesis of sg mRNAs required to express the structural protein genes, which reside in 
the 3’-proximal quarter of the genome. Novel genomes are packaged into nucleocapsids that become en-
veloped by budding from smooth intracellular membranes, after which the new virions leave the cell using 
the exocytic pathway. For further details, see text. Reprinted with permission from [392].
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Pathogenesis of PRRsv infection in swine 
PRRSV can be transmitted between swine through semen, milk, direct contact and 
aerosol transmission [376-378]. Type 1 PRRSV mainly causes reproductive failure in sows 
late during gestation, while type 2 also causes respiratory disease in growing pigs [379]. 
The virulence of different PRRSV isolates can vary from very mild to highly pathogenic 
[380, 381]. Primary target cells for viral replication are porcine alveolar macrophages 
(PAMs) [10, 382] and the virus replicates and persists mostly in lungs and lymphoid 
organs [383, 384]. The acute phase of PRRSV infection is usually characterized by a high 
viral load and the presence of clinical symptoms that can last up to one month post 
infection. This is followed by a phase with low replication levels of persisting virus, until 
the virus is eventually cleared, which can take up to 150 days [385]. Both innate and 
adaptive immune responses against PRRSV are generally weak. PRRSV modulates the 
innate immune response by suppressing the production of type I interferons [386, 387] 
and regulating the expression of other cytokines [388]. The production of neutralizing 
antibodies occurs only late and their levels are generally low [385]. Development of 
cell-mediated immunity is weak and slow [388, 389]. The immunity acquired after clear-
ance is often not effective against reinfection with a heterologous strain [389]. Vaccines 
against PRRSV are available, but are not completely effective [390, 391].
ouTLiNE PART 2
In part 2 of my thesis, the identification of a new PRF mechanism in arteriviruses is 
described, which was explored in detail using PRRSV. Chapter 6 presents the discovery 
of this mechanism, a highly efficient form of –2 PRF that ensures the expression of a pre-
viously unknown transframe protein, nsp2TF, that shares its N-terminal sequence with 
nsp2 but has a different C-terminal domain. In infected cells, nsp2 and nsp2TF localize 
to different cellular compartments and virus mutants that are incapable of expressing 
nsp2TF are seriously crippled. In chapter 7 –2 PRF in PRRSV is shown to depend on the 
expression of the PRRSV nsp1β protein. This chapter further shows that –1 PRF takes 
place at the same frameshift site, resulting in the translation of a truncated form of nsp2, 
nsp2N. Chapter 8 shows that –2/–1 PRF in PRRSV is also dependent on the presence of 
specific host proteins, namely poly (C) binding proteins (PCBP) 1 and 2, which appear to 
form a PRF-inducing protein complex together with nsp1β. In chapter 9 the findings of 
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AbsTRACT
Programmed −1 ribosomal frameshifting (−1 PRF) is a gene-expression mechanism used 
to express many viral and some cellular genes. In contrast, efficient natural utilization of 
−2 PRF has not been demonstrated previously in eukaryotic systems. Like all nidoviruses, 
members of the Arteriviridae (a family of positive-stranded RNA viruses) express their 
replicase polyproteins pp1a and pp1ab from two long ORFs (1a and 1b), where synthesis 
of pp1ab depends on −1 PRF. These polyproteins are posttranslationally cleaved into 
at least 13 functional nonstructural proteins. Here we report that porcine reproductive 
and respiratory syndrome virus (PRRSV), and apparently most other arteriviruses, use 
an additional PRF mechanism to access a conserved alternative ORF that overlaps the 
nsp2-encoding region of ORF1a in the +1 frame. We show here that this ORF is translated 
via −2 PRF at a conserved G_GUU_UUU sequence (underscores separate ORF1a codons) 
at an estimated efficiency of around 20%, yielding a transframe fusion (nsp2TF) with the 
N-terminal two thirds of nsp2. Expression of nsp2TF in PRRSV-infected cells was verified 
using specific Abs, and the site and direction of frameshifting were determined via mass 
spectrometric analysis of nsp2TF. Further, mutagenesis showed that the frameshift site 
and an unusual frameshift-stimulatory element (a conserved CCCANCUCC motif 11 
nucleotides downstream) are required to direct efficient −2 PRF. Mutations preventing 
nsp2TF expression impair PRRSV replication and produce a small-plaque phenotype. 
Our findings demonstrate that −2 PRF is a functional gene-expression mechanism in 




In eukaryotes, translation initiation largely involves 5′ end-dependent scanning of 
mRNAs during which the small ribosomal subunit, in a complex with initiation fac-
tors, first binds to the 5′ cap structure and then scans in a 5′-to-3′ direction until it 
encounters the first suitable initiation codon, at which point translation commences 
[310]. Consequently, the vast majority of cellular mRNAs are essentially monocistronic 
(although efficient reinitiation can occur after translation of very short ORFs). The fact 
that the cellular translational machinery essentially only decodes the 5′-most long ORF 
of an mRNA imposes a considerable constraint on nonsegmented RNA viruses, which 
must express a number of enzymatic and structural proteins to complete their replica-
tive cycle. Strategies to overcome this limitation include the synthesis of functionally 
monocistronic subgenomic mRNAs, the production of precursor polyproteins that are 
subsequently cleaved by virus- and/or host-encoded proteases, and the use of non-
canonical translational mechanisms (such as internal ribosomal entry, leaky scanning, 
ribosomal frameshifting, and stop codon readthrough) [323] by which additional ORFs 
may be translated from polycistronic mRNAs.
Members of the order Nidovirales (Arteriviridae, Coronaviridae, and Roniviridae), 
which includes the RNA viruses with the largest genomes currently known, use many 
of the above strategies (including polyprotein expression, subgenomic mRNA synthesis, 
ribosomal frameshifting, and leaky scanning) (Figure 1A) to organize one of the most 
complex RNA virus replication cycles described to date [347, 393, 394]. The replicative 
enzymes of nidoviruses are encoded in ORF1a and ORF1b, which occupy the 5′-proximal 
three quarters of their positive-stranded RNA genome. ORF1a and ORF1b encode two 
large replicase precursor polyproteins, pp1a and pp1ab, with expression of the latter 
depending on a −1 ribosomal frameshift in the short ORF1a/ORF1b overlap region [345, 
395]. Following their synthesis from the genomic mRNA template, pp1a and pp1ab are 
processed into at least 13–16 functional nonstructural proteins (nsps) by a complex 
proteolytic cascade that is directed by two to four ORF1a-encoded proteinase domains 
(Figure 1A) [361, 362]. The 3′-proximal region of the nidovirus genome contains the 
genes encoding the viral structural proteins, which are translated from a nested set of 
5′- and 3′-coterminal subgenomic mRNAs [371].
As indicated above, the genomes of a variety of viruses, including all currently known 
nidoviruses, harbor sequences that induce a proportion of translating ribosomes to 
frameshift −1 nt and continue translating in an alternative reading frame [345, 365, 
395-397]. Where functionally important, this process may be termed “−1 programmed 
ribosomal frameshifting” (−1 PRF). The eukaryotic −1 frameshift site typically consists 
of a “slippery” heptanucleotide fitting the consensus motif X_XXY_YYZ, where XXX nor-
mally represents any three identical nucleotides (although certain exceptions have been 
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figure 1: Arterivirus genome organization and expression mechanisms. (A) Map of the ~15-kb PRRSV 
genome. Two long 5′ ORFs encode nonstructural polyproteins, and at least eight shorter 3′ ORFs encode 
structural proteins. The 3′ ORFs are translated from a nested set of 3′-coterminal subgenomic mRNAs, two 
of which are bicistronic. ORF1a and ORF1b are translated from the genomic RNA, where translation of 
ORF1b depends on −1 PRF at the end of ORF1a. The newly described TF ORF overlaps a central region of 
ORF1a in the +1 reading frame and is accessed via −2 PRF. Domains in nsp2/nsp2TF are annotated as PLP2 
(papain-like protease), HVR (hypervariable region), TM/TM′ (putative TM domains), and C (Cys-rich domain). 
Predicted sizes (in aa) for nsp2-related products are shown for GenBank sequences NC_001961 (blue) and 
DQ489311 (red; the isolate SD01-08 used in this study). (B) Bioinformatic analysis of PRRSV ORF1a. Panels 1 
and 2 depict the conservation at ORF1a-frame synonymous sites in an alignment of 212 PRRSV sequences 
using a 25-codon sliding window. Panel 2 shows the ratio of the observed number of substitutions to the 
number expected under a null model of neutral evolution at synonymous sites. Panel 1 shows the cor-
responding P value. Summed over the whole TF ORF, the corresponding P value is 5.7 × 10−65. To map the 
conservation statistic onto the coordinates of a specific sequence, all alignment columns with gaps in a 
chosen reference sequence, NC_001961, were removed (note that the original alignment is gap-free within 
the TF ORF itself ). Panels 3–5 show the positions of stop codons (blue) in the three possible reading frames, 
and alignment gaps (green) in all 212 aligned sequences. Note the conserved absence of stop codons in the 
+1 reading frame in the TF region. (C) Positions of stop codons (blue) in an alignment of the three available 
SHFV sequences. The vertical red line indicates the location of the G_GUU_UUU/G_GUC_UCU motif. Note 




found); YYY represents strictly AAA or UUU; and Z represents A, C, or U, and underscores 
separate zero-frame codons. This consensus motif generally is followed by a stimula-
tory element that comprises a stable RNA secondary structure, such as a pseudoknot 
or stemloop, beginning 5–9 nt downstream of the shift site [396, 397]. In contrast, very 
little is known about the utilization of –2 programmed ribosomal frameshifting (–2 PRF) 
in eukaryotic systems, including the potential shift sites and stimulatory elements. Here 
we describe the identification of a short arterivirus ORF (TF) that is translated via efficient 
−2 PRF. In porcine reproductive and respiratory syndrome virus (PRRSV), frameshifting 
(with an efficiency of about 20%) occurs at a conserved G_GUU_UUU sequence (under-
scores separate ORF1a codons) in a central region of ORF1a and results in the expression 
of a transframe protein, nsp2TF, that comprises the N-terminal two thirds of nsp2 fused 
to a 169-aa C-terminal region encoded by the TF ORF. Mutations that prevent expression 
of nsp2TF seriously impair PRRSV replication in cell culture. Because ribosomes translat-
ing the TF ORF will not decode the remainder of the replicase gene, the combination of 
this −2 PRF mechanism and the downstream ORF1a/ORF1b −1 PRF results in differential 
expression of three replicase gene segments, suggesting that the regulation of genome 
translation plays a key role in fine-tuning the replicative cycle of arteriviruses, including 
PRRSV, one of the economically most important swine pathogens.
REsuLTs
Computational analysis reveals a conserved oRf overlapping the Arterivirus 
nsp2-coding sequence
Arteriviruses comprise a family of small, enveloped positive-stranded RNA viruses that 
currently includes PRRSV, equine arteritis virus (EAV), lactate dehydrogenase-elevating 
virus (LDV), and simian hemorrhagic fever virus (SHFV) [394]. The ORF1a sequences of 
212 PRRSV isolates available in GenBank as of February 26, 2012 were extracted, trans-
lated, aligned, and back-translated to a nucleotide sequence alignment. Both European 
(EU; type I) and North American (NA; type II) genotype isolates, which typically share 
50–55% amino acid identity within pp1a, were included. Next, the alignment was 
analyzed for conservation at ORF1a-synonymous sites, as described previously [398]. 
The analysis revealed a striking and highly statistically significant (P < 10−64) increase 
in synonymous-site conservation in a region covering around 170 codons toward the 
3′ end of the nsp2-encoding sequence (Figure 1B). Within this region the mean syn-
onymous substitution rate was reduced to 47% of the ORF1a average. Such peaks in 
synonymous-site conservation generally are indicative of functionally important over-
lapping elements, either coding or noncoding [398-400]. In this case, inspection of the 
+1 and +2 reading frames relative to ORF1a, in all 212 sequences, revealed an almost 
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complete absence of stop codons in the +1 reading frame in a region corresponding 
precisely to the region of enhanced conservation (Figure 1B). This finding suggested an 
overlapping ORF in the +1 reading frame as a possible explanation for the enhanced 
conservation at ORF1a synonymous sites.
An inspection of other arterivirus genomes revealed further evidence for a +1 frame 
ORF overlapping the equivalent region of ORF1a. Currently, three SHFV sequences are 
available [401]. With pairwise amino acid identities within pp1a of just 35–37%, these 
sequences are too divergent for the analysis of synonymous-site conservation. However, 
the conserved presence of a 219–225 codon ORF in the +1 frame in such divergent 
sequences is, in itself, statistically significant (P < 10−10) (Figure 1C; also see SI Materials 
and Methods). A 169-codon ORF also is present in one (LDV-P) of two published LDV 
sequences, but in the second sequence (LDV-C) the ORF is disrupted by a single stop co-
don. To assess the likeliness of a sequencing error in the LDV-C sequence, we sequenced 
the relevant region of an additional LDV isolate (795 nt, including the last 158 codons of 
the ORF; GenBank accession no. JX258842). This sequence is divergent from both LDV-P 
and LDV-C (locally 83–90% nucleotide identity) and lacks the interrupting stop codon 
that is present in LDV-C. Remarkably, no evidence for a corresponding ORF was found in 
EAV. In fact, in this part of the genome, EAV is highly divergent from other arteriviruses, 
and the nsp2 region is greatly reduced in size.
At the 5′ end of the conserved ORF, there is a G_GUU_UUU sequence that is present 
in 206/212 PRRSV sequences (4/212 have G_GUU_UUC), both LDV sequences, and one 
SHFV sequence. The other two SHFV sequences have G_GUC_UCU at the correspond-
ing position. Significantly, the G at position 1 is conserved although the corresponding 
ORF1a codon is CAG (Gln), UGG (Trp), or CGG (Arg) in different PRRSV isolates (Figure 2A). 
We hypothesized that this motif could facilitate −2 PRF from ORF1a into the overlapping 
ORF. We were not able to predict convincing downstream RNA secondary structures at 
a distance of 5–9 nt that might (by analogy to −1 PRF sites) be expected to be present, 
nor could we definitively rule out the existence of such structures. On the other hand, we 
did observe a highly conserved CCCANCUCC motif beginning 11 nt downstream of the 
G_GUU_UUU sequence. This motif is present in both LDV, all three SHFV, and 211/212 
PRRSV sequences. Such high conservation could reflect protein sequence constraints 
(in two overlapping reading frames) but also might be part of a frameshift-stimulatory 
RNA sequence.
In PRRSV, −2 frameshifting at the G_GUU_UUU sequence would produce a transframe 
fusion protein comprising the N-terminal 65–72% (typically 714–850 amino acids, de-
pending on isolate) of nsp2 fused to the 169 amino acids encoded by the overlapping 
ORF (Fig. 1A). We refer to the overlapping ORF as “TF ORF” and to the predicted transframe 
fusion protein as “nsp2TF.” In PRRSV, LDV, and SHFV, nsp2TF is 14–19% shorter than full-
length nsp2, and the TF ORF overlaps the part of ORF1a that encodes the predicted nsp2 
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transmembrane (TM) domain. The TF ORF appears to encode an alternative TM domain 
containing four or more potential TM regions, depending on species and isolate, but 
no other conserved amino acid motifs that might give further indications as to protein 
function were identified.
immunodetection of nsp2T in PRRsv-infected cells
To confirm expression of the predicted nsp2TF frameshift product in PRRSV-infected cells, 
a polyclonal Ab (pAb-TF) was raised against the C-terminal peptide (CPKGVVTSVGESV) 
of nsp2TF of PRRSV type I isolate SD01-08 [402]. We also used mAbs 36-19 and 58-46, 
raised against the N-terminal 436 amino acids of SD01-08 nsp2 [402, 403] and therefore 
expected also to recognize nsp2TF, which (in SD01-08) would share its N-terminal 714 
amino acids with nsp2. Expression of nsp2TF was first analyzed by immunoprecipita-
tion (IP) and Western blot analysis. Lysates of SD01-08–infected MARC-145 cells were 
harvested at 48 h postinfection (p.i.). PRRSV proteins were immunoprecipitated using 
mAb36-19 and were separated by SDS/PAGE. Four high-molecular-mass bands with 
apparent masses between 100–150 kDa were detected by Coomassie Brilliant Blue 
figure 2: Nucleotide sequences in the vicinity of the Tf frameshift site. (A) Sequences from repre-
sentative arteriviruses [GenBank accession numbers: NC_001639, LDV; NC_001961, PRRSV NA (type II); 
JX258843, PRRSV NA (type II) isolate SD23983; DQ489311, PRRSV EU (type I) isolate SD01-08; NC_003092, 
SHFV; HQ845737-8. SHFV strains krc1-2]. The proposed frameshift site (confirmed in SD01-08 and SD23983) 
is highlighted in orange, and nucleotide variations in SHFV isolates krc1-2 are indicated in green. The highly 
conserved downstream CCCANCUCC motif is highlighted in cyan. Spaces separate ORF1a codons. The 
length of the +1 frame TF ORF is indicated at the right. (B) Overview of mutants used to investigate TF ex-
pression and function by ORF1a expression and reverse genetics. Non-WT nucleotides are shown in pink. 
Coordinates of terminal nucleotides refer to sequence DQ489311. IFC, in-frame control; SS, shift-site mu-
tant; CC1 and CC2, disrupted CCCANCUCC motif; KO1, knockout mutant 1 (premature termination codons 
in TF); KO2, knockout mutant 2 (premature termination codon and disrupted frameshift cassette). Only the 
IFC and CC2 mutations are nonsynonymous with respect to the nsp2 amino acid sequence.
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staining, with the two smallest products clearly being less abundant. In addition, 
various lower-molecular-mass products were observed (Figure S1A). To confirm that the 
high-molecular-mass bands represented nsp2-related products, Western blot analysis 
was performed using anti-nsp2 mAb58-46 and pAb-TF. All four high-molecular-mass 
products were specifically recognized by mAb58-46 (Figure 3A), indicating that they 
must share N-terminal sequences. However, only the second- largest protein labeled 
nsp2TF was recognized by pAb-TF. The third protein labeled nsp2TF′ was not detected 
in a Western blot using pAb-TF, possibly because of its lower abundance and/or lower 
affinity for the Ab; this product was, however, detected in IP using pAb-TF (see below). 
We speculate that nsp2TF′ could be either a precursor to or a modified form of nsp2TF. 
The smallest product of the four proteins labeled nsp2N might derive from a −1 frame-
shift at the same conserved G_GUU_UUU sequence. Such a frameshift would lead to an 
immediate termination, because there is a −1/+2 frame stop codon adjacent to the shift 
site (Figure 2A; see also Figure S1D and Discussion).
A similar analysis for the PRRSV type II isolate SD23983 also revealed multiple products 
in the 100–150 kDa range (Figure 3B). The available SD01-08 pAb-TF did not cross-react 
with any of these bands, but this result was not surprising, because the sequence of the 
13-aa peptide used to produce this Ab is not conserved in type II viruses.
figure 3: Analysis of nsp2 and nsp2Tf expression in PRRsv-infected cells. MARC- 145 cells were in-
fected with type I (EU) PRRSV isolate SD01-08 (A) or type II (NA) PRRSV isolate SD23983 (B) or were mock 
infected. Proteins were immunoprecipitated with mAbs specific for the common N-terminal domain of 
nsp2 and nsp2TF, separated by SDS/PAGE, and probed by Western blotting using an alternative mAb rec-
ognizing the common N-terminal domain or a TF-specific pAb (SD01-08 only), as indicated at the bottom. 
Size markers and putative PRRSV proteins are indicated.
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mass spectrometric analysis of the site and direction of frameshifting
Although bioinformatic analysis suggested the site (G_GUU_UUU) and direction (−2) 
of frameshifting, we sought to confirm both predictions with direct protein sequence 
analysis. To this end, proteins from SD01-08–infected and mock-infected MARC-145 cell 
lysates were immunoprecipitated, resolved by SDS/PAGE, and stained with Coomassie 
Brilliant Blue (Figure S1A). The gel slice containing the putative nsp2TF band was ana-
lyzed by LC/MS/MS. Four peptides specific for the 169-aa TF region were identified in 
addition to many peptides from the common N-terminal domain of nsp2 and nsp2TF 
(Figure 4B). One of the peptides, LMTWvfLK, spanned the frameshift site itself (bold), 
and its sequence is fully compatible with −2 PRF (after decoding GUU_UUU as VF) 
(Figure 4A and Figure S1C) but not with +1 PRF, which would produce a shift-site peptide 
that is shorter by one amino acid (e.g., LMTWvfK). To verify the correct identification of 
the frameshift peptide, a synthetic version of the peptide was subjected to the same 
LC/MS/MS analysis. The tandem mass spectrum of the synthetic peptide was identi-
cal to that of the peptide derived from the gel slice, confirming that nsp2TF is indeed 
translated via −2 PRF at the G_GUU_UUU motif (Figure S1B). Again, the analysis was 
repeated for the type II isolate SD23983, for which a −2 frameshift tryptic peptide with 
a different sequence (QvfLTSSPISLFSSHAFSTR; shift site-encoded amino acids in bold) 
was predicted. Likewise, this sequence was identified in mass spectrometric analysis of 
the presumed nsp2TF band excised from an SDS/PAGE gel (Figure S2).
Estimation of the frameshifting efficiency
The frameshifting efficiency and turnover of nsp2 and nsp2TF were investigated in a 
pulse-chase labeling experiment in SD01-08–infected MARC-145 cells. After a 1-h pulse 
labeling with 35S-labeled amino acids, the incorporated label was chased for various peri-
ods (up to 24 h), and proteins were immunoprecipitated with nsp2- and nsp2TF-specific 
Abs. As shown in Figure 5A, this analysis revealed the existence of two smaller products 
(labeled “nsp2′” and “nsp2TF′”) that apparently are about 10 kDa smaller than nsp2 and 
nsp2TF. Its disappearance during the chase suggested that nsp2′ is a direct precursor of 
nsp2, although we cannot rule out the possibility that it may be a degradation product 
of nsp2. Nsp2 itself also appeared to be subject to further modification during the chase 
period, as indicated by its slight size increase and more heterogeneous migration in the 
gel (Figure 5A; compare C0h with later time points). The possible precursor status of 
nsp2TF′ was less obvious, because the amount of this product was more or less stable 
throughout the chase period, during which both the nsp2TF and nsp2TF′ bands also 
appeared to convert into doublets. In terms of protein turnover, the amount of nsp2TF 
declined much more rapidly than that of nsp2 during the chase period. This difference 
in turnover was even more pronounced for nsp2N, the putative −1 frameshift product 
(see above), which seems to be the least stable of the various nsp2 forms described here.
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figure 4: mass spectrometric analysis of nsp2Tf purified from mARC-145 cells infected with type 
i PRRsv isolate sd01-08. (A) Nucleotide sequence in the vicinity of the TF shift site G_GUU_UUU, with 
conceptual amino acid translations in all three reading frames shown. The product of −2 frameshifting is 
indicated in red. Consecutive tryptic peptides covering these amino acids were detected by mass spectro-
metric analysis. The peptide underlined in green, which spans the shift site, is compatible with −2 but not 
+1 frameshifting. Stylized P- and A-site tRNAs illustrate expected codon:anticodon duplexes before and 
after frameshifting (see also main text). In eukaryotes, GUU is expected to be decoded by the valine tRNA 
with anticodon 5′-IAC-3′ (I = inosine), but it is possible that it also is decoded by the valine tRNA with anti-
codon 5′-ncm5UAC-3′ (ncm5U = 5-carbamoylmethyluridine). Because currently it is not known whether one 
or both of these, or perhaps a hypomodified form, are compatible with frameshifting, the valine anticodon 
is indicated by 3′-CA*-5′ in the schematic. (B) Complete amino acid sequence of nsp2TF, with peptides 
identified by mass spectrometry indicated in red. The C-terminal 169 amino acids encoded by the +1 read-
ing frame are highlighted in gray. The N-terminal 714 amino acids are shared with nsp2. The epitopes rec-
ognized by mAbs 36-19 and 58-64 and pAb-TF, in order, are underlined in blue. Pink underlining indicates 
the locations of the premature termination codons of mutant KO1 (Figure 2B).
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Several smaller nsp2-specific products were observed in the C0h sample, including a 
prominent band migrating at around 90 kDa, a fainter band migrating slightly behind 
the 90-kDa band, and a faint band migrating at around 98 kDa (Fig. 5A). The prominent 
90-kDa product was not detected by pAb-TF and most likely derives from internal cleav-
age of nsp2. Two additional nsp2-specific products were observed to migrate at around 
200 kDa. Based on their size, these may represent nsp2–8 and a modified or precursor 
form of nsp2–8. The definitive identity of these products cannot be explained at this 
point in time, and they add to the puzzling complexity of nsp2 expression and post-
translational modification.
To assess the frameshifting efficiencies in the context of PRRSV infection, we measured 
the radioactive incorporation into the nsp2+nsp2′, nsp2TF+nsp2TF′, and nsp2N bands 
directly after the pulse labeling (Figure 5A; lane C0h) and corrected these numbers for 
the Met and Cys content of the different proteins (Table S1). Notwithstanding potential 
differences in Ab affinity for the different nsp2-related products and other potential 
confounding factors, these measurements suggested −2 and (putative) −1 frameshift-
ing efficiencies of ~20% and 7%, respectively. Because the presence and identity of the 
minor products, including those migrating at around 90, 98, and 200 kDa, could affect 
the calculated frameshifting efficiencies to a limited extent, we repeated the calculations 
under the conservative assumption that these minor products are all derived from non-
figure 5: Analysis of nsp2-related products in PRRsv sd01-08–infected cells and transient oRf1a 
expression. Following metabolic labeling with 35S, proteins were immunoprecipitated with mAb58-46 
or pAb-TF and were analyzed by SDS/PAGE and autoradiography. Size markers and putative nsp2-related 
products are indicated at the side of each panel. (A) Pulse-chase experiment with PRRSV-infected MARC-
145 cells, using a 1-h pulse labeling and various chase periods as indicated at the top. (B) Pulse-chase analy-
sis of transient ORF1a expression in the recombinant vaccinia virus/T7 RNA polymerase system. RK-13 cells 
were infected with recombinant vaccinia virus and either were mock transfected or were transfected with 
pL1a plasmid DNA. At 5 h post vaccinia virus infection, protein synthesis was labeled for 30 min and chased 
for up to 2 h. (C) Analysis of −2 PRF and nsp2TF mutants expressed using pL1a and the recombinant vac-
cinia virus/T7 RNA polymerase expression system as described for B. Arrows point to the C-terminally trun-
cated nsp2TF products from mutant KO1.
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frameshift products. These results, combined with those above, indicate frameshifting 
efficiencies in the range of 16–20% and 6–7% for −2 and −1 frameshifting, respectively.
The G_Guu_uuu and CCCANCuCC motifs are required for efficient 
frameshifting
The transient expression of ORF1a in the recombinant vaccinia virus/T7 polymerase 
expression system [403] was used to develop an assay for PRRSV −2 PRF in uninfected 
cells. A T7 promoter-driven, full-length ORF1a expression vector (pL1a) was constructed, 
and the synthesis of nsp2, nsp2TF, and nsp2N was monitored by radiolabeling (30-min 
pulse, 0- to 120-min chase) and IP (Figure 5B). With the exception of nsp2′, all products 
immunoprecipitated from PRRSV-infected cell lysates (Figure 5A) could be identified. 
Although differences in abundance, time of appearance, and stability were observed, 
these data clearly demonstrated that translation of the PRRSV ORF1a sequence is 
sufficient to allow efficient −2 frameshifting. In fact, the efficiency of frameshifting was 
estimated to be even higher in this system than in virus-infected cells (with an estimated 
−2 shift efficiency of around 50%).
Subsequently, using this ORF1a expression system, we investigated the requirement 
for an intact shift site and downstream elements for efficient frameshifting. First we 
engineered a shift-site mutant (SS) (Figure 2B) that contains two mutations in the shift 
site (G_GUU_UUU to G_GUA_UUC) and therefore is expected to express only nsp2. To 
mark the position at which WT nsp2TF migrates in gels, an in-frame control (IFC) was 
constructed in which the shift site was mutated synonymously and an extra 2 nt were 
inserted to force expression of the TF reading frame (G_GUU_UUU to G_GUG_UUC_UU) 
(Figure 2B). As shown in Figure 5C, WT pL1a produced both nsp2 and nsp2TF, and ex-
pression of the latter protein was confirmed by IP with pAb-TF. As expected, the IFC 
mutant produced only nsp2TF, as detected by both pAb-TF and mAb58-46. For the SS 
mutant, production of nsp2TF was greatly reduced, although, unexpectedly, frameshift-
ing was not totally inhibited (Figure 5C). Next we investigated whether the conserved 
CCCANCUCC motif (see above and Figure 2A) is involved in the stimulation of frame-
shifting at the G_GUU_UUU shift site by constructing two additional mutants in which 
the CCCANCUCC motif was disrupted (CC1 and CC2) (Figure 2B). The CC1 mutations are 
synonymous in the nsp2 frame; the CC2 mutations disrupt the motif more thoroughly 
but include substitutions that are not synonymous with respect to nsp2. The CC1 and 
CC2 mutants produced nsp2, but no nsp2TF was detected (Figure 5C). These results 
indicate that both the G_GUU_UUU shift site and the downstream CCCANCUCC motif 
are required for ribosomal frameshifting at the WT efficiency. When frameshifting is 
prevented (in the mutants SS, CC1, and CC2), expression of nsp2 is expected to increase 
substantially, because ribosomes no longer are being diverted into the alternative read-
ing frame (Figure 5C).
Chapter 6 125
6
inactivation of nsp2Tf expression affects PRRsv replication 
To investigate whether nsp2TF expression and/or the diversion of a proportion of the 
ribosomes out of ORF1a are relevant for virus replication, two mutants were gener-
ated (KO1 and KO2) (Figure 2B) in which nsp2TF expression was partially or completely 
knocked out with mutations that are translationally silent with respect to ORF1a. KO1 
makes a truncated nsp2TF protein because of the mutagenesis of codons 100 and 
102 of the 169-codon TF ORF into stop codons (nsp2-frame UUG_GCU_CUU_GAG to 
UuA_GCU_CuA_GAG; stop codons indicated in bold) (Figure 2B and 4B). Consequently, 
the truncated nsp2TF lacks the C-terminal pAb-TF epitope. KO2 contains nine mutations 
that disrupt the frameshift site and the downstream CCCANCUCC motif, besides intro-
ducing a stop codon into the TF ORF (Figure 2B). This mutant was intended to knock out 
the frameshift signal completely and to express only nsp2. KO1 and KO2 differ from WT 
virus by two and nine nucleotide substitutions, respectively, none of which affect the 
encoded nsp2 amino acid sequence (Figure 2B).
The mutants were tested in the ORF1a expression system to verify synthesis of the 
expected proteins. As expected, the KO1 frameshift product could not be detected us-
ing pAb-TF because of the truncation of the C-terminal epitope region. However, IP with 
mAb58-64 revealed the synthesis of truncated forms of nsp2TF and nsp2TF′ (Figure 5C, 
arrows) and a ratio between full-length nsp2 and the frameshift product similar to that 
in WT. On the other hand, the mutations introduced in KO2 indeed were found to elimi-
nate frameshifting, and, as anticipated, a much larger amount of full-length nsp2 was 
produced (Figure 5C).
The KO1 and KO2 mutations subsequently were transferred to a PRRSV full-length 
cDNA infectious clone, and the resulting recombinant viruses, vSD-KO1 and vSD-KO2, 
were found to be viable. However, both mutants produced plaques that were clearly 
smaller than those of the WT virus (vSD-WT), with vSD-KO2 producing somewhat smaller 
plaques than vSD-KO1 (Figure 6A). Analysis of growth kinetics consistently showed that 
replication of both vSD-KO1 and vSD-KO2 is seriously impaired in MARC-145 cells, with 
peak titers of both mutants being 50–100-fold lower than those of the WT control, and 
vSD-KO2 again displaying the larger reduction (Figure 6B).
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PRRsv nsp2 and nsp2Tf localize to different intracellular compartments
The localization of nsp2TF in PRRSV SD01-08–infected cells was investigated using 
immunofluorescence (IF) microscopy. As shown in Figure 7A, pAb-TF labeled specific 
foci mainly localizing to the perinuclear region of infected cells. This region also is 
known to contain the arterivirus replication structures, modified membranes that label 
abundantly for most of the viral nsps [369, 403, 404]. We used an mAb that recognizes 
nsp4 [403] to visualize these structures, which revealed a labeling pattern clearly differ-
ent from that observed with pAb-TF. Surprisingly, a control labeling with nsp2-specific 
mAbs (36-19 and 58-46, recognizing different epitopes in the common N-terminal do-
main of nsp2 and nsp2TF) (Figure 4B) revealed that the pAb-TF–specific foci were not, or 
were barely, recognized by nsp2-specific mAbs (Figure 7B), even though these mAbs did 
detect nsp2TF convincingly in other immuno-assays (Figure 3 and 5). Apparently, this 
part of nsp2TF is not accessible in these formaldehyde-fixed, Triton X-100-permeabilized 
cells. Confocal microscopy further corroborated that the labeling patterns obtained 
with nsp2-specific mAbs and pAb-TF in PRRSV-infected cells did not overlap (Figure 7C).
figure 6: Comparison of growth characteristics of WT PRRsv and nsp2Tf knockout mutants. (A) 
Plaque morphology of WT and nsp2TF knockout PRRSVs on MARC-145 cells. Confluent cell monolayers 
were infected with 10-fold serial dilutions of the virus suspension, and after 2 h an agar overlay was applied. 
Plaques were detected after 4 d of incubation at 37 °C and stained with 0.1% crystal violet. (B) Growth kinet-
ics of WT and nsp2TF-knockout PRRSV on MARC-145 cells. The results shown are mean values from three 
replicates. Virus titers are expressed as numbers of fluorescent-focus units (FFU) per milliliter.
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To investigate this phenomenon in more detail, nsp2 and nsp2TF were expressed indi-
vidually in MARC-145 cells (nsp2TF was expressed using the in-frame control sequence 
to mimic −2 frameshifting) (Figure 2B). In the absence of replication structures and 
other nsps, arterivirus nsp2 localizes to endoplasmic reticulum (ER) (Figure 7D), as was 
confirmed using an Ab recognizing an ER-specific marker protein (Figure S3F). Individual 
expression of nsp2TF (Figure 7 E and F and Figure S3E) again yielded a pattern clearly 

















figure 7: if microscopy analysis of the subcellular localization of nsp2Tf in PRRsv-infected mARC-
145 cells at 18–24 h p.i. (A–C) and a CMV promoter-driven expression system for nsp2 and nsp2TF (D–F). 
(A) Infected cells were double labeled with pAb-TF and a PRRSV nsp4-specfic mAb (mAb54-19) (19), reveal-
ing that nsp2TF does not colocalize with the viral replication structures. (B) Double labeling with pAb-TF 
and PRRSV nsp2-specific mAb36-19 results in nonoverlapping labeling patterns suggesting that the nsp2-
specific mAb cannot access the N-terminal domain of nsp2TF in fixed PRRSV-infected cells. (C) Confocal 
microscopy of a 0.8-μm slice through the nucleus confirming the nearly complete spatial separation of the 
structures labeled with pAb-TF and mAb36-19. (D) Nsp2-expressing MARC-145 cells labeled with mAb58-
46. (E and F ) Nsp2TF-expressing MARC-145 cells double labeled with pAb-TF (E) and mAb58-46 (F) show 
that, in contrast to PRRSV-infected cells, the latter antibody is able to recognize nsp2TF in this expression 
system. Cell nuclei were stained with Hoechst 33342. (Scale bars, 20 nm.) See also Figure S3.
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cells, but in this case these foci could be labeled with both pAb-TF and mAbs recogniz-
ing the N-terminal domain of nsp2, suggesting a conformational difference between 
nsp2TF (or nsp2TF-containing structures) in infected cells and the expression system. In 
both systems, however, the foci labeled by pAb-TF partially overlapped with the staining 
for exocytic pathway markers (specifically intermediate compartment and Golgi com-
plex) (Figure S3 A–D), an observation that currently is being investigated in more detail. 
Together, our microscopy studies strongly suggest that, unlike nsp2, nsp2TF is targeted 
not to the arterivirus replication structures but instead to an alternative intracellular 
destination.
disCussioN
RNA viruses of eukaryotes use a variety of non-canonical translational mechanisms to 
express multiple proteins from a limited number of transcripts, regulate gene expres-
sion, and otherwise manipulate the host cell translational machinery for their own 
specific needs. However, in contrast to −1 PRF, little was known about the potential for 
efficient functional utilization of −2 PRF. We now have demonstrated that PRRSV uses 
this mechanism to produce an nsp2-related transframe protein, nsp2TF. Bioinformatic 
analysis strongly suggests that such an nsp2TF product is encoded by all arteriviruses, 
with the striking exception of EAV, in which the relevant region of ORF1a has diverged 
dramatically. Efficient expression of nsp2TF in virus-infected cells was verified experi-
mentally in multiple independent immunoassays using nsp2- and nsp2TF-specific Abs. 
Mass spectrometric analysis of proteins purified from infected cells further confirmed 
the expression of nsp2TF and the exact site and direction of frameshifting. Both nsp2TF 
knockout mutants exhibited a crippled phenotype with a smaller plaque size, indicating 
an important role for nsp2TF (KO1) and possibly also for frameshifting per se (compare 
KO1 and KO2) in virus replication.
Currently, there are very few, if any, other examples of natural utilization of −2 PRF 
in eukaryotic systems. In diverse animals and fungi, expression of the cellular gene 
antizyme involves +1 PRF [405]. However, when mammalian antizyme is expressed 
artificially in the yeast Saccharomyces cerevisiae, the full-length antizyme product is 
expressed via −2 frameshifting [406]. Here the stimulatory elements comprise a stop 
codon (bold, lower case) 3′ adjacent to the shift site (UGC_UCC_uga) and a 3′-proximal 
RNA pseudoknot structure. The −2 frameshift translation reads CSPD, and frameshifting 
is thought to involve mainly P-site slippage on GC_UCC with an empty A-site. Recently it 
was found that by artificially reducing the spacer length to the downstream stimulator 
(either an RNA secondary structure or an antisense oligonucleotide), the slippery site for 
−1 PRF in HIV, i.e., U_UUU_UUA, also could serve as a slippery site for efficient −2 frame-
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shifting [407]. In prokaryotic systems, relatively inefficient −2 PRF (about 2.2%) is used in 
the expression of the gpGT tail-assembly protein in phage Mu, although the majority of 
dsDNA phages that express gpGT via frameshifting appear to use −1 PRF instead [408]. 
Finally, although not yet formally demonstrated, sequence analysis suggests that −2 PRF 
on CC_CUU_UUU is used in the expression of Gag-Pol in Trichomonas vaginalis virus 1 
(TVV1) [409, 410]. However, PRF in TVV1 is likely to be relatively inefficient, because the 
Gag-Pol:Gag ratio in virions is extremely low (e.g., 1–2%) [409], in sharp contrast to the 
high efficiencies observed here for PRRSV −2 PRF (Figure 5A).
Although typical −1 PRF sites (X_XXY_YYZ) allow codon: anticodon re-pairing 
in both the P- and A-sites with mismatches only at the wobble positions, for −2 PRF 
on G_GUU_UUU perfect re-pairing is maintained only in the A-site (Figure 4A). The 
nucleotide preceding the heptanucleotide is typically a G or an A in different arterivirus 
sequences; thus the post-shift P-site anticodon:codon duplex, if a duplex forms at all, 
may have multiple mismatches. However, although the integrity of the A-site duplex is 
strictly monitored by the translating ribosome [411], the P-site duplex is not monitored 
so strictly, and, even for −1 PRF, a number of variations on the canonical XXX are al-
lowed, including UCC, GGA, GUU, and GGU [323, 345, 399]. The potential −2 PRF site in 
TVV1 (CC_CUU_UUU) and the site of presumed −2 PRF in SHFV isolates HQ845737 and 
HQ845738 (G_GUC_UCU) also concur with the theme of perfect re-pairing in the A-site 
but reduced potential for re-pairing in the P-site. 
With few exceptions, eukaryotic −1 PRF is stimulated by a 3′-proximal RNA secondary 
structure [396, 397]. Whether such structures are sufficient and/or necessary for the 
stimulation of −2 frameshifting remains to be determined. However, our results indicate 
that −2 PRF in PRRSV, and by implication other arteriviruses, may be stimulated instead 
by unstructured 3′ sequence elements including a highly conserved CCCANCUCC motif. 
Unstructured 3′ sequences also have been implicated in the stimulation of +1 PRF in 
yeast [412] and −1 PRF in Semliki Forest alphavirus [413]. Depending on their distance 
from the shift site, such sequences may exert their action via mRNA:rRNA base-pairing 
or interaction with other translational components, although precise mechanisms have 
not yet been elucidated.
A variety of nsp2-related proteins were observed in our analysis, as previously re-
ported for type II PRRSV isolate VR2332, in which such products were assumed to derive 
from the use of alternative N- and/or C-terminal cleavage sites [414]. At least one of 
these products now seems to correspond to nsp2TF; some others may correspond to the 
nsp2- and nsp2TF-related products observed in the pulse-chase experiments in Figure 5. 
Moreover, the G_GUU_UUU sequence is also a suitable shift site for −1 frameshifting 
[399], and a potential −1 frameshift product (nsp2N) was observed (Figure 3 and 5 and 
Figure S1D). In the vast majority of PRRSV sequences (205/212, including isolate SD01-
08), such a frameshift would result in immediate termination at a −1 frame stop codon 
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(with G_GUU_UUu_ga, G_GUU_UUu_ag, and G_GUU_UUu_aa all found in different 
PRRSV isolates; stop codons in −1 frame indicated in bold). Mass spectrometry of the 
nsp2N band identified a peptide corresponding to the predicted C terminus of a −1 
frameshift product (Figure S1D), although formally such a peptide also could derive 
from internal cleavage of nsp2 or nsp2TF at this position. The identification of the nsp2N 
band as the −1 frameshift product was supported further by the fact that this protein 
was not observed upon expression of the SS mutant, in which the frameshift site is 
mutated (Figure 5C). The identities and posttranslational modifications of the various 
nsp2-related products are currently under further investigation, but the data accumu-
lated thus far leave no doubt that efficient −2 PRF occurs, likely accompanied by a lower 
level of −1 PRF at the same nucleotide sequence.
As previously described, the balance between the synthesis of the arterivirus pp1a 
and pp1ab replicase polyproteins is regulated by another ribosomal frameshift event, a 
−1 PRF (Figure 1A), leading to an estimated pp1a:pp1ab ratio of about 4:1 [345]. It now 
is apparent that the expression level of the different replicase proteins also is affected by 
efficient −2 PRF (and probably also −1 PRF) at the TF shift site, leading to a more complex 
series of ratios. Of the ribosomes that translate nsp1α/nsp1β, ~20% synthesize nsp2TF, 
~7% synthesize nsp2N, the other ~73% synthesize nsp2–8, and only ~15% subsequently 
translate the ORF1b-encoded proteins nsp9–12. Interestingly, betaretroviruses and 
deltaretroviruses also use two ribosomal frameshifts (both −1 PRF) in the expression 
of their Gag-Pro-Pol polyprotein [415]. Here Gag, Pro, and Pol are encoded by consecu-
tive terminally overlapping ORFs, and, in contrast to the arteriviruses, the polymerase is 
translated by ribosomes that have frameshifted twice.
PRRSV nsp2, the largest replicase cleavage product, is released by the autoproteolytic 
activities of the upstream papain-like protease (PLPβ) in nsp1β and the PLP2 protease 
residing in the N-terminal domain of nsp2 (Figure 1A) [416, 417]. Nsp2 is a multi-domain 
and multifunctional protein. Besides cleaving the nsp2/3 site, nsp2 functions as a cofac-
tor for the nsp4 serine protease during processing of the C-terminal half of pp1a [418]. 
The C-terminal domain of nsp2, but not nsp2TF, is a highly conserved Cys-rich domain 
of unknown function [419]. Furthermore, nsp2 is predicted to be a multispanning TM 
protein that contributes to the formation of the membranous structures that scaffold 
the assembly of the viral replication complex [369, 404]. Recent studies also have 
implicated nsp2 in viral pathogenesis, specifically by virtue of PLP2’s deubiquitinating 
and deISGylating activities [420-423]. The biological significance of these activities 
was supported by the ability of PLP2 to inhibit type I IFN activation and antagonize 
the antiviral effect of ISG15. Finally, certain regions of nsp2 that appear to be less or 
nonessential for PRRSV replication are thought to play a role in the modulation of host 
immune responses in vivo [424].
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The nsp2TF protein adds to the complexity of functions potentially encoded in this 
region of the genome. Its conservation in three of four distantly related arteriviruses and 
our reverse-genetics studies (Figure 6) suggest it is an important protein. The frameshift 
site is located just upstream of the region encoding the predicted nsp2 TM domain. 
Thus, nsp2 and nsp2TF share the PLP2 domain and the hypervariable region of nsp2 but 
have distinct C-terminal segments of different sizes that appear to constitute alternative 
TM domains. Strikingly, IF microscopy revealed that, in both infected cells and expres-
sion systems, nsp2TF and nsp2 are targeted to different locations. Although nsp2TF’s 
specific destination and function in replication or pathogenesis requires further study, 
these data may be a first step in understanding the presence and conservation of this 
additional ORF in most arteriviruses. If a fraction of the frameshifting ribosomes indeed 
make a −1 rather than a −2 shift (see above), the production of an nsp2 variant lack-
ing either TM domain would add further to the complexity of nsp2 expression. Such a 
presumably cytosolic version of PLP2 may have major implications for the interactions 
of this protease with host cell targets.
Our reverse-genetics analysis suggests that, although nsp2TF is not essential for rep-
lication, it is crucial for maximum virus fitness. When nsp2TF expression was prevented 
(mutant KO2) or a C-terminally truncated nsp2TF was produced (mutant KO1), the virus 
exhibited a lower growth rate and a clearly reduced plaque size. KO1 was designed 
to truncate the TF ORF without disrupting frameshifting per se (Figure 5C). That this 
mutation still resulted in a crippled phenotype highlights the functional importance of 
full-length nsp2TF. In contrast, KO2 was intended to knock out frameshifting completely. 
There can be multiple reasons why KO2 was more crippled than KO1. KO2 does not ex-
press nsp2TF, and the absence of nsp2TF, as demonstrated by KO1, is sufficient to impair 
virus replication. However, knocking out the frameshift signal also would be expected 
to upregulate expression of all the downstream nsps (nsp3–12), perhaps disturbing the 
balance of viral protein synthesis in a way that is detrimental to virus growth. Potential 
disruptive effects might involve replicase proteolytic processing by nsp4 (also using 
nsp2 as a cofactor), the formation of replication complexes, or the overexpression of 
RdRp and helicase, all of which individually have the potential to affect viral RNA synthe-
sis directly or indirectly.
Because of its highly immunogenic nature, the PRRSV nsp2 region has been explored 
for the development of a diagnostic assay [425]. Although the immunological proper-
ties of nsp2TF have not yet been determined, it might represent a viral antigen and/or 
a potential target for diagnostic assay development. The nsp2-coding region also was 
explored for its potential application in the development of PRRSV vaccines (reviewed in 
[361]). Using reverse-genetics approaches, modified live viruses with engineered dele-
tions and foreign inserts were created in an attempt to generate differentiable marker 
vaccines. In addition, mutations and deletions were introduced into certain nsp2 regions 
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during attempts to attenuate the pathogenicity of the virus. The identification of −2 PRF 
and the TF ORF has important consequences for the rational design of such recombinant 
viruses. Engineering of the PRRSV nsp2-encoding sequence may unintentionally affect 
the integrity and/or expression level of nsp2TF and all downstream replicase subunits, 
perhaps crippling virus replication, as discussed above. On the other hand, such effects 
also could be useful in the context of modified live virus vaccine design.
mATERiALs ANd mEThods
Computational analysis
A total of 255 arterivirus nucleotide sequences in GenBank with full coverage of ORF1a 
(listed in SI Materials and Methods) were identified by applying tBLASTn [426] to the 
pp1a peptide sequence derived from GenBank sequences NC_001961 (PRRSV-NA), 
NC_001639 (LDV), NC_003092 (SHFV), and NC_002532 (EAV). Six ORF1a-defective 
PRRSV sequences were excluded from subsequent analysis. For each virus, the ORF1a 
sequences were extracted, translated, aligned, and back-translated to produce nucle-
otide-sequence alignments using EMBOSS and Clustal [427, 428]. Synonymous-site 
conservation was calculated as described previously [398].
viruses and cells
BHK-21, RK-13, and MARC-145 cells were cultured as described previously [402, 419]. The 
type I PRRSV isolate, SD01-08 (GenBank accession DQ489311) [402], and type II PRRSV 
isolate, SD23983 (GenBank accession JX258843), were used. Recombinant vaccinia virus 
vTF7-3 [429] was propagated in RK-13 cells.
immunoassays 
To detect nsp2 and nsp2TF expression in infected cells, proteins were immunoprecipi-
tated with mAb36-19 and analyzed by Western blot as described previously [403, 430]. To 
determine the nsp2TF subcellular localization, IF microscopy was conducted essentially 
as described previously [369, 403]. The frameshifting efficiency and turnover of nsp2 
and nsp2TF were investigated in a pulse-chase experiment using a method modified 
from that described by Snijder et al. [419]. Transient PRRSV ORF1a expression in RK-13 
cells, using plasmid pL1a and the recombinant vaccinia virus/T7 polymerase expression 
system, was performed as described previously [419]. See Supporting Information Ma-




Nsp2TF was immunoprecipitated from SD01-08–infected cell lysate using mAb36-19. 
Proteins from IP were separated on a 6% SDS/PAGE gel, which subsequently was fixed 
and stained with Coomassie Brilliant Blue G-250 (Bio-Rad). The gel was destained, 
and the band expected to contain nsp2TF was excised. Trypsin digestion and LC-MS/
MS analysis were performed as described previously [431]. MS spectra were searched 
against a custom-made protein database containing possible nsp2 frameshift proteins.
dNA constructs
Figure 2B lists the constructs used in this study. All constructs were made by standard 
PCR mutagenesis and recombinant DNA techniques and were verified by DNA sequenc-
ing. Further details are given in Supporting Information Materials and Methods.
Rescue and characterization of recombinant PRRsvs
Recombinant PRRSVs were recovered from WT (pSD01-08) or mutant (pSD01-08-KO1 
or pSD01-08-KO2) full-length cDNA clones as described previously [402]. Growth kinet-
ics was examined by infecting MARC-145 cells with passage 2 WT or mutant virus at a 
multiplicity of infection of 0.1. Supernatants from infected cells were collected at 12, 24, 
36, 48, 60, and 72 h p.i., and virus titers were determined by fluorescent focus or plaque 
assay as described previously [402].
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supporting information materials and methods
GenBank accession numbers of sequences used in the bioinformatic analysis. 
Porcine reproductive and respiratory syndrome virus (European genotype, type I)
M96262, AY366525, AY375474, AY588319, DQ489311, DQ864705, EU076704, FJ349261, 
GQ461593, GU047344, GU047345, GU067771, GU737264, JF276430, JF276431, JF276432, 
JF276433, JF276434, JF276435, JF802085.
Porcine reproductive and respiratory syndrome virus (North American genotype, type II)
NC_001961 = AF046869, AB288356, AF066183, AF159149, AF176348, AF184212, 
AF303354, AF303355, AF303356, AF303357, AF325691, AF331831, AF494042, AY032626, 
AY150312, AY150564, AY262352, AY424271, AY457635, AY545985, AY585241, AY612613, 
DQ056373, DQ176019, DQ176020, DQ176021, DQ217415, DQ459471, DQ473474, 
DQ779791, DQ988080, EF075945, EF112445, EF112446, EF112447, EF153486, EF484031, 
EF484033, EF488048, EF488739, EF517962, EF532801, EF532802, EF532803, EF532804, 
EF532805, EF532806, EF532807, EF532808, EF532809, EF532810, EF532811, EF532812, 
EF532813, EF532814, EF532815, EF532816, EF532817, EF532818, EF532819, EF535999, 
EF536000, EF536001, EF536002, EF536003, EF635006, EF641008, EU097706, EU097707, 
EU106888, EU109502, EU109503, EU144079, EU187484, EU200961, EU200962, EU236259, 
EU262603, EU360128, EU360129, EU360130, EU624117, EU678352, EU708726, EU807840, 
EU825723, EU825724, EU860248, EU860249, EU864231, EU864232, EU864233, EU880431, 
EU880432, EU880433, EU880434, EU880435, EU880436, EU880437, EU880438, EU880439, 
EU880440, EU880441, EU880442, EU880443, EU939312, FJ175687, FJ175688, FJ175689, 
FJ393456, FJ393457, FJ393458, FJ393459, FJ394029, FJ536165, FJ548851, FJ548852, 
FJ548853, FJ548854, FJ548855, FJ797690, FJ889129, FJ895329, FJ899592, GQ330474, 
GQ351601, GQ359108, GQ374441, GQ374442, GQ475526, GQ499193, GQ499194, 
GQ499195, GQ499196, GQ857656, GU143913, GU168567, GU168568, GU168569, 
GU169411, GU232735, GU232736, GU232737, GU232738, GU269541, GU454850, 
GU461292, HM011104, HM016158, HM016159, HM189676, HM214913, HM214914, 
HM214915, HM853673, HQ233604, HQ233605, HQ315835, HQ315836, HQ315837, 
HQ401282, HQ416720, HQ699067, HQ843178, HQ843179, HQ843180, HQ843181, 
JF268672, JF268673, JF268674, JF268675, JF268676, JF268677, JF268678, JF268679, 
JF268680, JF268681, JF268682, JF268683, JF268684, JF748717, JF748718, JF796180, 





NC_001639 = U15146, L13298. 
Simian hemorrhagic fever virus
NC_003092 = AF180391, HQ845737, HQ845738.
Equine arteritis virus
NC_002532 = X53459, AY349167, AY349168, DQ846750, EU252113, EU252114, 
EU586273, EU586274, EU586275, GQ903794, GQ903795, GQ903796, GQ903797, 
GQ903798, GQ903799, GQ903800, GQ903801, GQ903802, GQ903803, GQ903804, 
GQ903805, GQ903806, GQ903807, GQ903808, GQ903809, GQ903810, GQ903811, 
JN211316, JN211317, JN211318, JN211319, JN211320.
Statistical significance of the long ORF in simian hemorrhagic fever virus
The statistical significance of the conserved presence of the long TF ORF (Figure 1C) in 
the three highly divergent simian hemorrhagic fever virus (SHFV) sequences was evalu-
ated by randomly shuffling ORF1a-frame codon columns within the TF ORF region and 
calculating what fraction of shuffled alignments preserve an ORF in the +1 frame. This 
procedure controls for any bias for or against random long +1 frame ORFs resulting from 
ORF1a-frame amino acid use, codon use, or nucleotide biases and also controls for phy-
logenetic nonindependence. In fact, the proportion of randomizations that preserve a 
+1 frame ORF was too small to estimate directly (0 occurrences in 4,000 randomizations) 
and so was estimated instead from the mean number (per randomized alignment) of 
+1 frame alignment codon columns containing stop codons in one or more sequences 
(viz., 24.70), assuming Poisson statistics. Using this method, the P value for such a long 
+1 frame ORF occurring by chance in this region of the SHFV alignment is 1.9 × 10−11. 
Neither this statistic for SHFV (1.9 × 10−11) nor the conservation statistic quoted in the 
main text for porcine reproductive and respiratory syndrome virus (PRRSV) (1 × 10−64) 
has been corrected for multiple tests. In principle one might consider testing the whole 
genome (~15,000 nt) for conserved regions and/or conserved ORFs of ~200 codons, 
and, in principle, one might apply such an analysis to the ~1,000 RNA virus species rep-
resented in GenBank, making a total of ~25,000 independent tests. Thus, the P values 
should be scaled by ~25,000 (giving 2.5 × 10−60 and 4.8 × 10−7, respectively), although a 
correction for multiple testing is not, in fact, required for the SHFV statistic, because the 
location of the 5′ end of the TF ORF in SHFV is known a priori (it aligns to the 5′ end of 
the TF ORF in PRRSV). 
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DNA constructs
Plasmid pL1a was a derivative of a similar equine arteritis virus (EAV) ORF1a expression 
vector, in which the foreign gene is under the control of a T7 RNA polymerase promoter 
and an encephalomyocarditis virus internal ribosomal entry site and is followed by a 
downstream T7 terminator sequence [419]. The EAV ORF1a sequence was replaced by 
PRRSV SD01-08 ORF1a (nucleotides 1–7137 of the genome). To construct the nsp2TF 
knockout mutants (Fig. 2B), mutations were introduced into the nsp2 region of the 
expression vector pL1a or a PRRSV full-length cDNA infectious clone plasmid pSD01-08 
[402]. Except for the KO2 mutant, for which a synthesized oligonucleotide was used, all 
mutations were introduced by site-directed mutagenesis using the Quick-Change site-
directed PCR mutagenesis kit (Stratagene). The pCAGGS-nsp2 and pCAGGS-nsp2TF plas-
mids were constructed by PCR amplification of the nsp2- and nsp2TF-encoding regions 
from plasmid DNA of pL1a and pL1a-IFC, respectively, and cloning of PCR products into 
a eukaryotic expression vector, pCAGGS [432].
Antibodies
For type I PRRSV SD01-08, anti-nsp2 mAbs 36-19 and 58-46 were produced by immuniz-
ing mice with amino acids 386–821 of pp1a. Anti-nsp4 mAb 54-19 was produced by 
immunizing mice with amino acids 1677–1879 of pp1a [403]. For type II PRRSV SD23983, 
anti-nsp2 mAbs 140-68 and 148-43 were produced by immunizing mice with amino 
acids 435–514 of SD23983 pp1a. A polyclonal affinity-purified rabbit Ab, pAb- TF, was 
produced by GenScript using the synthetic peptide CPKGVVTSVGESV (C-terminal 13 
amino acids of nsp2TF). Abs for detection of cellular marker proteins comprised a pAb 
against protein disulfide isomerase (PDI) (Enzo), anti-giantin mAb G1/93 (Alexis), and 
anti-ERGIC-p53 mAb G1/133 (Alexis). 
Immunofluorescence microscopy
MARC-145 cells were infected with PRRSV [multiplicity of infection (MOI) 0.1] or were 
transfected with pCAGGS-nsp2 or pCAGGS-nsp2TF. At 18–24 h postinfection (p.i.) or 
24–48 h posttransfection (p.t.) cells were fixed with paraformaldehyde, and single or 
double immunolabeling and immunofluorescence microscopy were performed essen-
tially as described previously [369, 403]. 
Immunoprecipitation and SDS/PAGE
Whole-cell lysates of PRRSV- infected MARC-145 cells were suspended in RIPA buffer 
[0.5% (wt/vol) sodium deoxycholate, 1% (wt/vol) SDS, 1% (vol/vol) Nonidet P-40, 100 mM 
NaCl, 1 mM EDTA (pH 8.0), 10 mM Tris·HCl (pH 7.5)]. To reduce nonspecific background, 
cell lysates were precleared with preimmune rabbit sera or nonspecific mouse ascites. 
Protein A-Sepharose CL-4B beads (Pharmacia Biotech) and an nsp2-specific mAb were 
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added to precleared cell lysates. After incubating overnight at 4°C, immune complexes 
were washed three times with RIP buffer (10 mM Tris·HCl, 150 mM NaCl, 1% Nonidet 
P-40, 0.5% sodium deoxycholate) and three times with deionized H2O. After boiling in 
2× Laemmli sample buffer for 5 min, proteins were separated on a 6% SDS/PAGE gel.
Western blot
Western blot was performed as described previously [403]. The membrane was probed 
with primary nsp2- and/or nsp2TF-specific Abs. IRDye 680-conjugated goat anti-rabbit 
Ab and/or IRDye 800CW-conjugated goat anti-mouse Ab (LI- COR Biosciences) were 
used as secondary Abs. Imaging of the blot was performed using an Odyssey infrared 
imaging system (LI-COR-Biosciences).
Radioactive labeling and radioimmunoprecipitation analysis
To analyze PRRSV SD01-08 nsp2TF expression in infected MARC- 145 cells (MOI 0.1), cells 
were starved for 30 min in Met- and Cys-free medium, and at 24 h p.i. proteins were 
pulse-labeled for 1 h with 500 µCi/mL of a [35S]Met/Cys mixture (EXPRE35S35S Protein 
Labeling Mix; Perkin-Elmer). Following two PBS washes, cells were incubated for various 
chase periods up to 24 h in DMEM containing 2 mM each of unlabeled Met and Cys 
and 2% FCS. Transient PRRSV ORF1a expression in RK-13 cells, using plasmid pL1a and 
the recombinant vaccinia virus/T7 polymerase expression system, was performed as de-
scribed previously [419]. Pulse-chase experiments were performed as described above 
at 4 h p.t. using a 30-min pulse of 500 µCi of [35S]Met/Cys per mL. Protocols for cell 
lysis, immunoprecipitation, SDS/PAGE, and imaging (Typhoon Variable Mode Imager; GE 
Healthcare) have been described previously [403].
Calculation of frameshifting efficiencies
Band intensities (nsp2, nsp2′, nsp2TF, nsp2TF′, and nsp2N) were quantified with Im-
ageQuant TL (GE Healthcare) and normalized by the Met+Cys content of the respective 
products assuming that 35S Met and 35S Cys are incorporated with an efficiency ratio 
of 73:22 (the Met:Cys ratio in the mixture according to the manufacturer’s documenta-
tion). (Note that calculated frameshifting efficiencies were only 1.06–1.07 times higher if 
equal incorporation efficiencies were assumed instead.) Radioactivity in the two bands 
at around 200 kDa was quantified and normalized assuming that these products rep-
resent nsp2–8; the product migrating at around 98 kDa was assumed to have Met and 
Cys content similar to that of nsp2N; and the two products migrating at around 90 kDa 
were assumed, based on migration position, to have half as many Met and Cys residues 
as nsp2. Using these values (Table S1), frame- shifting efficiencies were calculated as 
(nsp2TF + nsp2TF′)/(nsp2 + nsp2′ + nsp2TF + nsp2TF′ + nsp2N) (upper bound) and 
(nsp2TF + nsp2TF′)/(nsp2 + nsp2′ + nsp2TF + nsp2TF′ + nsp2N + 200K products + 98K 
138 A + RNA virus diptych
product + 90K products) (lower bound) for −2 frameshifting, and similarly, using nsp2N 





% radioactive label Adjusted for Met/Cys* (%s) Adjusted for Met/Cys† (%s)
200K (upper) 2.4 1.1 1.0
200K (lower) 0.5 0.3 0.2
nsp2 59.1 50.7 51.8
nsp2′ 5.2 4.5 4.6
nsp2TF 13.3 13.8 13.0
nsp2TF′ 2.8 2.9 2.8
nsp2N 4.4 6.0 5.6
98K 1.2 1.6 1.5
90K (upper) 1.9 3.3 3.3
90K (lower) 9.2 15.8 16.1
supporting information Table s1. Radioactive incorporation into nsp2-related products in virus-infect-
ed cells. *Assuming equal incorporation efficiencies for 35S Met and 35S Cys. Met and Cys content for the 
unidentified nsp2-related products migrating at around 200K, 98K, and 90K are estimated as described in 
SI Materials and Methods. †Assuming 35S Met and 35S Cys are incorporated with an efficiency ratio of 73: 22.
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supporting information figures
supporting information figure s1: mass spectrometric analysis of nsp2Tf and nsp2N purified from 
cells infected with type i PRRsv isolate sd01-08. (A) PRRSV-infected or mock-infected MARC-145 cell 
lysates were immunoprecipitated with nsp2-specific mAb36-19. Immunoprecipitated proteins were sepa-
rated by SDS/PAGE and stained with Coomassie Blue. Positions of molecular mass markers and putative 
PRRSV proteins are indicated. (B) Fragmentation spectra of the shift-site peptide LMTWvfLK (shift site-
encoded amino acids in bold) identified from the gel slice containing the band labeled nsp2TF (Upper) and 
the synthetic peptide (Lower). (C) Peptide sequence of the nsp2TF shift-site peptide. The fragment ions that 
were identified in the LC-MS/MS analysis of the gel slice are indicated. (D) Complete amino acid sequence 
of the predicted −1 frameshift product, nsp2N (see main text for the corresponding figure, Figure 4B, for 
nsp2TF). Peptides identified by mass spectrometry of the gel slice containing the band labeled nsp2N are 




supporting information figure s2: mass spectrometric analysis of nsp2Tf purified from cells infect-
ed with type ii PRRsv isolate sd23983. (A) PRRSV-infected or mock-infected MARC-145 cell lysates were 
immunoprecipitated with nsp2-specific mAb140-68. Immunoprecipitated proteins were separated by SDS/
PAGE and stained with Coomassie Blue. Positions of molecular mass markers and putative PRRSV proteins 
are indicated. (B) Complete amino acid sequence of nsp2TF. Peptides identified by mass spectrometry are 
in red. The C-terminal 169 amino acids encoded by the +1 reading frame are highlighted in gray. The N-
terminal 850 amino acids are shared with nsp2. The peptide spanning the frameshift site is underlined in 
green. (C) Fragmentation spectrum of the shift-site peptide QvfLTSSPISLFSSHAFSTR (shift site-encoded 
amino acids in bold). (D) Peptide sequence of the nsp2TF shift-site peptide. The fragment ions that were 
identified in the LC-MS/MS analysis of the gel slice are indicated.




























supporting information figure s3: if microscopy analysis of the subcellular localization of nsp2Tf in 
PRRsv-infected mARC-145 cells at 24 h p.i. (A and B) and a CMV promoter-driven expression system for 
nsp2TF (C–E) and nsp2 (F). (A) Infected cells were double labeled with pAb-TF and an mAb recognizing the 
ERGIC marker p53, revealing a substantial overlap between the two labeling patterns. (B) Double labeling 
with pAb-TF and an mAb directed against the Golgi marker giantin. Partial colocalization was observed, 
and the two labelings seemed to influence each other, because cells with a strong nsp2TF signal showed 
a weaker giantin signal (e.g., the cell in the middle). (C) Nsp2TF-expressing MARC-145 cells double labeled 
with pAb-TF and the anti-p53 mAb. As in infected cells, a considerable overlap was observed. (D) Double 
labeling with pAb-TF and the anti-giantin mAb, again showing partial colocalization. (E) Double labeling 
with pAb-TF and anti-nsp2 mAb 58-46 showing identical labeling patterns, indicating that mAb 58-46 does 
recognize nsp2TF in nsp2TF-expressing MARC-145 cells, in contrast to observations in PRRSV-infected cells 
(Fig. 7). (F) Nsp2-expressing MARC-145 cells double labeled for the endoplasmic reticulum marker PDI 
(pAb) and nsp2 (mAb58-46), showing partial colocalization. Cell nuclei were stained with Hoechst 33258. 
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AbsTRACT
Programmed -1 ribosomal frameshifting (–1 PRF) is a widely used translational mecha-
nism facilitating the expression of two polypeptides from a single mRNA. Commonly, the 
ribosome interacts with an mRNA secondary structure that promotes –1 frameshifting on 
a homopolymeric slippery sequence. Recently, we described an unusual –2 frameshift-
ing (–2 PRF) signal directing efficient expression of a transframe protein [nonstructural 
protein 2TF (nsp2TF)] of porcine reproductive and respiratory syndrome virus (PRRSV) 
from an alternative reading frame overlapping the viral replicase gene. Unusually, this 
arterivirus PRF signal lacks an obvious stimulatory RNA secondary structure, but as 
confirmed here, can also direct the occurrence of –1 PRF, yielding a third, truncated nsp2 
variant named “nsp2N.” Remarkably, we now show that both –2 and –1 PRF are transac-
tivated by a protein factor, specifically a PRRSV replicase subunit (nsp1β). Embedded in 
nsp1β’s papain-like autoproteinase domain, we identified a highly conserved, putative 
RNA-binding motif that is critical for PRF transactivation. The minimal RNA sequence 
required for PRF was mapped within a 34-nt region that includes the slippery sequence 
and a downstream conserved CCCANCUCC motif. Interaction of nsp1beta with the PRF 
signal was demonstrated in pull-down assays. These studies demonstrate for the first 
time, to our knowledge, that a protein can function as a transactivator of ribosomal 
frameshifting. The newly identified frameshifting determinants provide potential anti-
viral targets for arterivirus disease control and prevention. Moreover, protein-induced 
transactivation of frameshifting may be a widely used mechanism, potentially including 
previously undiscovered viral strategies to regulate viral gene expression and/or modu-




Among the repertoire of mechanisms that viruses use to control or regulate their gene 
expression, non-canonical translation plays an important role, in particular for positive-
strand RNA viruses whose genomic RNA serves a dual function as mRNA and genome 
[reviewed in [323]]. A commonly used strategy is –1 programmed ribosomal frame-
shifting (–1 PRF), in which mRNA signals induce a significant proportion of translating 
ribosomes to change reading frame, with ribosomes slipping back (in the 5’ direction) 
by one nucleotide (nt) into an overlapping open reading frame (ORF) before continuing 
translation, generating a fusion protein composed of the products of both upstream 
and downstream ORFs [reviewed in [323, 336, 396, 433]]. PRF was first described as the 
mechanism by which the Gag-Pol polyprotein of the retrovirus Rous sarcoma virus (RSV) 
is expressed from overlapping gag and pol ORFs [434, 435] and related signals have 
since been documented in many other viruses of medical, veterinary, and agricultural 
importance [436-440]. PRF has also been increasingly recognized in cellular genes of 
both prokaryotes and eukaryotes as well as in other replicating elements, such as inser-
tion sequences and transposons [441].
Recently, we identified an unusual –2 programmed ribosomal frameshifting (–2 
PRF) event that operates during the translation of the genome of porcine reproduc-
tive and respiratory syndrome virus (PRRSV), a member of the arterivirus family in the 
order Nidovirales [442]. PRRSV can be divided into distinct European (EU, type 1) and 
North American (NA, type 2) genotypes. The viral genome comprises a positive-sense 
RNA molecule, ~15 kb in length [339]. As in other nidoviruses, its 5’ proximal region 
contains two large replicase open reading frames [ORF1a and ORF1b; [361]], with the 
ORF1b product being expressed as a fusion with the ORF1a product following –1 PRF in 
the short ORF1a/ORF1b overlap region (see Figure 1). Four ORF1a-encoded proteinases 
(residing in nsp1α, nsp1β, nsp2, and nsp4) subsequently cleave the pp1a and pp1ab 
polyproteins into (at least) 14 different nonstructural proteins (nsps; Figure 1A). The 
recently identified –2 PRF signal is located several kilobases upstream of the ORF1a/
ORF1b –1 PRF signal, and maps to the part of ORF1a that encodes nsp2. This large, 
multifunctional replicase subunit is involved in diverse steps of the arterivirus replica-
tive cycle, including replicase polyprotein processing [418], the formation of replication 
structures [369, 443], and innate immune evasion [167, 420-422]. At the PRRSV –2 PRF 
signal, a proportion of ribosomes back up two nucleotides, to generate a transframe 
fusion protein (nsp2TF) comprising the N-terminal two-thirds of nsp2 and the product 
encoded by a conserved alternative ORF (transframe; TF) in the –2 reading frame. Com-
pared to full-length nsp2, the nsp2TF product is truncated, equipped with an alternative 
C-terminal transmembrane domain (Figure 1A), and targeted to a different subcellular 
compartment [442]. Mutations preventing nsp2TF expression reduce PRRSV replication 
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efficiency in cell culture 50- to 100-fold, highlighting the biological importance of the 
frameshifting event and nsp2TF expression. The –2 PRF takes place at a highly conserved 
RG_GUU_UUU slippery sequence (R = G or A), and frameshifting is remarkably efficient 
[around 20% in virus-infected cells and up to 50% in expression systems; [442]]. 
As depicted in Figure 1B-C, the elements that promote PRF in PRRSV are quite distinct. 
The –1 PRF signal at the ORF1a/1b junction comprises a “slippery” sequence (generally 
U_UUA_AAC) where the ribosome changes frame, and a stimulatory RNA pseudoknot 
structure immediately downstream, an organization that is conserved throughout the 
Nidovirales order [345, 395] and widely used in other viral –1 PRF mechanisms. It is 
thought that interaction of the translating ribosome with the pseudoknot confounds 
its RNA-unwinding activity [444, 445] and may induce tension in the mRNA that assists 
in the uncoupling of codon:anticodon interactions at the shift site [337, 407, 446]. In 
contrast, only a few cases of –2 PRF in mammalian cells have been documented thus far 
[407, 442] and the elements involved are poorly understood. Our previous computer-
figure 1: PRRsv genome organization and location of ribosomal frameshifting signals. (A) Overview 
of the ~15-kb PRRSV genome. The long 5′ ORFs 1a and 1b encode nonstructural polyproteins, and at least 
eight shorter 3′ ORFs (2a-7) encode structural proteins. The 3′ ORFs are translated from a nested set of 
subgenomic mRNAs, two of which are bicistronic. ORF1a and ORF1b are translated from the genomic RNA, 
with translation of ORF1b depending on −1 PRF at the end of ORF1a. The TF ORF overlaps the central ORF1a 
region in the −2 reading frame and is accessed via −2 PRF [442]. A –1 frameshift at the same site generates 
the nsp2N product (see text). The vertical red line indicates the location of the RG_GUU_UUU shift site (R = 
A or G, in different arteriviruses). Domains in nsp2/nsp2TF: PLP2, papain-like proteinase; HVR, hypervariable 
region; TM/TM′, (putative) trans-membrane domains; C, Cys-rich domain. (B) Sequence of the SD01-08 RNA 
in the region of the −2/−1 PRF signal, with the slippery sequence (red) and C-rich motif (blue) highlighted. 
The −1 reading frame stop codon is underlined and codons for each of the reading frames are indicated. (C) 
Features of the canonical −1 PRF signal present in the PRRSV ORF1a/ORF1b overlap region. The stimulatory 
RNA pseudoknot is composed of two stems connected by single-stranded loops.
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based RNA folding analysis suggested that the RNA downstream of the slippery se-
quence (RG_GUU_UUU) used for –2 PRF in PRRSV is rather unstructured and does not 
fold into a structure compatible with canonical RNA-structure-stimulated PRF. However, 
mutations within a conserved CCCANCUCC motif located 11 nt downstream of the shift 
site can reduce or inhibit frameshifting, consistent with the presence of a 3’ stimulatory 
element of some form [442]. Remarkably, our previous study also provided indications 
for the occurrence of efficient –1 frameshifting at (or near) the same slippery sequence. 
Due to the presence of a translation termination codon in the –1 reading frame immedi-
ately following the slippery sequence, this would yield a truncated form of nsp2, termed 
nsp2N (Figure 1A).
In this report, we identify PRRSV replicase subunit nsp1β as a transactivator of efficient 
–2 and –1 PRF at the same slippery sequence and provide evidence that its frameshift-
stimulatory activity requires interaction with the viral mRNA. In support of this, a highly 
conserved putative RNA-binding motif (GKYLQRRLQ), integrated into the structure of 
nsp1β’s papain-like autoproteinase domain, was found to be critical for the stimulation 
of frameshifting and for interacting with the RNA sequence of the PRRSV PRF signal. 
The minimal RNA sequence required to direct efficient PRF was mapped within a 34-nt 
region of the PRRSV nsp2-coding sequence that includes the shift site and the con-
served CCCANCUCC motif. Our findings reveal an unusual non-canonical translation 
mechanism in which a viral protein functions as a transactivator of efficient –2 and –1 
PRF. This study advances our understanding of non-canonical translation, suggests that 
viruses may employ additional strategies to modulate viral and potentially host cell 
translation during infection, and has practical implications in biotechnology and the 
design of antiviral strategies.
REsuLTs
Alternative –2 and –1 PRf at the same PRRsv slippery sequence
Previously [442], we demonstrated expression of the PRRSV TF ORF (Figure 1A) using 
a rabbit antiserum raised against the epitope on the C-terminus of the polypeptide it 
encodes. Subsequently, the frameshift product was immunopurified from infected cells 
and mass spectrometry (MS) was employed to identify both the site (RG_GUU_UUU) 
and direction (–2, rather than +1) of ribosomal frameshifting. In both PRRSV-infected 
cells and an ORF1a expression system, and using distantly related type 1 and type 2 
PRRSV isolates, the same studies revealed an additional nsp2-related product (nsp2N) 
with a size consistent with –1 PRF occurring at the same site [estimated efficiency ~7%; 
[442]]. However, a stop codon is present in the –1 frame immediately downstream of the 
RG_GUU_UUU slippery sequence (Figure 1A) and consequently, if nsp2N were derived 
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from –1 frameshifting, it would lack a unique C-terminal sequence that could be used 
to discriminate it from a product derived through the internal proteolytic cleavage of 
full-length nsp2. In an attempt to confirm the occurrence of –1 PRF by IP-MS, we sought 
to extend the potential –1 frameshift product with a unique C-terminal signature. In a 
full-length cDNA clone of the previously used PRRSV isolate SD01-08 [a type 1 virus; 
[402]], the –1 frame stop codon (UGA) was replaced by a tryptophan codon (UGG), ex-
tending the –1 frame by an additional 87 codons (Figure S1, SD01-08-M1). However, this 
point mutation unavoidably also introduced amino acid substitutions in the overlap-
ping 0 and –2 frames encoding nsp2 and nsp2TF (Glu→Gly and Lys→Glu, respectively), 
and perhaps as a consequence, the resulting recombinant virus was severely crippled 
(titer reduced to 103 FFU/ml), preventing us from immunopurifying sufficient nsp2N for 
reliable MS analysis. We, therefore, reverted to a type 2 PRRSV isolate [SD95-21; [447]] 
and introduced the same A to G mutation, which in this case extended the –1 ORF by 23 
additional codons to generate mutant SD95-21-M1 (Figure S1). Fortunately, despite car-
rying Asp→Gly and Thr→Ala mutations in the nsp2 and nsp2TF products respectively, this 
recombinant virus replicated to much higher titers (106.2 FFU/ml) and the C-terminally 
extended nsp2N product (nsp2N*) could be immunopurified from infected MARC-145 
cells. A gel slice containing the nsp2N* band was analyzed by LC/MS/MS and a QVFWPR 
tryptic peptide that spanned the frameshift site and is compatible with −1 PRF at the 
RG_GUU_UUU sequence was identified (Figure S2). To verify correct identification of this 
peptide, a synthetic version was subjected to the same LC/MS/MS analysis. The tandem 
mass spectrum of this synthetic peptide was found to be identical to that of the peptide 
derived from the nsp2N*-containing gel slice (Figure S2D), confirming that nsp2N is in-
deed translated via −1 PRF at the RG_GUU_UUU slippery sequence, which is, therefore, 
able to direct both −1 and −2 PRF.
PRRsv nsp1β is required for efficient −1 and −2 frameshifting in the nsp2-
coding region
Previously we demonstrated that translation of the complete PRRSV ORF1a sequence is 
sufficient to allow efficient –2 PRF [442]. To define the minimal sequence requirements 
for –2/–1 PRF in PRRSV isolate SD01-08, we focused our attention on the N-terminal 
half of ORF1a (the nsp1α-nsp3 region) and generated a panel of truncated ORF1a con-
structs (Figure 2A) for expression in the recombinant vaccinia virus/T7 RNA polymerase 
system [429]. Following radiolabeling of proteins synthesized in transfected RK-13 cells, 
expression of nsp2, nsp2TF, and nsp2N was analyzed by immunoprecipitation using 
monoclonal antibody (mAb) α-EU-nsp2 and rabbit antiserum α-EU-TF, recognizing all 
three nsp2-related products and the unique C-terminal epitope of nsp2TF, respectively 
(see Figure S1B for a summary of antibody nomenclature and epitopes recognized). As 
shown in Figure 2B, constructs lacking the nsp1α- and/or nsp3-coding region still ef-
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figure 2: PRRsv nsp1β transactivates –2/–1 PRf. (A) Schematic representation of expression products 
from vectors encoding different combinations of replicase subunits from the nsp1α-nsp3 region of type 1 
PRRSV (isolate SD01-08), expressed as single nsps or self-cleaving multi-nsp polyproteins. PRRSV pp1a and 
its processing scheme are shown at the top and the –2 and –1 frameshift products, nsp2TF and 2N, are 
shown in light and dark grey with the polypeptide encoded by the TF ORF indicated in black. The arrow in-
dicates the PRF site and untranslated parts of the –2 and –1 reading frames are hatched. The scheme below, 
for each expression vector used in panel B, shows which nsps were expressed, with arrows indicating the 
occurrence of –2/–1 PRF and “X” indicating lack of efficient frameshifting. Nsp2-3-IFC (13) is an engineered 
in-frame control construct that expresses nsp2TF only, due to the insertion of two nucleotides at the PRF 
site (circle). (B) Expression of different protein combinations (see panel A) using the recombinant vaccinia 
virus/T7 RNA polymerase expression system and RK-13 cells, revealing that nsp1β expression is required 
for efficient –2/–1 PRF. After metabolic labeling, expression products were immunoprecipitated with the 
antibodies indicated below each panel; mAb α-EU-nsp2 recognizes the common N-terminal domain of 
nsp2, nsp2TF, and nsp2N, while α-EU-TF recognizes the C-terminal domain of nsp2TF. Immunoprecipitated 
proteins were separated by SDS-PAGE and visualized by autoradiography. (C) Analysis of –2/–1 PRF trans-
activation by nsp1β using the recombinant vaccinia virus/T7 RNA polymerase expression system as de-
scribed for B. RK-13 cells were transfected with plasmid DNAs expressing nsp2, nsp1β-2, nsp2+nsp1β (from 
separate plasmids), or nsp1βcc-2, with the latter containing an nsp1β-coding sequence in which the large 
majority of codons had been synonymously mutated (Figure S3). Expression products were immunopre-
cipitated using specific antibodies indicated at the bottom of each panel and visualized by SDS-PAGE and 
autoradiography.
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ficiently expressed nsp2TF and nsp2N. In contrast, constructs lacking the nsp1β-coding 
region expressed nsp2 but only trace amounts of nsp2TF or nsp2N were detected. This 
indicates that nsp1β, or the RNA sequence encoding nsp1β, is required for efficient 
–2/–1 PRF at the RG_GUU_UUU slippery sequence in the nsp2-coding region, located 
some 2.5 kb downstream of the nsp1β-coding region. 
Extending this further, using the same expression system, nsp2 and nsp1β were ex-
pressed from separate, co-transfected plasmids (pLnsp2 and pLnsp1β) rather than as 
a self-cleaving nsp1β-2 polyprotein (pLnsp1β-2). Again, both nsp2TF and nsp2N were 
produced (Figure 2C), indicating that nsp1β can stimulate –2/–1 PRF in the nsp2-coding 
region in trans. To establish whether this effect was mediated by the nsp1β protein or 
the nsp1β-coding RNA sequence, a drastically altered version of the nsp1β-2 expression 
vector was produced in which almost every codon of the nsp1β-coding sequence was 
mutated synonymously, while avoiding rare codons (mutant pLnsp1βcc-2; Figure S3). 
This pLnsp1βcc-2 construct expresses an unaltered nsp1β protein, but the nucleotide 
sequence encoding it is changed to such an extent that we would expect to have 
disrupted any primary sequence or RNA secondary structure elements that might 
be involved in –2 PRF (for example, an element having a long-range interaction with 
the PRF region in the nsp2-coding sequence). Immunoprecipitation analysis revealed 
that nsp2TF and nsp2N were expressed with equal efficiency in cells transfected with 
pLnsp1βcc-2 and wild-type pLnsp1β-2 (Figure 2C), indicating that PRF stimulation 
involves the nsp1β protein rather than an RNA signal in the nsp1β-coding sequence.
minimal RNA sequence requirements for –2/–1 PRf
We next set out to define the minimal RNA sequences in the nsp2-coding region that 
are required for efficient –2/–1 PRF. To this end, we prepared a reporter gene construct 
in which PRRSV RNA sequences from the PRF-inducing region were placed between two 
luciferase genes [pDluc [448, 449]; Figure 3A]. Whereas the ORF1a frame of the PRRSV 
insert was placed in-frame with the upstream (Renilla) luciferase gene, the downstream 
(firefly) luciferase was in the –2 frame and thus its expression depended on the occur-
rence of –2 frameshifting. Also –1 PRF could be monitored, since the native stop codon 
in the –1 frame was retained and –1 PRF would, therefore, yield a polypeptide slightly 
shorter than the product resulting from translation termination in the zero reading 
frame. As controls, an in-frame control (IFC) construct was also prepared in which the 
two luciferase genes were aligned in the same frame by inserting two nucleotides (CU) 
immediately downstream of the slippery sequence. A previously described PRF knock-
out construct [KO2; Figure S1; [442]] containing point mutations within the slippery 
sequence and downstream C-rich region was also included in the analysis. 
Initially, a 79-nt region spanning 5-nt upstream of the slippery sequence to 66-nt 
downstream (including the conserved CCCANCUCC motif ) was cloned between the 
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figure 3: delineation of RNA elements required for PRRsv –2/–1 PRf. (A) Schematic representation of 
the pDluc dual luciferase construct. The GG_GUU_UUU shift site, 5 upstream nucleotides and 66 down-
stream nucleotides (79 nt in total) were inserted between the Renilla and firefly luciferases genes such that 
–2 PRF is required for firefly luciferase expression. (B) Dual luciferase reporter assay showing that efficient –2 
PRF depends on co-expression of nsp1β. For type1 PRRSV (isolate SD01-08), nsp1β was co-expressed with 
dual luciferase constructs containing a WT or –2 PRF knock out (KO2) frameshift signal. Mutant KO2 [Figure 
S1; [442]] contains point mutations within both slippery sequence and downstream C-rich motif. The –2 
PRF efficiencies were calculated by comparing the ratio of firefly and Renilla luciferase activities, using the 
in-frame control mutant (IFC, Figure S1A) as a reference. Error bars represent the standard deviation of three 
independent experiments, in which each construct was transfected in duplicate. The bottom panel shows 
a Western blot analysis confirming equal expression of nsp1β and equal loading (β tubulin). (C) Delineation 
of the minimal RNA sequence requirements for efficient –2/–1 PRF. Starting from a construct containing 
the 66 nt downstream of the slippery sequence, a series of 3’ truncations was engineered in pDluc. Upon 
co-expression with nsp1β, cell lysates were analyzed by Western blot, using an antibody recognizing the 
common Renilla luciferase part of all pDluc translation products (see panel A). The number below each lane 
represents the remaining PRRSV-specific RNA sequence downstream of the slippery sequence, of which 21 
nt were sufficient for efficient –2/–1 PRF in this assay. 
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two luciferase genes (construct pDluc-WT). Frameshifting efficiencies were determined 
by comparing the ratio of enzymatic activities of firefly and Renilla luciferase in parallel 
HEK-293T cell cultures transfected with individual pDluc constructs with or without co-
transfection of the plasmid expressing nsp1β. As shown in Figure 3B, in comparison to 
the IFC control, the wild-type PRRSV –2 PRF efficiency was ~38%, and this high-level of 
–2 PRF was only observed in cells co-transfected with the nsp1β-expressing plasmid; 
in the absence of the transactivator, only low levels of –2 PRF (<5%) were observed. As 
expected, frameshifting was not observed in cells transfected with pDluc-KO2. Western 
blot analysis of transfected cell lysates revealed that both efficient –2 PRF and efficient 
–1 PRF could be observed with pDluc-WT provided that an nsp1β expression plasmid 
was co-transfected (Figure 3C). These data indicated that the 79-nt PRRSV sequence 
included in pDluc-WT contains all cis-acting sequences required for efficient –2/–1 PRF, 
and that, as documented above, both types of frameshift depend on the presence of 
nsp1β. In the absence of this transactivator, only low levels of PRF were observed. 
To further investigate the key RNA sequences required for PRF, in-frame deletions 
were introduced into pDluc-WT, starting from the 3’ end of the PRRSV insert. As shown 
in Figure 3C, an initial deletion that reduced the PRRSV sequence downstream of the 
shift site to 45 nt (pDluc-45) led to a small reduction in –2 PRF (about 2-fold), albeit with 
a concurrent increase in –1 PRF. Subsequent deletions had no further effect until part 
of the conserved CCCANCUCC motif was removed (Figure 3C; compare pDluc-21 and 
pDluc-15). In pDluc-15, which lacked the second half (CUCC) of the conserved motif, 
the capacity for transactivation of PRF by nsp1β was lost. These data provided further 
support for a role of the C-rich motif in PRF, and allowed us to define the functional 
PRRSV –2/–1 PRF cassette as a 34-nt region containing the slippery sequence and the 3’ 
C-rich motif.
identification of a conserved nsp1β motif that is critical for PRf transactivation
The nsp1α-nsp1β region has previously been implicated in a variety of processes in the 
arterivirus replicative cycle, including replicase polyprotein processing [416], transcrip-
tional control [450, 451], and innate immune evasion [447, 452]. An analysis of nsp1β se-
quence conservation (Figure 4A), together with the published crystal structure of nsp1β 
from a type 2 PRRSV isolate [[453]; Figure 4B-C], pointed towards a previously identi-
fied conserved sequence motif as a potential RNA interaction domain. This sequence, 
GKYLQRRLQ in both type 1 and type 2 PRRSV, forms one of three alpha-helices [labeled 
α4 in [453]] in the region between the active site Cys and His residues of the papain-
like proteinase domain (PLP1β) that constitutes the C-terminal two-thirds of nsp1β. 
Interestingly, compared to the active site of the PLP1β proteinase, helix α4 maps to the 
other side of the molecule and, in the available crystal structure, the three conserved 
basic residues of the GKYLQRRLQ motif are exposed on the nsp1β surface. Moreover, in 
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figure 4: PRRsv nsp1b sequence and structure. (A) Amino acid sequence alignment of the PLP1b do-
mains from selected arterivirus nsp1β proteins. Secondary structure elements [based on the published 
crystal structure from type 2 PRRSV isolate XH-GD; [453]] are shown above the alignment and are color-
matched to the nsp1β structure in panel B. Conserved basic residues in PLP1b helix a4 are boxed in orange; 
#, residues mutated in mutant 1βKO (see text for details); *, PLP1b active site residues. PRRSV sequences are 
numbered (black) from the nsp1α/nsp1β cleavage site, whereas all other sequences are numbered (grey) 
starting from the N-terminus of the pp1a polyprotein. EAV, equine arteritis virus; LDV, lactate dehydroge-
nase elevating virus; SHFV, simian hemorrhagic fever virus; names of specific isolates used are indicated. 
Genbank accession numbers of sequences used: EU624117 (PRRSV XH-GD), DQ489311 (PRRSV SD01-08), 
KC469618 (PRRSV SD95-21), NC_001639 (LDV P), NC_003092 (SHFV LVR), HQ845737 (SHFV krc1), HQ845738 
(SHFV krc2), JX473847 (SHFV krtg1), NC_002532 (EAV Bucyrus). (B) Cartoon representation of the crystal 
structure of the nsp1b dimer from a type 2 PRRSV isolate [PRRSV XH-GD; PDB entry 3MTV; [453]]. For both 
monomers, the N-terminal domain is colored purple, whereas the PLP1b domain and the C-terminal exten-
sion (leading up to the nsp1b/nsp2 site cleaved by PLP1b) are colored green and red, respectively. Helix a4 
of PLP1b, containing the conserved GKYLQRRLQ motif, is colored orange with basic residues represented 
as sticks. (C) Electrostatic surface representation of the nsp1b dimer showing the positively charged (blue) 
patches on helix a4 of PLP1b (boxed in orange) created by the basic residues of the GKYLQRRLQ motif. 
Both patches reside on the same side of the structure, potentially allowing for RNA to bind across the entire 
dimer surface. 
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the nsp1β homodimer that was the basis for structural studies, the α4 helices of both 
monomers map to the same side of the dimer and may form a continuous surface across 
the protein that binds nucleic acid (Figure 4C; see Discussion). 
In a recent study [447], the GKYLQRRLQ motif was targeted by site-directed muta-
genesis and the Lys and the first Arg of the motif were replaced with Ala (mutant 1βKO, 
Figure S1). For both PRRSV genotypes, the replication of the 1βKO mutant in MARC-145 
cells was found to be seriously crippled. The fact that we had observed similar defects in 
mutants in which the –2/–1 PRF signal had been inactivated, or in which the expression 
of a functional nsp2TF was prevented [442], prompted us to investigate whether this 
KR→AA double mutation affected nsp2TF/nsp2N expression. Strikingly, upon expression 
of nsp1β-nsp2 from either PRRSV genotype carrying these nsp1β mutations, neither 
nsp2TF nor nsp2N could be detected (Figure 5). These data indicate that the GKYLQRRLQ 
motif plays a key role in PRF activation.
To investigate nsp1β transactivation of PRF in the context of PRRSV infection, we 
analyzed nsp2 expression using the 1βKO mutant of both PRRSV genotypes. As controls, 
we included the corresponding KO2 mutants, which carry mutations within the slippery 
sequence and C-rich region that eliminate frameshifting [Figure S1 [442]]. Using reverse 
genetics, KO2 and 1βKO mutant viruses were recovered from full-length infectious 
clones of the two PRRSV genotypes. Both mutants replicated poorly in MARC-145 cells, 
but for the type 2 PRRSV isolate (SD95-21), they produced titers (105.1 and 105.3 FFU/ml for 
KO2 and 1βKO, respectively) that sufficed for the subsequent experiments of infection, 
metabolic labeling and radioimmunoprecipitation analysis. As expected (Figure 6A), 
the expression of nsp2, nsp2TF, and nsp2N was detected in SD95-21-WT-infected cells, 
figure 5: A conserved motif in PRRsv PLP1β is critical for trans- activation of –2/–1 PRf in an expres-
sion system. The recombinant vaccinia virus/T7 RNA polymerase expression system and HEK-293T cells 
were used to express WT and 1βKO mutant nsp1β-nsp2 polyproteins from (A) type 1 and (B) type 2 PRRSV. 
The 1βKO mutant carried a double Ala substitution of basic residues in the highly conserved GKYLQRRLQ 
motif of nsp1β (see also Figure 4 and S1). Expression products were immunoprecipitated with mAbs rec-
ognizing the common N-terminal domain of the nsp2-related products. Following SDS-PAGE, they were 
identified in Western blot analysis using antibodies recognizing the common nsp2 domain, the C-terminus 
of nsp2TF, or nsp1β. A tubulin antiserum was used for a loading control. 
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whereas only nsp2 was recovered from cells infected with either SD95-21-KO2 or SD95-
21-1βKO, while their nsp1β was expressed at a level similar to that observed with the 
wild-type (WT) virus. 
Unfortunately, the 1βKO mutant of the PRRSV type 1 isolate (SD01-08) yielded very 
low titers in MARC-145 cells (102 FFU/ml). Considering the number of viral functions 
and properties potentially affected by nsp1β mutations (see Discussion), we therefore 
performed a so-called ‘first-cycle analysis’ of the phenotypes of SD01-08 WT, KO2, and 
1βKO. The three viruses were launched by transfecting in vitro transcribed full-length 
RNA into BHK-21 cells, which support replication of transfected PRRSV RNA but cannot 
be infected by the progeny virus released from the transfected cells, due to the lack of 
the appropriate receptor(s) on their surface [454]. Moreover, BHK-21 cells have a defect 
in interferon production [455], thus minimizing the (potential) impact of host innate 
responses on the comparison of viral replication phenotypes. Following metabolic 
labeling of protein synthesis in transfected cells, a radioimmunoprecipitation analysis 
revealed that SD01-08-1βKO produced large amounts of nsp2, whereas the production 
of nsp2TF was greatly reduced and nsp2N was not detected (Figure 6B). As previously 
established, SD01-08-KO2 produced only nsp2, while SD01-08-WT produced all three 
nsp2 variants. Equal expression of nsp1β in WT-, KO2-, and 1βKO-transfected cells was 
figure 6: A conserved motif in PRRsv PLP1β is critical for transactivation of –2/–1 PRf in infected 
cells. (A) Analysis of nsp2-related products in MARC-145 cells infected with WT type 2 PRRSV (isolate SD95-
21) or mutants KO2 and 1βKO. Mutant KO2 (Figure S1) contained PRF-inactivating point mutations in both 
slippery sequence and downstream C-rich motif, whereas 1βKO carried a double Ala substitution of ba-
sic residues in the highly conserved GKYLQRRLQ motif of nsp1β. Following metabolic labeling, proteins 
were immunoprecipitated using mAb α-NA-nsp2 and visualized by SDS-PAGE and autoradiography. The 
expression of nsp1β was monitored by Western blot analysis. (B) BHK-21 cells were transfected with in vitro 
transcribed full-length RNA of WT, KO2 or 1βKO PRRSV SD01-08 (type 1) or were double-transfected with 
equal amounts of KO2 and 1βKO RNA to demonstrate complementation between these two virus mutants. 
Following metabolic labeling, viral proteins were immunoprecipitated using specific mAbs that recognize 
a common nsp2 domain (α-EU-nsp2 panel), the polypeptide encoded by the TF ORF (α-EU-TF panel), or 
nsp1β (α-EU-nsp1β panel). Protein products were visualized using SDS-PAGE and autoradiography.
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confirmed by immunoprecipitation with an nsp1β-specific mAb. We also investigated 
whether the mutations in 1βKO affected the activity of the PLP1β protease or the (po-
tential) involvement of nsp1β in the control of viral subgenomic mRNA synthesis. While 
the total amount of nsp1β and viral RNA was somewhat reduced in 1βKO-transfected 
cells, cleavage of the site between nsp1β and nsp2 and subgenomic mRNA production 
(Figure S4B-C), were not affected by the mutations in the GKYLQRRLQ motif, nor did 
they affect nsp1β stability (Figure S4D). Finally, we included a double-transfection of 
BHK-21 cells with KO2 and 1βKO full-length RNA (Figure 6B) and demonstrated comple-
mentation between the two PRF-negative mutants leading to reactivation of nsp2TF/
nsp2N expression. As expected, the wild-type nsp1β expressed by mutant KO2 was 
able to transactivate -2/-1 PRF on the wild-type ORF signal in the 1βKO genome, again 
confirming that the GKYLQRRLQ motif plays a critical role in the PRF stimulatory activity 
of nsp1β in PRRSV-infected cells.
PRRsv nsp1β interacts with the RNA signals that direct –2/–1 PRf
To test the hypothesis that nsp1β, and specifically its GKYLQRRLQ motif, interacts with 
the PRRSV RNA sequences that direct –2/–1 PRF, we developed an RNA-binding protein 
immunoprecipitation assay. To produce an RNA target, we engineered plasmid pR79WT-
EGFP yielding an RNA in which a 79-nt PRRSV SD01-08 RNA sequence (Figure 3A) 
containing the shift site and conserved CCCAUCUCC motif was fused to the enhanced 
green fluorescent protein (EGFP) open reading frame (Figure 7A). The latter served as a 
target for quantitative RT-PCR (qRT-PCR) amplification of target RNA bound to nsp1β. As 
controls, we included plasmids pR79KO2-EGFP and pR79CC2-EGFP, containing combina-
tions of point mutations in the shift site and/or CCCAUCUCC motif that were previously 
demonstrated to completely inactivate PRF [Figure S1; [442]]. To express the nsp1β bait, 
we used constructs pFLAG-nsp1β-WT and pFLAG-nsp1β-KO, producing wild-type and 
mutant (K130A/R134A) nsp1β, respectively, each fused to an N-terminal triple FLAG tag. 
The empty vectors pFLAG and pEGFP were included as negative controls.
Following co-transfection of vectors expressing RNA target and nsp1β into 293T cells, 
cell lysates were prepared. Western blot and qRT-PCR analysis (Figure 7B) were first used 
to determine the expression levels of nsp1β bait and target RNA, respectively, and con-
firmed the presence of similar amounts of both molecules in all co-transfection samples. 
Subsequently, we immunoprecipitated FLAG-nsp1β using an anti-FLAG mAb and ana-
lyzed these samples for co-immunoprecipitation of target RNA using the same qRT-PCR 
method, while verifying successful immunoprecipitation of nsp1β with a specific mAb 
(Figure 7C). A strong and specific RNA co-immunoprecipitation signal was detected only 
in samples from cells co-transfected with pFLAG-nsp1β-WT and pR79WT-EGFP. In con-
trast, when mutant 1βKO carrying the K130A/R134A double mutation in the GKYLQR-
RLQ motif was used, only very low levels of target RNA were pulled down, suggesting 
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figure 7: An RNA carrying the PRRsv –2/–1 PRf signal co-immunoprecipitates with nsp1β. A protein-
RNA interaction assay was designed based on co-immunoprecipitation of nsp1β and RNA transcripts con-
taining 79-nt of type1 PRRSV sequence, including the –2/–1 PRF signal. (A) Schematic representation of the 
target RNA in which a WT 79-nt PRF signal (R79WT-EGFP), or its mutant KO2 or CC2 derivatives (see Figure 
S1A), was fused to the EGFP sequence. The latter served as a target for qRT-PCR amplification (primer set 
and TaqMan probe indicated), which was used to quantify the amount of RNA target bound to nsp1β. 
(B-C) HEK-293T cells were co-transfected with a plasmid expressing WT or 1βKO FLAG-tagged nsp1β and 
a plasmid expressing a WT or mutant target RNA. Empty vectors (pFLAG and pEGFP) were included as 
negative controls. (B) Detection of input levels of nsp1β bait and RNA target in cell lysates prior to the co-
immunoprecipitation assay. Quantitative qRT-PCR was used to determine the levels of WT or mutant R79-
EGFP mRNA in transfected cells (top panel). Western blot analysis was used to monitor the input of 1βKO 
or WT nsp1β bait (middle panel) and to verify the use of equal amounts of cell lysate (β-tubulin control; 
bottom panel). Lane numbers are explained in panel B. (C) Following FLAG-nsp1β immunoprecipitation, 
the amount of co-precipitating target RNA was determined by qRT-PCR (see panel A). Western blot analysis 
using a mAb α-EU-nsp1β was used to monitor the amount of immunoprecipitated nsp1β. A legend explain-
ing the co-transfected plasmids for each lane number is given on the right side of the panel.  
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that the K130A/R134A mutations impaired the interaction of nsp1β with PRRSV RNA. 
Only background signal was detected when using a negative control mouse IgG for im-
munoprecipitation, or when expressing the pFLAG empty vector control, demonstrating 
specificity for nsp1β. When the PRRSV PRF-specific sequences in the RNA target were 
mutated (R79KO2-EGFP or R79CC2-EGFP) or the pEGFP empty vector control was used, 
only trace amounts of RNA (6% or less of the R79WT-EGFP signal) could be captured, 
thus demonstrating that co-immunoprecipitation of the target RNA strongly depends 
on the presence of the CCCAUCUCC motif.
To further corroborate the interaction between nsp1β and the 79-nt RNA sequence 
from the PRF region, we employed a complementary assay [RiboTrap system; [456]] 
in which RNA transcripts were labeled with 5-bromo-uridine, facilitating their immu-
nopurification using a 5-bromo-U-specific mAb, and subsequent analysis of immuno-
precipitates for the presence of proteins binding to the RNA bait. Using PCR amplicons 
containing T7 promoter and 79-nt PRRSV RNA sequence (R79WT, R79KO2, or R79CC2) 
as template, 5-bromo-U-labeled RNA transcripts were produced in vitro and incubated 
with lysates of 293T cells transfected with the plasmid expressing 1βKO or wild-type 
nsp1β. Following immunoprecipitation with the 5-bromo-U-specific mAb, samples 
were analyzed for the presence of nsp1β using SDS-PAGE and Western blot analysis 
(Figure 8). A strong and specific nsp1β signal was detected only when the R79WT bait 
was incubated with cell lysates containing nsp1β-WT. When using lysates containing 
1βKO of nsp1β, only a very small fraction of the available protein was bound to the RNA. 
Likewise, only trace amounts of wild-type nsp1β were pulled down when 5-bromo-U-
labeled R79KO2 or R79CC2 RNA was used as bait. These data are consistent with those 
obtained in the RNA-binding protein immunoprecipitation assay presented in Figure 7 
figure 8: PRRsv nsp1β can be pulled-down using an RNA carrying the –2/–1 PRf signal. Cell lysates 
from 1βKO or WT nsp1β-expressing HEK-293T cells were incubated with in vitro produced BrU-labeled RNA 
transcripts containing WT or mutant (KO2 or CC2, Figure S1) versions of a 79-nt sequence from the –2/–1 
PRF region of type 1 PRRSV (isolate SD01-08). RNA-protein complexes were immunoprecipitated with an 
anti-BrU antibody and subjected to Western blot analysis using an nsp1β-specific mAb. The amount of 
β-tubulin in the initial samples was monitored to verify equal loading.
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and further support a key role for the GKYLQRRLQ motif in the specific trans-activation 
of the PRRSV –2/–1 PRF by nsp1β.
disCussioN
In this paper, we report the remarkable discovery that efficient ribosomal frameshifting 
in the expression of the PRRSV nsp2TF and nsp2N proteins requires the viral nsp1β pro-
tein as a transactivator. Protein-stimulated PRF is unprecedented. It has been reported 
that cellular annexin A2 may interact with the –1 PRF signal of the coronavirus infectious 
bronchitis virus, but its role appears to be to down-regulate frameshifting through de-
stabilization of the stimulatory pseudoknot [457], and no specific frameshift-stimulatory 
protein factors have been identified to date. While downregulation of eukaryotic trans-
lation release factor levels can lead to a low-level stimulation of –1 PRF [458, 459], this 
is a poorly-characterized phenomenon, likely to be a rather non-specific effect brought 
about by changes in translation rates [460]. It is known that –1 PRF at the human im-
munodeficiency virus type 1 slippery sequence can be promoted by replacing the 
natural stimulatory RNA with a combination of the iron-responsive element (IRE) RNA 
and its cognate binding partner (the IRE-binding protein), but this is a highly artificial 
experimental system and the stimulation of –1 PRF is very weak [461].
Exactly how nsp1β stimulates frameshifting remains to be determined. Based on 
the RNA binding experiments, we propose that the region 3’ of the PRRSV PRF slippery 
sequence acts to recruit nsp1β, or an nsp1β-containing protein complex, which modu-
lates ribosome function to promote frameshifting. Our evidence to date supports the 
view that nsp1β binds directly to the C-rich region, since point mutations within this 
region strongly reduce RNA binding (Figure 7). However, we cannot rule out the involve-
ment of other factors, for example, poly (C) binding proteins [PCBPs; [462]], which are 
known to interact with C-rich regions. Moreover, certain PCBPs have been reported to 
bind to PRRSV nsp1β in pull-down assays [463]. As the C-rich region is located only 11 
nt downstream of the slippery sequence, this would likely place bound nsp1β, or an 
nsp1β-containing complex, in close proximity to a ribosome decoding the slippery 
sequence, permitting interactions that may lead to frameshifting. While this model is 
speculative, there is growing evidence that proteins can modulate the elongation step 
of protein synthesis. The fragile X mental retardation protein reversibly stalls ribosomes 
on its target mRNAs [464] and the HIF-1α mRNA-associated cytoplasmic polyadenylation 
element binding protein 2 binds eEF2 and slows elongation [465]. Conceivable routes 
through which bound proteins could modulate ribosomal function include induction 
of ribosomal pausing by acting as a roadblock, recruitment of, or localized depletion 
of translation factors, and direct interaction with a ribosomal component(s). It may be 
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significant that nsp1β was reported to interact with rpS14 [463], a protein immediately 
adjacent to rpS3 of the ribosomal helicase [466], and PCBP1, which is known to interact 
with RACK1, a ribosome-associated protein located close to the mRNA entry channel 
[467]. These features are consistent with a role for nsp1β in modulating the ribosomal 
helicase, the suspected target for the stimulatory RNA sequences of canonical –1 PRF 
signals. 
An interesting aspect of this PRRSV PRF signal is that both –2 and –1 frameshifting 
events are promoted. Tandem slippage of ribosome-bound tRNAs on RG_GUU_UUU 
would allow complete A-site re-pairing in both –1 and –2 frames (tRNA anticodon:mRNA 
codon pairing in 0-frame is 3’-AAG-5’ : 5’-UUU-3’; single tRNAPhe isoacceptor AAG), but 
especially for –2 PRF, P-site re-pairing appears to be compromised [at least at the 2nd 
and 3rd positions (lower case), 3’-Cai-5’ : 5’-Ggg-3’; i is inosine]. Some tolerance for P-site 
mispairing has been noted at certain viral –1 PRF signals, but usually, these are associ-
ated with single mismatches in the anticodon:codon interaction [323, 468]. It may be 
that in the particular context of a –2 PRF, stable P-site repairing is not required, remi-
niscent of the unusual “single-tRNA” slippage events seen in prokaryotic systems with 
slippery sequences ending in AAG, where P-site repairing does not appear to be present 
[469, 470]. In a recent study on RNA secondary structure-stimulated –1 and –2 PRF on 
a GU_UUU_UUA slippery sequence [407], it was noted that the length of the spacer 
between slippery sequence and secondary structure affected the relative utilisation of 
–1 or –2 PRF modes, perhaps a reflection of differences in mRNA tension arising as the 
ribosomal helicase unwinds the secondary structure, with increased tension forcing the 
ribosome into the –2 rather than the –1 frame. Interestingly, the relative levels of the 
PRRSV –2 and –1 PRF products were seen to change as the length of the PRRSV region 3’ 
of the slippery sequence was shortened from 67 to 45 nt (Figure 3C), although the sum 
total of PRF was similar. This may hint at the involvement of additional factors, or some 
subtle effect on the positioning of a bound protein (or complex), that can influence 
frameshift magnitude, although it remains to be determined whether this is linked to 
mRNA tension. 
Analysis of the published structure of nsp1β from a type 2 PRRSV isolate provides 
insights into the mechanism of how the protein may interact with viral RNA. The PLP1β 
domain of nsp1β adopts a papain-like fold consisting of three a-helices that pack 
against a b-sheet of 4 antiparallel strands [453] (Figure 4B). One of the helices (helix α4 in 
the overall nsp1β structure) contains a conserved GKYLQRRLQ motif that we now show 
plays a critical role in the transactivation of frameshifting. The crystal structure of nsp1β 
suggests that the protein exists as a homodimer [453] and, interestingly, helix α4 of both 
nsp1β monomers resides on the same side of the dimer, which may generate a continu-
ous, positively charged surface that could bind a long single- or double-stranded RNA 
molecule (Figure 4C). The involvement of an a-helix in RNA binding is consistent with 
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the observation that nucleoproteins of many RNA viruses encapsidate the viral genome 
using domains of a-helical structure [471, 472]. Thus, it is plausible that the GKYLQRRLQ 
motif of helix α4 directly binds viral RNA, although we cannot exclude the possibility 
that this helix may be a binding site for a cellular protein that in turn could bind to the 
PRF signal in the viral RNA.
Except for equine arteritis virus (EAV), the –2 PRF mechanism seems to be conserved 
in all currently known arteriviruses as judged by the presence of a TF ORF overlapping 
ORF1a and a conserved slippery sequence and downstream C-rich region [442]. In PRRSV 
and lactate dehydrogenase elevating virus (LDV) –1 PRF can occur, but in contrast the 
RG_GUC_UCU shift site in some of the recently identified simian haemorraghic fever 
virus (SHFV)-like viruses [352] would preclude –1 PRF while still allowing –2 PRF. It is 
expected that such PRF events in LDV and SHFV would also be controlled by nsp1β, and 
indeed the transactivating motif in nsp1β was found to be largely conserved in these 
viruses (Figure 4A). Possibly, the nsp1β component of the frameshift mechanism, which 
is encoded several kilobases upstream of the PRF site, evolved secondarily, for example 
to enhance the efficiency of nsp2TF/nsp2N expression, since in the absence of nsp1β 
low levels of PRF could still be observed (Figure 2A). Amino acid sequence comparisons 
reveal that the GKYLQRRLQ motif-containing helix is highly conserved in the PLP1β 
domains of PRRSV, SHFV, and LDV, but the motif is lacking in EAV. For the latter virus, 
the three helices of the PLP1β domain are predicted to be present, but with an inser-
tion of three amino acids in the EAV equivalent of the α4 helix compared to the other 
arteriviruses. The nsp2-encoding region of EAV lacks an equivalent of the (overlapping) 
TF ORF and produces a substantially smaller nsp2. Assuming the TF ORF was lost at some 
point during the evolution of the EAV lineage, changes in this helix may have been toler-
ated when it was no longer required to stimulate PRF in trans. Although an alternative 
evolutionary scenario (i.e. a common ancestor of PRRSV, SHFV, and LDV independently 
acquiring a TF ORF) cannot be excluded, loss of the requirement to transactivate PRF 
may also explain a second remarkable difference between the nsp1 region of EAV and 
other arteriviruses: the inactivation of the proteolytic activity of the PLP1α proteinase, 
resulting in the synthesis of a single nsp1 protein rather than nsp1α and nsp1β [416, 
473]. In particular, the N-terminal zinc finger of nsp1 (EAV) or nsp1α (PRRSV) has been 
implicated in the control of viral subgenomic mRNA synthesis [450, 474-476], a function 
that may not be compatible with a role in PRF transactivation, thus requiring the internal 
cleavage of nsp1 by PLP1α in arteriviruses that employ nsp1β-mediated transactivation 
of TF ORF expression.
The capacity of nsp1β to stimulate both –1 and –2 PRF suggests that protein transac-
tivation could be employed more widely in the induction of programmed frameshifting 
events in diverse systems. With regards to arteriviruses, it is possible that nsp1β might 
also modulate translation of host cell mRNAs containing appropriate signals. A cursory 
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search of porcine mRNAs revealed hundreds of –1 and/or –2 frameshift-compatible 
shift sites followed by C-rich motifs at an appropriate spacing, though no site that is 
exactly identical to the PRRSV minimal PRF cassette (8-nt shift site plus the downstream 
21 nt). Whether and to what extent frameshifting occurs at such sites remains to be in-
vestigated. While the occurrence of nsp1β-responsive frameshift signals in host mRNAs 
would presumably be spurious, the overall effect may perturb cellular gene expression, 
thus adding an extra dimension to virus-host interactions.
When screening PRRSV nonstructural proteins for their capacity to suppress type I 
IFN expression, both nsp1β and nsp2 were found to possess such activities [167, 421, 
447, 452, 463]. In reporter gene-based assays, nsp1β had the strongest potential to 
inhibit IFN-β promoter activity and could also inhibit downstream IFN-induced signaling 
pathways for expression of IFN-stimulated genes (ISGs), including ISG15 [447, 452, 463, 
477, 478]. On the other hand, the PLP2 activity of nsp2 is able to disrupt innate immune 
signalling by removing ubiquitin (Ub) and Ub-like modifiers from host cell substrates, 
exhibiting a general deubiquitinating (DUB) activity towards cellular ubiquitin conju-
gates and also cleaving the ubiquitin homolog ISG15 [167, 420-422]. As documented 
here, nsp1β transactivates both nsp2TF and nsp2N expression, resulting in the synthesis 
of three nsp2-related proteins (nsp2, nsp2TF, and nsp2N) that have the N-terminal 
PLP2-DUB domain in common. Thus, it remains to be established to which extent 
nsp1β directly modulates the innate immune response or does so by stimulating the 
expression of nsp2TF and nsp2N. Furthermore, nsp1β may affect the immune response 
through modulation of host cell mRNA translation. The identification of viral/host ele-
ments responsible for innate immune evasion is fundamental for the development of 
modified live virus vaccines. As illustrated by our reverse genetics studies, mutagenesis 
of key residues in nsp1β and the PRF site could attenuate virus growth and improve 
host innate immune responses [442, 447]. Since the GKYLQRRLQ motif and PRF site are 




HEK-293T, RK-13, BHK-21, and MARC-145 cells were cultured as described previously 
[402, 419]. The US type 1 PRRSV isolate SD01-08 (GenBank accession #DQ489311) and 





Antibodies recognizing PRRSV proteins (see also Figure S1B for the nomenclature used 
in this paper), including mAb 22–28 (α-EU-nsp1β), mAb 123-128 (α-NA-nsp1β), mAb 36-
19 (α-EU-PLP2), mAb 58-46 (α-EU-nsp2), mAb140-68 (α-NA-PLP2), mAb 148-43 (α-NA-
nsp2), and a rabbit antiserum recognizing the C-terminal part of nsp2TF (α-EU-TF) were 
produced as described previously [442]. A rabbit antiserum (α-NA-TF) recognizing the 
C-terminal epitope (CFLKVGVKSAGDLV) of nsp2TF of type 2 PRRSV was generated by 
GenScript (Piscataway, NJ). For detection of FLAG-tagged proteins, an anti-FLAG mAb 
was obtained from Sigma® Life Science. Anti-β-tubulin and anti-dsRNA (J2-0601) mAbs 
were obtained from Lamda Biotech and English & Scientific Consulting, respectively.
dNA constructs and reverse genetics
Except for the KO2 (Figure S1) and pLnsp1βcc–2 (Figure S3) mutants, for which synthetic 
DNA was used, all other constructs were made by standard PCR-based mutagenesis and 
recombinant DNA techniques. Procedures for the construction of plasmids are provided 
in SI Materials and Methods. Methods for in vitro transcription, virus rescue from full-
length cDNA clones, and virus titration were described previously [402, 447], [442].
mass spectrometry
Nsp2N was immunoprecipitated from SD95-21-M1–infected MARC-145 cell lysate using 
mAb α-NA-PLP2 and samples were separated on a 6% SDS-PAGE gel, which was fixed 
and stained with Coomassie Brilliant Blue G-250 (Bio-Rad). The band expected to con-
tain nsp2N* (based on predicted protein size) was excised. Trypsin digestion and LC-MS/
MS analysis were performed as described previously [431]. MS spectra were searched 
against a custom-made protein database containing the nsp2N* sequence. As positive 
control, a synthetic version of the identified frameshift peptide was made and analyzed 
by LC-MS/MS. 
immunoassays
Different regions of PRRSV ORF1a were transiently expressed in RK-13 or HEK-293T cells 
using truncated derivatives of expression plasmid pL1a and the recombinant vaccinia 
virus/T7 polymerase expression system [419]. Expression products were 35S-labeled, 
immunoprecipitated, and analyzed by SDS-PAGE and autoradiography as described 
previously [442]. Alternatively, nsp1β and nsp2-related products were detected by 
consecutive immunoprecipitation of (unlabelled) proteins and Western blot analysis, 
using a combination of PRRSV nsp-specific monoclonal antibodies as described previ-
ously [442, 447]. Wild-type and mutant SD01-08 viruses were launched by transfecting in 
vitro transcribed full-length RNA into BHK-21 cells, and radioimmunoprecipitation was 
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conducted to detect the expression of nsp1β and nsp2-related products (See SI Materi-
als and Methods for detailed procedures).
dual luciferase assay
Using FuGENE HD transfection reagent (Roche Molecular Biochemicals), HEK-293T cells 
were co-transfected with 0.2 μg of dual luciferase plasmid containing the PRRSV PRF 
sequence and 50 ng of pFLAG-nsp1β.  At 24h post-transfection, cells were harvested 
and luciferase expression was measured using the Dual Luciferase Stop & Glo® Reporter 
Assay System (Promega) and a luminometer (Bethold). Frameshifting efficiencies were 
calculated from the ratio of firefly to Renilla luciferase activities, using the IFC control 
construct as the standard.
Analysis of protein sequences and structure
Sequence alignment of the PLP1β domain of PRRSV, LDV, and SHFV nsp1β and EAV nsp1 
was performed using the MUSCLE algorithm in Geneious 6 (Biomatters Ltd, Auckland, 
NZ). Potential RNA-binding residues in nsp1β were identified using the program BindN 
[479].  Images of the crystal structure of the PRRSV nsp1β dimer (PDB: 3MTV) [453] were 
created using PyMOL [480].
Assays for detecting interactions between nsp1β and viral RNA
Immunoprecipitation assays to detect RNA-binding proteins were performed using the 
Magna RIP™ kit (Millipore) and Ribo Trap kit (Medical & Biological Laboratories) follow-
ing the manufacturer’s instructions. The amount of target mRNA bound to nsp1β was 
determined by quantitative RT-PCR, and the presence of nsp1β in RNA-protein com-
plexes was verified by Western blot. Detailed experimental procedures are presented in 
SI Materials and Methods.
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supporting information materials and methods
DNA constructs
Plasmids for expression of full-length or partial PRRSV ORF1a were constructed by RT-
PCR amplification of corresponding regions from genomic RNA (nt 191-7702 nt of the 
SD95–21 genome; nt 222-7361 of the SD01-08 genome). The PCR product was digested 
with NcoI and NotI restriction enzymes and ligated into a pL1a backbone digested with 
the same enzymes. The design of pL1a was described previously [442]. Except for the 
KO2 (Figure S1) and nsp1βcc–2 (Figure S3) constructs, which were generated by gene 
synthesis, all mutations were introduced by using the Quick-Change site-directed muta-
genesis kit (Stratagene) following the manufacturer’s instruction.
Plasmid pLnsp1βcc–2 was constructed by extensively mutating the SD01-08 PRRSV 
nsp1β-coding region with synonymous replacements (Figure S3), while keeping the 
encoded amino acid sequence intact and avoiding rare codons. The modified sequence 
(nsp1βcc) was produced as a synthetic gene and fused back with the nsp2-coding re-
gion to generate the nsp1βcc–2 construct. To construct plasmids for the dual-luciferase 
assay, a 79-nt oligonucleotide (3506 to 3584 nt of SD01-08 genome) containing the WT 
sequence or mutations (Figure S3, IFC and KO2) at the PRF region was synthesized and 
cloned into the dual luciferase vector pDluc as described previously [448, 449]. 
The plasmid expressing FLAG-tagged nsp1β (pFLAG-nsp1β) was generated by PCR 
amplification of the nsp1β-coding region (nt 762-1376 of the SD01-08 genome) and 
cloned into the plasmid vector p3xFLAG-CMV–24 (Sigma). Plasmids expressing EGFP-
tagged PRF sequence (pR79WT-EGFP, pR79KO2-EGFP, and pR79CC2-EGFP) were gener-
ated by cloning the PRF region (nt 3506 to 3584 of SD01-08) into the plasmid vector 
pEGFP-N1 (Clontech).
In vitro transcription and radioimmunoprecipitation analysis of SD01-08 WT and mutants
Full length SD01-08-WT, KO2, or 1βKO RNA was transcribed from 1 ug of linearized plas-
mid DNA using the mMESSAGE mMACHINE T7 kit (Ambion) following the manufacturer’s 
instructions. BHK-21 cells (4x106) were electroporated with 8 ug of in vitro transcribed 
RNA using program T-020 of the Amaxa Nucleofector and kit T (Lonza). Newly synthe-
sized proteins were labeled from 16.5 to 18.5 hours post transfection in cysteine- and 
methionine-free medium containing 200 µCi/ml [35]S-methionine and [35]S-cysteine 
(Perkin-Elmer). Cell lysis and immunoprecipitation analysis were performed as described 
previously [419]. The mAbs α-EU-nsp1β and α-EU-nsp2 were used to immunoprecipitate 
nsp1β and nsp2/nsp2TF/nsp2N, and precipitated proteins were separated on a 12% SDS-
PAGE gel. Protein bands were visualized using phosphorimaging and a Typhoon Variable 
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Mode Imager (GE Healthcare). Image analysis was performed with the ImageQuant TL 
software (GE Healthcare).
Pulse-chase analysis of nsp1β expression by SD01-08 WT and mutants KO2 and 1βKO 
Following electroporation with in vitro transcribed SD01-08 WT, KO2, 1βKO RNA, or 
a 1:1 mixture of KO2 and 1βKO RNA, 0.3x106 BHK-21 cells were labeled at 16.5h post 
transfection for 15’ in cysteine- and methionine-free medium containing 500 µCi/ml 
[35]S-methionine and [35]S-cysteine (Perkin-Elmer). After removal of the label medium, 
cells were either lysed immediately or chased for 1h in the presence of an excess of 
unlabeled methionine and cysteine. Immunoprecipitation was performed as described 
previously [419] with mAb α-EU-nsp1β. Precipitated proteins were separated on a 12% 
SDS-PAGE gel and phosphorimaging was performed as described above.
Immunofluorescence microscopy of transfected BHK-21 cells 
Following electroporation with in vitro transcribed SD01-08 WT, KO2, or 1βKO RNA, 
0.15x106 BHK-21 cells were seeded on glass coverslips. At 18 h post transfection, cells 
were fixed in 3% para-formaldehyde in PBS. Cells were double-labeled with a mAb 
recognizing dsRNA and Hoechst 33342 to stain nuclear DNA. 
RNA isolation, denaturing formaldehyde gel electrophoreses and in gel hybridization
BHK cells (0.75x106) were electroporated with in vitro transcribed RNA of SD01-08 WT, 
KO2, and 1βKO. At 18 h post transfection, cells were lysed in 20 mM Tris-HCl (pH 7.4), 
100 mM LiCl, 2 mM EDTA, 5 mM DTT, 5% (w/v) lithium dodecyl sulfate, and 100 μg/
ml proteinase K. Total RNA was extracted and separated on a denaturing formaldehyde 
gel. Positive-stranded viral RNA was visualized by gel drying and hybridization with a 
32P-labeled oligonucleotide probe (PRRSV-hyb1 5’-TCGCCCTAATTGAATAGGTG-3’) that 
is complementary to the 3’ end of the viral genome and therefore recognizes all viral 
mRNAs. 18S ribosomal RNA was used as a loading control and was detected with probe 
5’-ATGCCCCCGGCCGTCCCTCT-3’. Hybridized gels were analyzed by phosphorimaging as 
described above. Correction for loading variations was performed using the amount of 
18S RNA in the same lane. The sum of the signal for all viral mRNAs in each lane was used 
to calculate the relative abundance of each individual mRNA.
RNA-binding protein immunoprecipitation and RNA pull-down assay
RNA-binding protein immunoprecipitation was performed using a Magna RIP™ kit (Mil-
lipore) according to the manufacturer’s instruction. Briefly, HEK-293T cells seeded in 
10-cm petri dishes were co-transfected with plasmids expressing the RNA bait (R79WT-
EGFP, R79KO2-EGFP, R79CC2-EGFP, or pEGFP; 8 ug) and the nsp1β bait (nsp1β-WT, 
nsp1β-KO, or pFLAG; 2 μg). At 24 h post transfection, cell lysates were prepared for co-
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immunoprecipitation. FLAG-tagged nsp1β was immunoprecipitated using an α-FLAG 
mAb, and co-precipitating target RNA was quantified by qRT-PCR using TaqMan® Gene 
Expression Assay kit (Life technologies) targeting the EGFP RNA sequence. The expres-
sion of nsp1β in all co-transfected samples was determined by Western blot analysis 
using an nsp1β-specific mAb. Ribo Trap kit (MBL International Corporation) was used to 
further confirm the interaction between nsp1β and the 79-nt RNA sequence from the 
PRRSV PRF region. The R79WT, R79KO2, or R79CC2 RNA was labeled with 5-bromo-U 
and in vitro synthesized using the MEGAscript® T7 Kit (Life technologies). The 5-bromo-
U-labeled RNA transcripts were bound to magnetic beads conjugated with anti-BrU 
mAb. Subsequently, these magnetic beads were incubated with lysates of HEK-293T cell 
expressing FLAG-tagged 1βKO or WT of nsp1β. The amount of nsp1β pulled-down with 
the RNA bait was determined by western blot analysis using an nsp1β-specific mAb. 
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supporting information figures
supporting information figure s1: overview of mutants and antibodies used in this study. (A) List of 
WT and mutant sequences of the PRRSV PRF region (GGUUUUU shift site and conserved CCCANCUCC mo-
tif indicated with orange and magenta boxes, respectively). Mutated nucleotides are highlighted in cyan. 
Coordinates of starting nucleotides refer to PRRSV sequences DQ489311 (type 1 PRRSV) and KC469618 
(type 2 PRRSV). IFC, in-frame control; CC2, disrupted CCCANCUCC motif; M1, mutated –1 frame termination 
codon to C-terminally extend nsp2N; KO2, knockout mutant 2 (premature –2 frame termination codon and 
disrupted frameshift cassette); 1βKO, nsp1β knockout mutant (double mutation introduced into the nsp1β 
GKYLQRRLQ motif ). (B) Sizes of nsp2-related polypeptides described in this study and location of epitopes 
recognized by the PRRSV-specific antibodies in the nsp1β-2 region. Nsp2N* refers to the C-terminally ex-
tended version of nsp2N that is produced by mutant M1, due to removal of the stop codon (see panel A). 
Origin and original name of each antibody are provided in the Materials and Methods section. Sizes (in 
aa) for nsp2-related products are shown for GenBank sequences DQ489311 (SD01-08, PRRSV type 1) and 
KC469618 (SD95-21, PRRSV type 2). 
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supporting information figure s2: mass spectrometric analysis of nsp2N* (a C-terminally extended 
version of nsp2N) purified from cells infected with mutant sd95-21-m1. (A) PRRSV-infected or mock-
infected MARC-145 cell lysates were immunoprecipitated with nsp2-specific α-NA-PLP2. Immunopre-
cipitated proteins were separated by SDS-PAGE and stained with Coomassie Blue. The positions of nsp2, 
nsp2TF, and nsp2N are indicated. (B) Fragmentation spectrum of the –1 frameshift-specific peptide QVF-
WPR. (C) Complete amino acid sequence of nsp2N* comprising nsp2N and a 23-amino-acid C-terminal 
extension (highlighted in gray). Peptides identified by mass spectrometry are depicted in red. The peptide 
spanning the –1 frameshift site is underlined in green. (D) Peptide sequence of the nsp2N* –1 frameshift-
specific peptide. The fragment ions that were identified in the LC-MS/MS analysis of the gel slice are indi-
cated. (E) Nucleotide sequence and -1 PRF-directed translation of nsp2N* at the frameshift site.
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supporting information figure s3: Nucleotide sequences of the WT and synonymously mutated 
nsp1β-coding region. For each block, the top, middle, and bottom line gives the wild type nsp1β-coding 
sequence (black), the synonymously mutated sequence (mutations present in pLnsp1βcc-nsp2 given in 





supporting information figure s4: first-cycle analysis of RNA synthesis and nsp1β stability of WT 
and mutant (Ko2 or 1βKo) sd01-08 virus in bhK-21 cells. (A) IF microscopy analysis of transfection 
rate in BHK-21 cells electroporated with in vitro transcribed full-length PRRSV RNA. Transfected cells were 
double labeled with a mAb specific for viral dsRNA (green) and Hoechst 33342 (blue) for staining of DNA 
in cell nuclei. (B, C) Gel hybridization analysis and quantification of PRRSV-specific mRNA accumulation in 
cells transfected with mutants KO2 and 1βKO or a WT control. (B) Total intracellular RNA was isolated at 18 
h post-transfection and resolved by denaturing formaldehyde agarose gel electrophoresis. PRRSV-specific 
mRNAs were detected by hybridization of the dried gel with a 32P-labelled probe complementary to the 
3’-end of the viral genome and subsequent phosphorimaging. The positions of the PRRSV genome (RNA1) 
and the six sg mRNAs (RNA2 to RNA7) are indicated. (C) The volume of the bands corresponding to each 
of the viral mRNAs was quantified by phosphorimaging and adjusted for the control 18S ribosomal RNA 
band in the same lane. The sum of the signals for all viral mRNA bands in each lane was used to calculate 
the relative abundance of each individual mRNA. (D) Pulse-chase analysis of nsp1β expression. BHK-21 cells 
were transfected with RNA transcribed from WT or mutants of PRRSV full-length cDNA clones. At 16.5 h post 
transfection, protein synthesis was labeled for 15 min and chased for 1h. Cells were lysed and, following 
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AbsTRACT
Porcine reproductive and respiratory syndrome virus (PRRSV) utilizes programmed ribo-
somal frameshifting (PRF) to direct efficient expression of a transframe protein (nsp2TF) 
from an alternative reading frame overlapping the viral replicase gene. This arterivirus 
frameshifting signal induces both –2 and –1 PRF and, unusually, lacks an obvious stimu-
latory RNA structure downstream of the shift site. The minimal RNA sequence required 
for frameshifting maps to a 34-nucleotide region that includes the slippery sequence 
(GG_GUU_UUU) and a downstream conserved C-rich motif (CCCAUCUCC). Unusually, ef-
ficient frameshifting is also dependent upon expression of a viral protein, non-structural 
protein (nsp) 1β, one of the 14 subunits produced from the PRRSV replicase polyproteins. 
Nsp1β is released by the combined action of two papain-like protease (PLP) domains, 
which reside in nsp1α and nsp1β and each cleave at their own C-terminus. Here we show 
that, in addition to this viral transactivator, frameshifting also requires the participation 
of cellular poly (C) binding proteins (PCBPs), which were previously identified as nsp1β 
interaction partners. In vitro translation assays demonstrated that both nsp1β and either 
PCBP1 or PCBP2 are required for efficient –2/–1 PRF. When cells were depleted for PCBP1 
and PCBP2 by siRNA-mediated knockdown and subsequently transfected with a plasmid 
expressing nsp1β and nsp2, we observed a ~40% reduction of the expression of nsp2TF 
and nsp2N, the respective –2 and –1 PRF products. PCBP1 predominantly stimulates 
–2 PRF, while PCBP2 stimulates –1 PRF. We hypothesize that a complex of nsp1β and 
PCBP binds to the RNA signal downstream of the slippery sequence and here mimics the 
action of the more typical RNA pseudoknot stimulators of PRF. This unprecedented viral 
frameshift-stimulatory signal may provide new insights as to how the ribosomal elonga-
tion cycle can be modified by transacting protein factors. Furthermore, it broadens the 
repertoire of activities associated with poly (C) binding proteins and prototypes a new 




Programmed –1 ribosomal frameshifting (–1 PRF) is a commonly used translational con-
trol strategy in which mRNA signals induce ribosomes to change reading frame at high 
frequency, allowing the co-ordinated expression of two or more proteins from a single 
mRNA (reviewed in: [323, 336, 396, 433]). In –1 PRF, the ribosome slips backwards (in the 
5’ direction) by one nucleotide (nt) into an overlapping open reading frame (ORF) and 
continues translation, generating a fusion protein composed of the products of both 
upstream and downstream ORFs. First described as the mechanism by which the Gag-
Pol polyprotein of the retrovirus Rous sarcoma virus (RSV) is expressed from overlapping 
gag and pol ORFs [434, 435], related –1 PRF signals have been documented in many 
other viruses of clinical, veterinary and agricultural importance [436-440]. Programmed 
ribosomal frameshifting has also been increasingly recognized in the expression of 
conventional cellular genes of both prokaryotes and eukaryotes as well as in other 
replicating elements, such as insertion sequences and transposons [441, 481-484].
Central to almost all examples of –1 PRF is the interaction of the ribosome with a 
stimulatory mRNA structure - a stem-loop (SL) or RNA pseudoknot (PK) - which acts to 
promote the –1 frameshift on a stretch of homopolymeric bases known as the slippery 
sequence. How these RNA structures act is incompletely understood, but accumulating 
evidence supports the view that by presenting an unusual topology [92, 336, 337, 396, 
446], they confound an intrinsic unwinding activity of the ribosome with consequent 
effects on the elongation cycle and frame maintenance [444, 445, 485]. Indeed, kinetic 
analyses indicate that stimulatory RNAs can impair movements of the ribosomal small 
subunit (30S) head, delaying dissociation of EF-G, and the release of tRNA from the ribo-
some [338, 486, 487]. 
Recently, we identified a novel, highly efficient –2/–1 PRF event that functions without 
a recognizable stimulatory RNA structure [442, 488]. This signal operates during transla-
tion of the genome of porcine reproductive and respiratory syndrome virus (PRRSV), a 
member of the arterivirus family in the order Nidovirales [442, 488]. The PRRSV genome 
(Figure 1A) is a ~15 kb positive-sense RNA molecule, and its 5’-proximal ORF (the large 
replicase ORF1a) in fact harbors two consecutive PRF signals. A “canonical” –1 PRF signal, 
conserved in all nidoviruses, is located in the short overlap region of ORF1a and the 
downstream replicase ORF1b [361]. It facilitates expression of the ORF1b-encoded 
sequence as a fusion with the ORF1a product and defines the ratio of the synthesis of 
the two viral replicase polyproteins, pp1a and pp1ab, produced by nidovirus genome 
translation. The second signal, which stimulates both –2 PRF and –1 PRF, is only found in 
(most) arterivirus genomes, where it is located within the region of ORF1a that encodes 
a large, multifunctional replicase subunit, nonstructural protein 2 (nsp2). Here, about 
20% of ribosomes translating nsp2 frameshift into the –2 reading frame to generate a 
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figure 1: (A) Overview of the PRRSV genome organization and localization of ribosomal frameshifting sig-
nals. The long 5′ ORFs 1a and 1b encode nonstructural polyproteins, and at least eight shorter 3′ ORFs 
(2a-7) encode structural proteins. The 3′ ORFs are translated from a nested set of subgenomic mRNAs, two 
of which are bicistronic. ORF1a and ORF1b are translated from the genomic RNA, with translation of ORF1b 
depending on −1 PRF at the end of ORF1a. The TF ORF overlaps the central ORF1a region in the −2 read-
ing frame and is accessed via −2 PRF. A −1 frameshift at the same site generates the nsp2N product. The 
vertical red line indicates the location of the RG_GUU_UUU shift site (R = A or G, in different arteriviruses). 
Domains in nsp2/nsp2TF: C, Cys-rich domain HVR, hypervariable region; PLP2, papain-like proteinase; TM/
TM′, (putative) transmembrane domains. Below the genome organization, the sequence of the SD01-08 
RNA in the region of the −2/−1 PRF signal is shown, with the slippery sequence (red) and C-rich motif (blue) 
highlighted. The −1 reading frame stop codon is underlined and codons for each of the reading frames are 
indicated. Figure reproduced from [488] (B) PRRSV nsp1β sequence and structure. Amino acid sequence 
alignment of the PLP1β domains from selected arterivirus nsp1β proteins. Secondary structure elements 
(based on the published crystal structure from type 2 PRRSV isolate XH-GD) [453] are shown above the 
alignment and are color matched to the nsp1β structure shown below. Conserved basic residues in PLP1β 
helix α4 are boxed in orange. #, residues mutated in RBD- mutant. *, residue mutated in PR- mutant. The 
PRRSV sequence is numbered (black) from the nsp1α/nsp1β cleavage site, whereas the two other sequenc-
es are numbered (gray) starting from the N terminus of the pp1a polyprotein. The names of specific isolates 
used are indicated. GenBank accession nos. of sequences used are as follows: DQ489311 (PRRSV SD01-08), 
NC_001639 (LDV P), NC_003092 (SHFV LVR). In the cartoon representation of the nsp1β dimer structure, the 
N-terminal domains are colored purple, whereas the PLP1β domains and the C-terminal extensions (lead-
ing up to the nsp1β/nsp2 site cleaved byPLP1β) are colored green and red, respectively. Helix α4 of PLP1β, 
containing the conserved GKYLQRRLQ motif, is colored orange with basic residues represented as sticks. 
Figure modified from [488].
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transframe fusion protein (nsp2TF) comprising the N-terminal two-thirds of nsp2 and 
the product encoded by a conserved alternative ORF (transframe; TF) in the –2 reading 
frame. An estimated further 7% of ribosomes shift into the –1 reading frame where they 
immediately encounter a stop codon resulting in the synthesis of a truncated version of 
nsp2 termed nsp2N [442]. As depicted in Fig. 1A, the RNA downstream of the slippery 
sequence (GG_GUU_UUU) used for –2/–1 PRF in PRRSV does not harbor an obvious 
higher-order structure compatible with canonical RNA-structure-stimulated PRF. How-
ever, mutations within a conserved CCCAUCUCC motif located 11 nt downstream of the 
shift site reduce or inhibit frameshifting, consistent with the presence of a 3’ stimula-
tory element of some form [442]. A further novelty of the PRRSV –2/–1 PRF signal is a 
requirement for the presence of viral protein, nsp1β, which functions as a transactivator 
of both –2 and –1 PRF [488]. The 205-amino acid nsp1β contains a papain-like protease 
domain (PLP1β) that cleaves the nsp1β/nsp2 junction in the arterivirus nonstructural 
polyprotein [363]. How nsp1β acts to stimulate frameshifting is unclear, although basic 
residues in a highly conserved putative RNA-binding motif (GKYLQRRLQ) (Figure 1B), 
integrated into the structure of nsp1β’s papain-like autoproteinase, were found to be 
critical for the stimulation of frameshifting [488].
In PRRSV-infected cells, in addition to its role in PRF control and the PLP1β–mediated 
cleavage of the nsp1β-nsp2 junction, nsp1β has also been implicated in arteriviral innate 
immune evasion (reviewed by [361, 489]). Part of nsp1β can be detected in the nucleus of 
infected cells and ectopic expression of nsp1β can suppress the induction of innate im-
mune responses [452, 490, 491], possibly by inhibiting downstream interferon-induced 
signaling pathways [452, 478]. The highly conserved nsp1β motif that was implicated 
in the control of PRF was also linked to innate immune evasion [447], as mutagenesis 
of its conserved basic residues yielded viable recombinant viruses inducing increased 
expression of IFN-α, IFN-β, and ISG15. Whether this effect should be attributed directly 
to nsp1β’s role in mediating the expression of nsp2TF/nsp2N or may (in part) be linked 
to the protein’s other functions remains to be investigated in more detail. 
We previously determined the –2 and –1 PRF frameshifting efficiencies in different 
cell culture settings. In PRRSV SD01-08-infected MARC-145 cells the –2 PRF efficiency 
was around 20%, while in RK13 cells transiently expressing PRRSV ORF1a a much higher 
–2 PRF efficiency of about 50% was observed [442]. These large differences led us to 
hypothesize that frameshifting may be modulated by host factors expressed at differ-
ent levels in these cells. Given its involvement in PRF outlined above, cellular proteins 
interacting with nsp1β were obvious candidates for such a role. During a previous study 
that used GST-tagged nsp1β as bait and aimed to discover cellular factors involved in 
PRRSV replication, a number of nsp1β interaction partners was identified, including the 
poly(C) binding proteins 1 and 2 (PCBP1 and PCBP2) [463]. PCBP1 and PCBP2 belong 
to a family of proteins that is characterized by three nucleic acid-binding hnRNP K 
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homology (KH) domains. The KH1 and KH2 domains are grouped near the N-terminus 
and KH3 is located at the C-terminus, separated from KH1 and KH2 by a sequence of 
variable length [492]. The other members of this family are PCBP3, PCBP4 and hnRNP 
K [492]. Yeast two-hybrid binding assays revealed that the interaction between nsp1β 
and PCBP2 requires minimally the PLP1β and C-terminal extension (CTE) domains of 
nsp1β and the KH2 domain of PCBP2 [493]. Interestingly, the conserved C-rich motif 
required for –2/–1 PRF in PRRSV shares some similarities with previously established 
PCBP-binding consensus sequences, although these sequences commonly have three 
(or more) C-triplets, each potentially binding one KH domain. Thus, PCBPs could bind 
to the PRRSV mRNA either directly or indirectly, by virtue of an association with nsp1β. 
In PRRSV-infected cells, overexpressed recombinant PCBP1 and PCBP2 were reported 
to partially localize to the region of the cell in which viral RNA synthesis is presumed to 
occur [463]. Endogenous PCBP2 was shown to be predominantly present in the nucleus 
of mock-infected cells, but to translocate to the cytoplasm in PRRSV-infected cells, after 
which it partially co-localized with nsp1β [493]. Furthermore, recombinant PCBPs were 
found to bind RNA transcripts representing the 5’ untranslated region (5’-UTR) of the 
PRRSV genome [463]. Finally, siRNA-mediated knockdown of the two PCBPs moderately 
inhibited PRRSV replication. In these PCBP-depleted cells, viral genome translation was 
claimed to be not affected, but this was concluded on the basis of measuring nsp1α and 
nsp1β expression levels only (the occurrence of –2 and –1 PRF in the nsp2-coding region 
was unknown at the time; [463]). In another study in which PCBP2 was depleted, both 
viral replication and nsp1β expression were decreased during PRRSV infection [493]. 
Beura et al. postulated that PCBP1 and PCBP2 are important host cell factors for PRRSV 
RNA synthesis [463], but our subsequent discovery of nsp1β-mediated PRF, at a signal 
containing a conserved poly(C)-containing RNA motif, prompted us to revisit this hy-
pothesis. If indeed PCBP1 and PCBP2 are interaction partners of nsp1β and have affinity 
for poly(C)-containing RNA sequences, their presence or absence may (also) affect the 
occurrence of –2/–1 PRF. As previously described, the inactivation of –2/–1 PRF in itself 
suffices to severely cripple PRRSV replication [442, 488], a defect that should also be 
reflected in viral RNA accumulation levels, but is in fact determined at the translational 
level.
In this paper, through reconstitution of the PRRSV –2/–1 PRF mechanism in vitro and 
studying the PRF-specific effects of PCBP knockdown in an expression system, we have 
established that efficient frameshifting indeed depends on the presence of cellular 
PCBPs, and that their presence is essentially equally important as that of the viral trans-
activator nsp1β. Through in vitro translation assays, we demonstrate that the combined 
presence of nsp1β and PCBP1 or PCBP2 mimics the action of the more typical RNA pseu-
doknot stimulators of programmed frameshifting. PCBP depletion in a cell culture-based 
expression system resulted in a significant reduction of nsp2TF and nsp2N expression. 
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This unprecedented arteriviral frameshift-stimulatory signal may provide new insights 
as to how the ribosomal elongation cycle can be modified by transacting protein factors. 
Furthermore, our study confirms and extends the important role of PCBPs as pro-viral 




MARC-145 and RK-13 cells were cultured in DMEM (Lonza) containing 8% fetal calf 
serum (FCS; PAA), 100 IU/ml penicillin and 100 μg/ml streptomycin at 37 °C and 5% CO2. 
Recombinant vaccinia virus vTF7-3 [429] was propagated in RK-13 cells. 
Protein expression and purification
Full-length, N-terminally hexa-histidine tagged nsp1β, PCBP1 and PCBP2 were expressed 
in Escherichia coli Rosetta2(DE3)pLysS (Novagen). Bacteria were grown in 2× TY medium 
to an A600 of 0.8 at 37 °C and cooled to 22 °C, and protein expression induced by the ad-
dition of 0.2 mM isopropyl β-d-thiogalactopyranoside. After 16 h, cells were harvested 
by centrifugation at 5000 × g for 15 min at 4 °C, and the pellet was stored at −20 °C until 
required.
Cells were thawed and resuspended in 20 mM Tris, 500 mM NaCl, 30 mM imidazole, 
1.4 mM β-mercaptoethanol, 0.05% Tween 20, pH 7.5, supplemented with 400 units of 
bovine DNase I (Sigma-Aldrich) and 200 μl of EDTA-free protease inhibitor mixture (Sig-
ma-Aldrich) before lysis at 165.5 MPa using a TS series cell disruptor (Constant Systems) 
and centrifugation at 40,000 × g for 30 min at 4 °C. Cleared lysate was incubated with 
Ni2+-NTA-agarose (Qiagen) for 1 h at 4 °C, the beads were washed, and the bound protein 
eluted in 20 mM Tris, 500 mM NaCl, 250 mM imidazole, pH 7.5, before dialysis against 20 
mM Tris, pH 7.6, 200 mM NaCl, 2 mM DTT. Purified proteins were concentrated, snap-
frozen in liquid nitrogen, and stored at −80 °C until required.
frameshift reporter plasmids and in vitro translation
Dual luciferase reporter plasmids were prepared by inserting a 79-nt sequence from 
PRRSV isolate SD01-08 containing the GG_GUU_UUU shift site, 5 upstream nucleotides 
and 66 downstream nucleotides between the Renilla and firefly luciferase genes in pDluc 
[448, 449] to create pDluc-PRRSV/wt so that −2PRF is required for firefly luciferase expres-
sion. To create pDuc-PRRSV/stop, the stop codon (UGA) in the –1 frame was changed to 
UUA, extending the –1 reading frame by a further 56 codons, whilst terminating the Rluc 
gene slightly earlier. In vitro transcribed RNA from the pDluc constructs was translated in 
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rabbit reticulocyte lysates (RRL) and wheat germ extracts (WG) as previously described 
[407] with or without recombinant nsp1β, PCBP1 and PCBP2 present. Translation prod-
ucts were separated by SDS-PAGE and visualized by WB using an antibody recognizing 
Renilla luciferase which is common to all pDluc translation products. 
siRNA-mediated knockdown 
To determine frameshifting efficiencies after siRNA-mediated knockdown of PCBP ex-
pression, 6x104 MARC-145 or 4.8x104 RK-13 cells were seeded per well in 12-well clusters 
in DMEM containing 8% FCS. MARC-145 cultures were transfected with siGENOME 
Human siRNA SMARTpools targeting PCBP1, PCBP2, PCBP3, PCBP4, or hnRNPK (final 
concentration 10 nM) using 2 ul of Dharmafect1 lipofection reagent (Dharmacon) per 
well. RK-13 cultures were transfected with siRNA pools targeting PCBP1 or PCBP2 (final 
concentration 25 nM) using 3 ul Lipofectamine 2000 (LifeTechnologies) per well. A non-
targeting pool (NTP) of “scrambled” siRNAs (Dharmacon) was used as a negative control. 
At 24 h post transfection (p.t.), the transfection medium was replaced with DMEM con-
taining 8% FCS. Possible cytotoxic effects of siRNA transfection were monitored at 48 h 
p.t., using the CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega). 
After 120 min, the reaction was stopped by the addition of 25 µl of 10% SDS and absor-
bance at 490 nm (A490) was measured using a 96-well plate reader (Berthold). At 48 h 
p.t., the cells were infected with a T7 RNA polymerase-expressing recombinant vaccinia 
virus [429] and 1 h later transfected with plasmid pL-nsp1β-2 [363], which encodes a 
self-cleaving nsp1β-nsp2 polyprotein under the control of a T7 promoter. Four hours 
later, the cells were starved for 30 min in methionine- and cysteine-free DMEM (Gibco) 
containing 2% FCS prior to a 45- (MARC-145) or 30-min (RK-13) metabolic labeling with 
500 µCi/mL of a [35S]Met/Cys mixture (EXPRE35S35S Protein Labeling Mix; Perkin-Elmer). 
Subsequently, cells were washed twice with PBS and harvested in lysis buffer (20 mM 
Tris, pH 7.6, 150 mM NaCl, 1% v/v NP-40, 0.1% DOC, 0.1% SDS and Complete protease 
inhibitor (Roche)). 
The human sequences targeted by the siRNA pools were compared with the sequences 
of the African green monkey (Chlorocebus sabaeus) genes encoding PCBP1 (Genbank ac-
cession XM_007970341), PCBP2 (Genbank accession XM_008003436), PCBP3 (Genbank 
accession XM_007970531), PCBP4 (Genbank accession XM_007984435) and hnRNPK 
(Genbank accession XM_007969613) and the rabbit (Oryctolagus cuniculus) PCBP1 and 
PCBP2 genes (Genbank accession NM_001082124 and XM_002711018, respectively). 
immunoassays
Following siRNA pool transfection, MARC-145 and RK-13 cells were harvested at 48 
h p.t. or 72 h p.t./24 h p.i. by first washing with PBS and then lysing in 4× Laemmli 
sample buffer (100 mM Tris-HCl, pH 6.8, 40% glycerol, 8% SDS, 40 mM DTT, 0,04 mg/
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ml bromophenol blue). Proteins were visualized by Western blot analysis as described 
previously [208] using primary antibodies mAb-nsp2 Eu58-46, mAb-nsp1beta Eu22-28 
[403], rabbit polyclonal anti-hnRNP E1 (C-terminal) (PCBP1) (Sigma-Aldrich), mouse 
monoclonal anti-PCBP2 (M07) (Abgent), rabbit polyclonal anti-human MGC10 (PCBP4) 
(PromoKine), mouse monoclonal anti-hnRNPK (Abcam), or mouse monoclonal antibody 
H68.4 against the transferrin receptor (Invitrogen) diluted in PBST containing 1% casein. 
Biotin-conjugated swine-a-rabbit (DAKO) or goat-a-mouse (DAKO), and Cy3-conjugated 
mouse-a-biotin (Jackson, Pennsylvania, USA) diluted in PBST containing 0.5% casein 
were used for fluorescent detection with a Typhoon-9410 imager (GE Healthcare, UK). 
Lysates from [35S]Met/Cys-labelled cells were used to immunoprecipitate nsp2, nsp2TF 
and nsp2N using mAb-nsp2 Eu58-46 [403], which recognizes the common N-terminal 
domain of the three products. Proteins were separated on a 6% SDS-PAGE gel and im-
aged as described previously [403]. Band intensities of nsp2, nsp2′, nsp2TF, nsp2TF′, 
nsp2N and nsp2N’ (nsp2’, nsp2TF’ and nsp2N’ are faster migrating forms of the three 
products; [442]) were quantified using ImageQuant TL (GE Healthcare) and normalized 
using the Met+Cys content of the respective products, while assuming that [35S]Met 
and [35S]Cys are incorporated with an efficiency ratio of 73:22 (the Met:Cys ratio in the 
mixture according to the manufacturer’s documentation). Using these values, –2 PRF 
efficiencies were calculated as (nsp2TF + nsp2TF′)/(nsp2 + nsp2′ + nsp2TF + nsp2TF′ + 
nsp2N + nsp2N’) and –1 PRF efficiencies were calculated as (nsp2N + nsp2N’)/(nsp2 + 
nsp2′ + nsp2TF + nsp2TF′ + nsp2N + nsp2N’). Quantification was performed in triplicate. 
REsuLTs
Reconstitution of the PRRsv –2/–1 PRf signal in vitro
Transactivation of the PRRSV –2/–1 PRF signal by nsp1β was previously demonstrated by 
co-expression of nsp1β and nsp2 in cultured cells and by site-directed mutagenesis of 
the viral genome to inactivate the critical RNA and protein signals described above [488]. 
To study the phenomenon in vitro, a 79-bp cDNA fragment encompassing the slippery 
sequence and C-rich region was subcloned between the Renilla and firefly genes of the 
frameshift-reporter plasmid pDluc [448] such that expression of the downstream cistron 
(fluc) was dependent upon a –2 PRF within the inserted PRRSV sequences (Figure 2A). 
Upon in vitro translation in the rabbit reticulocyte system (RRL), mRNAs transcribed 
from pDluc/PRRSV/wt specified the synthesis of only the product of the 5’ cistron of 
the reporter mRNA (Rluc) and no frameshifting was evident (Figure 2B). However, in 
translation reactions supplemented with recombinant, purified His6-tagged nsp1β, two 
additional bands were observed, the most abundant corresponding to the product of 
–2 ribosomal frameshifting. The second band migrated more rapidly than that of the 
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Rluc product (generated by ribosomes that do not frameshift) and we surmised that this 
protein corresponded to the product of a –1 PRF, as a –1 frame stop codon is present 
immediately downstream of the slippery sequence (underlined in Fig. 1A; see also [488]. 
To confirm this, the stop codon (UGA) in the –1 frame was changed to UUA, extending 
the –1 reading frame by a further 56 codons, whilst terminating the Rluc gene slightly 
earlier (Figure 2A). As anticipated, this point mutation in pDLuc/PRRSV/stop increased 
the size of the putative –1 PRF product, and slightly reduced the size of the Rluc protein 
(stop) (Figure 2B). These experiments indicate that the 79-nt PRRSV sequence cloned 
into pDluc likely contains all of the cis-acting elements required for –2/–1 frameshift-
ing and that supplementation of the RRL translations with nsp1β alone is sufficient to 
transactivate frameshifting. 
The previously reported crystal structure of nsp1β reveals an overall elliptical structure 
consisting of six α-helices and seven β-strands [453]. The protein is composed of two 
figure 2: Nsp1β is required for reconstitution of –2/–1 PRf in vitro in RRL (A) Schematic representa-
tion of the pDluc dual luciferase constructs used. for PRRSV/wt the GG_GUU_UUU shift site, 5 upstream 
nucleotides and 66 downstream nucleotides (79 nt in total) from the SD01-08 sequence were inserted be-
tween the Renilla and firefly luciferase genes such that −2PRF is required for firefly luciferase expression. 
For PRRSV/stop the stopcodon in the −1 frame immediately downstream from the slippery sequence was 
removed to extend the −1 PRF reading frame and the Rluc gene (zero frame) terminates earlier than in the 
WT sequence. (B) In vitro transcribed PRRSV/wt and PRRSV/stop RNA were translated in vitro in RRL with 
and without supplementation of purified His6-tagged nsp1β. DB; dialysis buffer. (C) The PRRSV/wt RNA was 
translated in RRL in the presence of WT nsp1β, a putative RNA binding mutant (RBD-; K124A/R128A) or a 
protease-defective mutant (PR-; C96S). GST: his-tagged GST negative control.
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major domains, a 48-amino acid N-terminal domain (NTD), which adopts an architecture 
similar to that of several metal ion-dependent nucleases, and a C-terminal papain-like 
cysteine protease (PLP1β) domain [453]. Within the latter domain, we previously identi-
fied a conserved sequence motif GK124YLQR128RLQ as a potential RNA binding domain 
(RBD) (Figure 1B). This sequence forms one of three α helices in the region between 
active site C96 and H165 residues of PLP1β [488]. To investigate the importance of pro-
tease or RNA binding activities to PRF transactivation, amino acid substitutions were 
introduced into the protease active site (C96S; mutant PR-) or within the putative nsp1β 
RBD (K124A/R128A; mutant RBD-, previously described as mutant 1βKO [488]) of the 
recombinant His6-tagged nsp1β used to transactivate frameshifting in vitro (Figure 1B). 
These variants were expressed and tested in the RRL-based PRF assay (Figure 2C). In this 
experiment, the protease-defective variant retained full activity, ruling out the involve-
ment of PLP1β’s protease activity in the stimulation of PRF by nsp1β. The RBD- mutation, 
on the other hand, inactivated nsp1β’s potential to induce frameshifting, supporting a 
role for RNA binding by nsp1β.
A requirement for poly (C) binding proteins in PRRsv –2/–1 PRf in vitro
To explore the potential role of PCBPs in PRRSV PRF, we translated the pDluc/PRRSV/
wt mRNA in RRL reactions supplemented with nsp1β, His6-tagged PCBP2 or both pro-
teins (Figure 3A). We found that PCBP2 alone did not stimulate PRF, but when added 
together with nsp1β, a substantial increase in the synthesis of the –1 PRF product was 
observed. To account for this observation, we reasoned that if the “active” transacting 
stimulator of PRRSV PRF is indeed a complex of nsp1β and PCBP, then the RRL system 
must already contain an abundant form of PCBP, but one which would, in complex with 
nsp1β, preferentially lead to –2 PRF. In this scenario, supplementation with PCBP2 may 
have generated nsp1β-PCBP2 complexes that could preferentially promote –1 PRF. We 
therefore translated the PRRSV frameshift reporter mRNA in the wheat germ (WG) in 
vitro translation system in the hope that this lysate would contain fewer endogenous 
PCBPs, or PCBPs of sufficient evolutionary diversity to preclude any interactions with 
nsp1β. Consistent with this expectation, ribosomal frameshifting at the PRRSV signal 
in WG was found to be completely dependent upon the simultaneous addition of both 
nsp1β and PCBP2, with neither protein alone having any frameshift-stimulatory activity 
in this system (Figure 3B). In further support of the hypothesis above, supplementation 
of WG translations with PCBP2 led preferentially to a –1 PRF, whereas with PCPB1, the 
–2 PRF was most evident (Figure 4), suggesting that the abundant form in RRL is PCBP1. 
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figure 3: PCbPs are required for reconstitution of –2/–1 PRf in vitro in WG. (A) In vitro translation reac-
tions with RRL and PRRSV/wt RNA were supplemented with nsp1β, his-tagged PCBP or both proteins. (B) In 
vitro translation reactions with WG and PRRSV/wt RNA were supplemented with nsp1β, his-tagged PCBP2 
or both proteins.
figure 4: PCbP1 and PCbP2 can reconstitute –2/–1 PRf in WG. In vitro translation reactions with RRL or 
WG and in vitro transcribed PRRSV/wt RNA were supplemented with nsp1β and his-tagged PCBP1 or his-
tagged PCBP2 or both PCBPs.
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Knockdown of poly (C) binding proteins reduces frameshifting efficiency in 
cultured cells
To explore the potential involvement of PCBPs on –2/–1PRF in living cells, siRNA-medi-
ated knockdown of PCBP1, PCBP2, PCBP3, PCBP4, and hnRNPK in MARC-145 cells was 
combined with transient expression of nsp1β and nsp2 using the recombinant vaccinia 
virus/T7 polymerase expression system (Figure 5ABC). For PCBP1 and PCBP2 the find-
ings from MARC-145 cells were further confirmed in RK-13 cells (Figure 5DEF). 
The siRNA pools that were used target human sequences, but most of these pools are 
expected to also mediate knockdown in MARC-145 (African green monkey) and RK-13 
(rabbit) cells. For example, the four sequences targeted by the siRNA pool against PCBP1 
are fully conserved in African green monkey, and only one of these has a 1-nt mismatch 
with the rabbit PCBP1 sequence. Likewise, only one of the four sequences targeted by 
the siRNA pool against PCBP2 has a 1-nt mismatch in African green monkey, while two 
of these sequences have a 1-nt mismatch in rabbit. The four sequences targeted by the 
siRNA pools for PCBP3 and hnRNPK are fully conserved in African green monkey, but one 
of the sequences targeted by the siRNA pool against PCBP4 contains a 1-nt mismatch 
and one sequence contains three 1-nt mismatches. In MARC-145 cells, knockdown of 
PCBP1, PCBP2, PCBP4 and hnNRPK was successful, as established by Western blot analy-
sis (Figure 5A). Unfortunately, a suitable antibody to monitor PCBP3 knockdown was not 
available. Also in RK-13 cells knockdown of PCBP1 and PCBP2 was successful (Figure 5D). 
When assessed via an MTS-based cell viability assay, knockdown of none of these targets 
was toxic to uninfected cells. However, knockdown of PCBP3 in MARC-145 cells resulted 
in accelerated cell death during infection with recombinant vaccinia virus vT7-3, result-
ing in lower band intensities for the three nsp2 products upon immunoprecipitation 
compared to the other conditions (Figure 5B).
In line with the observations made during the in vitro translation experiments outlined 
above (Figure 4), PCBP1 knockdown mostly reduced the efficiency of the –2 shift, while 
PCBP2 knockdown mostly impaired the –1 shift (Figure 5C and F). Whereas knockdown 
of a single PCBP reduced –1 or –2 PRF by about 40%, simultaneous knockdown of 
PCBP1 and PCBP2 reduced the total amount of –2/–1 PRF by ~50% in MARC-145 cells 
(Figure 5C) and ~70% in RK13 cells (Figure 5F). In multiple independent experiments, 
PCBP1 depletion, while decreasing –2 PRF, at the same time increased the –1 PRF ef-
ficiency in RK-13 cells, but not in MARC-145 cells. Interestingly, PCBP2 knockdown also 
induced knockdown of PCBP1 in RK-13 cells (Fig. 5D) and as a result the –2 shift was also 
reduced in these cells when only siRNAs targeting PCBP2 were used (Figure 5F). This 
might be caused by siRNA off-target effects because the PCBP1 and PCBP2 sequences 
are very similar and one of the siRNAs targeting PCBP2 has only a single mismatch with 
rabbit PCBP1, while there are two mismatches with African green monkey PCBP1. The 
mismatch is located at position 14 of the siRNA and siRNAs with a mismatch at this posi-





























































































































































figure 5: siRNA knockdown of PCbP1 and PCbP2 decreases –2/–1 frameshifting efficiency in cell cul-
ture. (A & D) MARC-145 (A) and RK-13 cells (D) were transfected with siRNA pools targeting PCBP1, PCBP2, 
PCBP3, PCBP4, hnRNPK. Knockdown of proteins targeted by siRNAs was assessed using WB analysis. A suit-
able antibody for PCBP3 was not available. (B & E) MARC-145 (B) and RK-13 cells (E) were transfected with 
siRNA pools targeting PCBP1, PCBP2, PCBP3, PCBP4, hnRNPK. The recombinant vaccinia virus–T7 RNA poly-
merase expression system was used to express pLnsp1β-2. After metabolic labeling, expression products 
were immunoprecipitated with mAb α-EU-nsp2, this antibody recognizes the common N-terminal domain 
of nsp2, nsp2TF, and nsp2N. Immunoprecipitated proteins were separated by SDS/PAGE and visualized 
by autoradiography. (C & F) Protein bands were quantified (triplicates) using ImageQuant TL software for 
MARC-145 cells (C) and RK-13 cells (F). The total intensity for all protein bands (nsp2, nsp2’, nsp2TF, nsp2TF’, 
nsp2N and nsp2N’) was set as 100%. Efficiencies were corrected for the methionine and cysteine content of 
each protein product. nsp2’, nsp2TF’ and nsp2N’ are precursors. 
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tion are often still able to induce knockdown [494]. Knockdown of PCBP3, PCBP4 and 
hnRNPK in MARC-145 cells increased PCBP1 expression, most likely due to some kind of a 
compensatory mechanism at the level of genome expression (Figure 5A). Knockdown of 
PCBP3, PCBP4 and hnRNPK had little or no effect on frameshifting (Figure 5BC), but such 
effects may have been masked by the increased PCBP1 levels in these cells (Figure 5A). If 
this is the case, these proteins are more likely to affect –2 PRF than –1 PRF. 
disCussioN
In this paper we describe the discovery that –2/–1 PRF in arteriviruses does not only 
depend on the presence of viral protein nsp1β, but both frameshifts also require PCBPs 
as additional, host cell-encoded protein transactivators. 
RNA-protein complex 
In mammalian cells, two PCBP subsets have been described, hnRNPs K/J [495] and the 
αCP proteins αCP1 and αCP2, commonly referred to as PCBP1 and PCBP2 [496, 497]. 
The latter group also includes the more recently described isoforms PCBP3 and PCBP4 
[498]. Being members of the KH domain superfamily of nucleic acid binding proteins, 
PCBPs have been implicated in a wide spectrum of biological activities, including the 
regulation of RNA splicing, the stabilization of cellular and viral mRNAs, transcriptional 
activation and inhibition, and translational silencing and enhancement (reviewed in: 
[492, 499]. The PCBPs are ubiquitously expressed across many tissues, but the level of 
expression and isoform(s) predominantly expressed varies per cell type [496, 500-502]. 
This probably explains why we observed different frameshifting efficiencies when 
expressing pLnsp1β-2 in MARC-145 and RK-13 cells. Likewise, the levels of PCBP1 and 
PCBP2 in a PRRSV-infected cell will most likely determine the relative efficiencies of the 
two PRF events, which must to a certain extent be connected because they are mutu-
ally exclusive translational events. In the siRNA-based knockdown experiments, PCBP1 
depletion mainly reduced –2 PRF, while PCBP2 knockdown mainly affected –1 PRF. In the 
in vitro translation assays PCBP1 and PCBP2 were both able to induce –2 as well as –1 
PRF, although PCBP1 was concluded to be more efficient at promoting –2 PRF, whereas 
PCBP2 more efficiently induced –1 PRF. In an artificial experimental system in which 
alternative shifts at a single slippery sequence could be observed, the spacing between 
slippery sequence and downstream stimulatory RNA structure was found to determine 
whether –1 or –2 PRF was more prominent. The optimal distance for –2 PRF was 1-2 nt 
shorter than the optimal distance for –1 PRF [407]. This suggests that the RNA-protein 
complexes containing PCBP1 might have a slightly different orientation or conformation 
than those containing PCBP2, resulting in more frequent induction of –2 PRF. For –1 
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PRF it has been shown that roadblocks, such as RNA pseudoknots downstream of the 
slippery site, stall ribosomes in a metastable conformational state. Slippage into the –1 
frame accelerates completion of translocation [337, 338, 486, 487, 503]. The complexes 
containing PCBP1 might induce more tension on a paused ribosome, thus favoring slip-
page into the –2 rather than the –1 frame to allow completion of translocation. The exact 
composition of the RNA-protein complex will likely have to be determined by structural 
biology techniques to understand exactly how the proteins interact with each other and 
the viral RNA and whether the complexes formed by PCBP1 have a different conforma-
tion than the ones formed by PCBP2. Another explanation for the different effects that 
PCBP1 and PCBP2 have on inducing PRF would be that the affinity of the KH domains of 
PCBP1 for the C-rich motif is different than the affinity of those present in PCBP2, which 
could also result in variable degrees of tension on the ribosome. We postulate that PCBPs 
interact with the C-rich motif through KH1 and KH3 and that KH2 interacts with nsp1β 
since it has previously been shown that this domain is required for nsp1β binding [504]. 
For PCBP1 it has been determined that for optimal binding to its KH1 domain, cytosine 
is preferred in all four positions in the oligonucleotide binding cleft and that a C-tetrad 
binds KH1 with 10 times higher affinity than a C-triplet [505]. The PRRSV C-rich motif, the 
evolution of which may have been restricted by its presence within overlapping ORFs, 
only contains two sets of three consecutive cytosines and this probably does not result 
in a high enough affinity of PCBPs for the RNA to induce frameshifting on their own, but 
requires the additional interaction with nsp1β.
Potential interaction of other PCbP family members
The involvement of PCBP1 and PCBP2 as protein transactivators of PRF is clear, but for 
the other members of the PCBP family their involvement is still uncertain. The study of 
separate PCBPs in living cells was complicated by an apparently compensatory mecha-
nism that resulted in an increase in PCBP1 levels when PCBP3, PCBP4 or hnRNPK were 
knocked down in MARC-145 cells. It seems likely that PCBP3, PCBP4 and hnRNPK are also 
capable of stimulating frameshifting, but additional studies are required to determine 
their potential role in more detail. Knockdown of these targets in combination with 
knockdown of PCBP1 could perhaps clarify their involvement. For PCBP3 we will, how-
ever, need to use another system since knockdown of this factor appeared to influence 
vaccinia virus replication resulting in accelerated cell death. Supplementation of the WG 
in vitro translation assay with these proteins could also help to assess their (potential) 
involvement. 
The involvement of PCbPs in frameshifting in infected cells
Experiments to determine the impact of PCBP knockdown on –2/–1 PRF in PRRSV-
infected cells are currently ongoing. However, combining efficient siRNA-mediated 
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knockdown with a single-cycle PRRSV infection is a technical challenge. During the 
primary phase of PRRSV infection in MARC-145 cells only a subset of cells is permissive 
to infection, even when an amount of virus is used that should result in a high MOI. The 
majority of the cells become infected in subsequent rounds of infection, by cell-to-cell 
transmission to clusters of neighboring cells [506]. We hope to be able to overcome this 
issue by efficient transfection of in vitro transcribed, full-length viral RNA into siRNA-
treated cells. An additional complicating factor is the reported possible interaction of 
PCBP1 and PCBP2 with sequences in the 5’-UTR of the PRRSV genome, which might 
influence viral replication and transcription, even though this interaction did not appear 
to be very strong and remains to be corroborated in infected cells [463]. Beura et al, 
hypothesized that PCBP1 and PCBP2 play a role in regulating PRRSV RNA synthesis be-
cause knockdown of both proteins resulted in a reduction of genomic and subgenomic 
RNA synthesis [463]. However, this effect might also result from the reduced expression 
of nsp2TF and nsp2N when PCBP1 and PCBP2 are depleted. We previously showed that 
PRRSV mutants lacking a functional –2/–1 PRF mechanism are seriously crippled in their 
replication [442, 488]. The siRNA-mediated depletion of PCBP1 and PCBP2 was reported 
to result in a ~ 0.5-1 log reduction in viral progeny titers [463, 493] which, for example, 
is slightly less than what was observed with a mutant virus (KO2) in which –2/–1 PRF is 
completely knocked out by mutating the RNA signals involved (1.5 log reduction) [442]. 
This difference may be explained by the incomplete depletion of PCBPs when perform-
ing siRNA-mediated knockdown. In our transient expression system, we were able to 
reduce the total amount of frameshifting by only ~50-70% when PCBP1 and PCBP2 were 
depleted simultaneously. The small amount of PCBP1 and PCBP2 that remains present in 
the cell after knockdown, or the presence of PCBP3, PCBP4 and hnRNPK if these proteins 
are also capable of transactivating PRF, most likely still suffices to induce a reasonable 
level of frameshifting and, consequently, expression of nsp2TF and nsp2N during PRRSV 
infection. We may be able to distinguish between the role PCBPs play in PRF transactiva-
tion and additional functions during PRRSV infection by using this KO2 mutant virus. 
During a KO2 infection, any effects of PCBP knockdown on viral RNA or protein synthesis 
should be explained as an involvement of PCBPs in other processes than PRF transacti-
vation, since –2/–1 PRF is already completely knocked out in this mutant virus. 
There have been some reports that PCBP1 and PCBP2 co-localize with nsps during 
PRRSV infection. Overexpressed recombinant PCBP1 and PCBP2 were reported to par-
tially co-localize with nsp1β and nsp2/3 during PRRSV infection [463] and endogenous 
PCBP2 was shown to translocate from the nucleus to the cytosol upon PRRSV infection 
where it co-localized with nsp1β [493]. A proportion of nsp1β localizes to the nucleus 
during infection [403] and we hypothesize that PCBP1 and PCBP2 are recruited to the 
cytosol through their interaction with nsp1β. If this were true, most of the PCBPs that 
remain after siRNA-mediated knockdown might still be recruited to the site of viral 
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genome translation and stimulate frameshifting. This would explain the relatively high 
level of frameshifting observed even after efficient siRNA-mediated knockdown of 
PCBPs. It will be interesting to determine whether PCBP1 and PCBP2 are still recruited to 
the cytosol during infection with the virus mutant containing the nsp1β RBD- mutations, 
since this mutant is no longer able to transactivate –2/–1 PRF. This could be because it 
can no longer interact with the PRRSV RNA, but might also be because its interaction 
with PCBPs is abolished.
binding partners of nsp1β and PCbPs
It might be possible that other binding partners of either nsp1β or PCBPs are also part 
of the frameshift stimulatory complex that presumably interacts with the translating 
ribosome to induce frameshifting. Nsp1β has been reported to interact with rpS14 [463], 
which is located adjacent to rpS3 of the ribosomal helicase [466]. Cytosolic PCBP1 has 
been shown to interact with RACK1 [467], a protein that interacts with the head region 
of the 40S ribosome close to the mRNA exit channel [507]. It was recently shown that 
ribosomes lacking Asc1, a yeast homolog of RACK1, frameshift more often at CGA codon 
repeats [508], suggesting that an interaction of PCBP1 with RACK1 could potentially 
modulate frameshifting frequency on the PRRSV mRNA as well. 
PCbP interactions with viral genomes
The interaction of PCBPs with the PRRSV (C-rich) mRNA is not unique, as interactions 
with other viral RNAs have been described previously and such interactions often 
modulate viral protein translation and RNA replication. PCBP1 and PCBP2 interact 
with the terminal clover leaf structure of the poliovirus (PV) genome and that of other 
picornaviruses, forming a ribonucleoprotein complex with viral protein 3CD [509-511]. 
This interaction promotes mRNA stability by protecting it from degradation by 5’ exo-
nucleases [512, 513]. The interaction of PCBPs with the clover leaf structure also plays a 
role in circularization of the viral genome through an RNA-protein-protein-RNA bridge 
that is required for the initiation of negative strand RNA synthesis [514]. PCPB2 also in-
teracts with stem-loop IV of the type 1 picornavirus IRES to mediate translation initiation 
[515, 516]. During mid-to-late phase of PV infection, PCBP1 and PCBP2 are cleaved by 
viral proteinases 3C/3CD resulting in a truncated protein lacking the KH3 domain [517]. 
The same has been reported for PCBP2 and the 3C protease of hepatitis A virus, an atypi-
cal picornavirus [518]. Cleaved PCBP2 can no longer function in translation initiation but 
retains its activity in viral RNA replication. It was suggested that this cleavage mediates 
the shift from viral translation to RNA replication [517, 518]. 
Binding of PCBPs to 5’ UTRs has also been reported for hepatitis C virus (HCV) and 
Norwalk virus [519, 520]. For HCV, PCBP2 is also required for circularization of the viral 
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genome [521]. Finally, PCBP1 has been reported to interact with Npro, a cysteine-like 
autoprotease, of classical swine fever (CSFV) and promotes virus growth [522]. 
Protein-dependent recoding
This is the first time that cellular proteins have been shown to stimulate PRF. Previously, 
Annexin A2 was shown to inhibit –1 PRF in the coronavirus infectious bronchitis virus by 
destabilizing the stimulatory pseudoknot [457]. In a very artificial system the –1 HIV-1 
PRF signal could be stimulated by replacing the RNA structure with the iron-responsive-
element (IRE) from ferritin mRNA. Binding of iron regulatory proteins to the IRE did 
increase frameshifting efficiency about 2-3 fold, but efficiency was still less than 10% 
[461]. While this was a very unnatural example, it did show that RNA-protein interactions 
can stimulate frameshifting. 
Only one other example of protein-dependent recoding where a protein interacts 
directly with the mRNA has been described. The vascular endothelial growth factor A 
(VEGFA) mRNA undergoes stop codon readthrough which generates an isoform con-
taining a unique 22-amino acid C terminus extension called VEGF-Ax. This readthrough 
is transactivated by a high affinity interaction of hnRNPA2/B1 with a near-consensus 
hnRNPA2/B1 recognition element (A2RE) in a 63-nt long Ax element located in between 
the two stop codons in the VEGFA 3’ UTR RNA sequence. The A2RE starts 11 nt down-
stream from the stopcodon and the authors suggest that bound hnRNPA2/B1 interacts 
with ribosomal proteins to induce translational pausing allowing the incorporation 
of serine at the stop codon position [523]. Like hnRNPK, hnRNPA2/B1 belongs to the 
heterogeneous ribonucleoproteins, but RNA recognition of hnRNPA2/B1 goes through 
two RNA recognition motifs (RRMs) and an arginine/glycine-rich (RGG) box instead of 
KH domains [524]. 
Over 1500 RNA binding proteins have been described [525] and it does seem likely 
that more of these proteins might interact with RNA sequences downstream from slip-
pery sequences forming RNA-protein complexes that could potentially block translating 
ribosomes. 
CoNCLusioN
The requirement of a host protein in the RNA-protein complex that induces ribosomal 
frameshifting in this, so far, unique arterivirus mechanism was a surprise. This mecha-
nism thus constitutes a novel type of arterivirus-host interaction and shows that protein 
complexes can replace RNA structures to stimulate frameshifting with high efficiency. It 
raises the question whether protein-mediated frameshifting might be more common, 
since many different RNA binding proteins that interact with RNA through various RNA 
194 A + RNA virus diptych
binding domains could potentially interact with RNA motifs downstream of slippery 
sequences to induce shifting on their own (or as a protein-complex) or interact with 
(viral) RNA structures to modulate the shifting frequency. 
The WG in vitro translation assay allowed us to study the effects of the protein factors 
of the PRRSV mechanism separately. For other eukaryotic frameshifting sequences this 
might also be a good system to test whether these are also modulated by cellular or 
viral protein factors. This unique frameshift-stimulatory signal may also provide novel 
insights into how transacting protein factors can modify the ribosomal elongation cycle. 
The siRNA-mediated knockdown experiments clearly showed that the expression 
level of individual PCBPs determines the direction and efficiency of frameshifting in 
cells. PCBP1 predominantly stimulated –2 PRF and PCBP2 stimulated –1 PRF, but other 
PCBP family members may be able to stimulate –2/–1 PRF as well. This study adds yet 
another function to the already broad repertoire of cellular PCBP activities.
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Chapters 6-8 of this thesis describe a novel programmed ribosomal frameshifting (PRF) 
mechanism in arteriviruses. This mechanism involves a slippery sequence, C-rich motif, 
and – uniquely – a protein complex consisting of the viral protein nsp1β and the host 
poly (C) binding proteins PCBP1 and/or PCBP2. These signals and factors interact to 
stimulate translating ribosomes to slip backwards 1 or 2 nucleotides at a relatively high 
frequency. This results in the synthesis of two previously unknown nsp2 variants, nsp2TF 
(the –2 frameshift product) and nsp2N (the –1 frameshift product), which each share 
their N-terminal domain with the full-length nsp2 encoded by ORF1a. 
While most examples of ribosomal frameshifting have been found in viruses, ribo-
somal frameshifting mechanisms are employed by organisms from all kingdoms of life 
to regulate gene expression [526]. Especially in +RNA- and retroviruses, –1 PRF is a quite 
common strategy to regulate the expression of their RNA-dependent RNA polymerase 
(RdRp) or reverse transcriptase [323]. 
For –1 PRF, the frameshifting signals are commonly embedded in the mRNA in the 
form of a bipartite signal consisting of a heptanucleotide slippery sequence and a 
downstream stimulatory RNA structure, either a pseudoknot or stable RNA stem-loop 
structure, which are separated by a 6-8 nt spacer sequence [336, 527]. The mechanism 
described in this thesis contains several atypical aspects compared to these well-
characterized –1 PRF mechanisms. These features are the occurrence of efficient –2 PRF, 
alternative shifts (–2 or –1) occurring at the same slippery site and the requirement for 
a transactivating protein complex that appears to replace the stimulatory RNA struc-
ture downstream of the shift site, presumably by forming a similar kind of roadblock 
for the translating ribosome. This chapter summarizes the findings of chapters 6-8 and 
assesses whether certain features of this novel frameshifting mechanism are unique for 
arteriviruses or may be employed more commonly, without having been discovered so 
far. Furthermore, the function of PCBPs during PRRSV infection and possible roles of the 
frameshift products nsp2TF and nsp2N are discussed. 
how widespread is –2 ribosomal frameshifting? 
The first time –2 PRF was shown to be possible was almost 30 years ago, in an artificial 
system using a synthetic mRNA sequence on which a 2% PRF efficiency was observed 
[528]. Since then, only a handful of other examples have been described, with only three 
of them, including the arterivirus mechanism discussed here, occurring in natural situ-
ations. 
In an in vitro system, homopolymeric stretches of nucleotides, in particular a U8 stretch, 
were able to induce both –1 and –2/+1 frameshifting (direction of frameshift in the latter 
case not confirmed, but not unlikely that it was –2) [468]. The construct containing the 
U8 stretch was even able to induce 20% of –2/+1 shifting when the downstream RNA 
pseudoknot was destabilized [468]. It has been shown that naturally occurring +1 and 
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–1 PRF signals can also induce –2 PRF in artificial systems. Expression of mammalian 
ornithine carboxylase antizyme completely depends on +1 PRF and frameshifting ef-
ficiencies are regulated by polyamine levels [529, 530]. However, when a cassette con-
taining the antizyme frameshifting signals was expressed in yeast, translation occurred 
via –2 instead of +1 PRF. When the distance between the shift site and downstream 
pseudoknot was increased by 3 nucleotides both +1 and –2 PRF were stimulated [406]. 
The HIV-1 U6A slippery sequence induced both –1 and –2 frameshifting in an in vitro 
system with a pseudoknot, stem-loop or antisense oligonucleotide (AON) as stimulator. 
The spacer length influenced frameshift frequencies, with the optimal spacer length for 
–2 PRF being 1-2 nucleotides shorter than for –1 PRF [407]. 
The first natural occurrence of –2 PRF was described in 2004 in bacteriophage Mu, 
regulating translation of two tail assembly genes with an efficiency of 2.2%. For this 
frameshifting mechanism a slippery site was identified, but no obvious downstream 
RNA secondary structure could be found. [408]. Translation of the RdRp from the dsRNA 
Trichomonas vaginalis viruses (TVV) as a fusion with the capsid protein depends on a 
ribosomal frameshift. In TVV2 and 3 this shift is –1 and in TVV1 it was thought to be 
+1 [531]. In chapter 6 we predicted that TVV1 might employ –2 PRF instead of +1 
because the slippery site CC_CUU_UUU is very similar to the –2/–1 shift site in PRRSV 
(GG_GUU_UUU) [442]. Parent et al. later used mass spectrometry to show that it is in-
deed a –2 shift [532]. If the ribosome would slip –1 at this site in TVV1, it would also run 
into a stop codon [533], as in the case of PRRSV SD01-08. Parent et al. were, however, 
not able to verify the synthesis of a –1 PRF product [532]. The efficiency of –2 PRF in 
this system is supposedly much lower (1-2%)[409] than that observed for PRRSV, which 
would probably make –1 PRF an even rarer event and would complicate the detection 
of the corresponding frameshift product. Interestingly, the RNA downstream of the slip-
pery site in TVV also lacks an obvious secondary RNA structure and the downstream 
sequences are not very conserved across the three species [531] which suggests the 
downstream RNA sequence may not be crucial for stimulating PRF in this virus. 
So far, the high efficiency of –2 PRF that is induced by the interaction of nsp1β and 
PCBPs with the C-rich motif in arteriviruses appears to be unique as in the other two 
known cases of naturally occurring –2 PRF only 2% of the ribosomes make the shift. 
However, the occurrence of –2 PRF is likely not unique in itself. The examples of naturally 
occurring –2 PRF described above indicate that –2 PRF can occur in different organ-
isms and most likely also through different mechanisms. It is interesting that in none 
of these three examples a downstream stimulatory RNA structure could be identified. 
In arterivirus –2/–1 PRF, the RNA structure is presumably replaced by the formation of 
an mRNA-protein complex inducing a much higher frameshifting efficiency than what 
has been observed for the other two viruses. There is, however, some evidence that 
slippery sequences on their own can also induce –1 PRF, although at low frequencies 
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[338]. When PRRSV nsp2 was expressed in the absence of nsp1β, frameshifting was 
almost completely abolished, but a trace amount of the –2 frameshift product (nsp2TF) 
could still be observed (figure 2, chapter 7). Perhaps –2 PRF in bacteriophage Mu and 
TVV1 is not stimulated by additional factors, which may explain the low PRF frequencies 
observed for these viruses. If this is true, it is not unlikely that –2 PRF is much more com-
mon, probably also outside of the virus world. However, the low shift efficiencies make 
it a challenge to find more examples, as it can be difficult to detect such low-abundant 
frameshift products. 
how common are alternative frameshifts at the same site in natural situations? 
One of the unusual features of the arterivirus PRF mechanism described in this thesis is 
the occurrence of alternative frameshifts at the same site, which both occur with rela-
tively high frequency, ~7 and ~20% for –1 and –2 PRF, respectively, in PRRSV-infected 
MARC-145 cells (Chapters 6 and 7). In the case of PRRSV –2/–1 PRF, the –2 shift is the 
predominant shift while –1 PRF occurs at a lower frequency, although the –2/–1 ratio 
can be modified by changing the levels of PCBP1 and PCBP2 through siRNA-mediated 
knockdown (figure 5, chapter 8) and in vitro by modulating the relative PCBP con-
centrations (figure 2 and 3, chapter 8). This is the first example of naturally occurring 
alternative shifts at a single shift site [488]. In artificial systems it has already been shown 
that alternative shifts are possible in various contexts [406, 407, 468]. This raises the 
question whether there could also be natural shift sites where –1 PRF is the predominant 
shift with occasional occurrence of –2 PRF. At least 22 possible slippery sites have been 
described for –1 PRF [527] and for some of these, proper base-pairing in the A-site would 
also be maintained when a –2 shift would take place. However, on most mRNAs the ribo-
some will in all likelihood quickly run into a termination codon after –2 PRF resulting in 
a truncated protein that most likely is degraded rapidly, making it a challenge to prove 
its existence. Whether such truncated products would have any biological relevance 
remains to be investigated, but there is some evidence that frameshifting can be used 
as a strategy for the post-transcriptional regulation of gene expression [483]. For +RNA 
viruses, given their limited genome size, the possibility to express an additional protein, 
even at low expression levels, may have a selective advantage. 
how common is protein-mediated ribosomal frameshifting? 
The most surprising feature of the arterivirus –2/–1 frameshifting mechanism is that it is 
induced by a complex of multiple protein transactivators instead of a stimulatory higher-
order RNA structure (Chapter 7 and 8). It is now clear that such RNA-protein complexes 
can have the same function as an RNA structure and are capable of inducing high levels 
of frameshifting. However, the molecular basis for the interactions between the RNA 
and protein players involved remains to be elucidated. Do both nps1β and PCBP1 or 
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2 interact with the C-rich motif in the mRNA, or is it only one of the proteins and does 
the other only interact with the other protein factor? Furthermore, it is possible that 
there are multiple copies of each protein in the complex since nsp1β was crystallized 
as a homodimer [453] and PCBPs are known to be capable of forming homo- or het-
erodimers through interactions between their KH domains [534]. It is likely that nsp1β 
and PCBP form a complex prior to binding to the RNA, since these proteins individually 
could not bind strongly enough to shift an RNA probe in a band shift assay (Napthine et 
al, unpublished data).
The discovery that proteins are capable of stimulating frameshifting in a natural sys-
tem raises the question whether this mechanism may be employed more often. The first 
time it was shown that –1 PRF could be stimulated by an RNA-protein interaction was 
in an artificial system where the RNA hairpin of the HIV-1 gag-pol frameshift cassette 
was replaced by the iron-responsive-element (IRE) from ferritin mRNA. The IRE is a stem-
loop structure that can bind iron regulatory proteins and in this system the IRE could 
substitute for the HIV-1 hairpin. When proteins interacted with the IRE frameshifting 
increased 2- to 3-fold, although the frameshift efficiency was still less than 10% [461]. 
This was clearly a very artificial set-up, but the possibility of binding of viral or cellular 
proteins to RNA stem-loops or pseudoknots to stimulate or inhibit frameshifting does 
not seem implausible. After all, non-canonical translation initiation via viral and cellular 
internal ribosomal entry sites (IRESes) can also be modulated by the interaction of vari-
ous proteins, including PCBP1 and PCBP2, with RNA structures [535]. 
In natural systems, the presence of protein factors has also been shown to modulate 
–1 PRF efficiency, although in these cases the protein did not stimulate frameshifting 
but reduced the PRF frequency. Annexin A2 (ANXA2) binds to the infectious bronchitis 
virus (IBV) RNA pseudoknot. Overexpression of this protein reduced IBV frameshifting, 
while its RNAi-mediated knockdown had the opposite effect [457]. The HIV-1 Tat protein 
was shown to decrease the –1 PRF shift that produces the Gag-Pol fusion protein in a 
dose-dependent manner by increasing the rate of translation initiation. It was proposed 
that increased translation initiation would decrease the spacing between translating ri-
bosomes, thus reducing the chance that a stimulatory RNA signal will refold in between 
translating ribosomes. As a result, fewer ribosomes will encounter the signal and make 
the frameshift [460, 536]. 
Over 1500 proteins have already been described to bind RNA through various RNA 
binding domains [525, 537]. If proteins bind RNA sequences close enough to slippery 
sites, with sufficient affinity, they could form a roadblock for translating ribosomes. If 
these proteins interact with stimulatory RNA structures this could modulate frameshift-
ing frequencies, either by destabilization of the structure to reduce the efficiency or by 
doing the opposite and enhance frameshifting by forming more stable roadblocks. 
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The involvement of a specific protein as a modulator of the frameshifting efficiency is 
more difficult to prove than the presence of an RNA pseudoknot stimulatory structure. 
When studying the arterivirus mechanism, substantial differences in frameshifting 
efficiencies were observed when different cell lines were used for the experiments 
(Chapter 6). This was the first observation that led us to believe that cellular factors may 
be involved as well, as differences in their expression level may explain the differences 
in PRF efficiency observed between cell lines. If such an observation would be made 
for another system, this may also indicate that other factors are involved in stimulating 
(or inhibiting) frameshifting. The wheat germ-based in vitro translation system (Chapter 
8) made it possible to study the mechanism in the absence of the cognate protein 
factors. Since the sequence of most eukaryotic, viral and bacterial proteins will not be 
conserved in plants, this system would be a useful tool to probe whether, besides the 
RNA sequence, other factors are also required for frameshift induction or stimulation. 
Vice versa, for studying plant frameshifting signals the rabbit reticulocyte lysate system 
may prove to be a useful alternative to the wheat germ extract.
If additional stimulators are required in a PRF mechanism, this stimulator (or inhibitor) 
does not necessarily have to be a protein. In artificial systems, metabolite-responsive 
pseudoknots from RNA riboswitches were able to stimulate –1 PRF when placed in re-
porter constructs [538, 539]. The pseudoknot derived from the S-adenosylhomocysteine 
(SAH) riboswitch induced up to 4 % –1 PRF (10-fold increase) in the presence of an optimal 
concentration of SAH [538]. Pseudoknots derived from 7-aminomethyl-7-deazaguanine 
(preQ1) riboswitches induced 7-20% –1 PRF in the presence of preQ [539]. These two 
studies suggest that small molecules are able to interact with PRF-stimulatory RNA 
structures and could potentially modulate frameshifting frequencies. It has also been 
shown that the –1 PRF events in cytokine mRNAs, which are directed by a pseudoknot, 
can be stimulated by miRNAs through mRNA-miRNA interactions. On these mRNAs 
frameshifting directs ribosomes to a premature termination codon resulting in desta-
bilization of the mRNA through the nonsense-mediated mRNA decay pathway which 
might be a mechanism to post-transcriptionally regulate gene expression [483, 540]. 
Many viruses employ PRF as a method to generate a defined ratio of their polymerase 
relative to other replicase components [323]. For some of these viruses, the artificial al-
teration of their frameshifting efficiency, by mutating the frameshift signal, resulted in a 
crippled virus [541-543]. In instances where a fixed frameshifting frequency is essential, 
it seems unlikely that PRF would be regulated by a protein factor that may not always be 
present at the same concentration. On the other hand, regulation of PRF efficiency by 
protein factors would offer a feedback mechanism that could control frameshift product 
abundance in certain conditions. Such a use of protein-mediated PRF would be more 
likely to be employed in cellular mRNAs though than in +RNA genomes, since cells may 
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require much more variation in gene expression levels than most viruses (e.g. during 
circadian clock and cell cycle regulation [544]). 
Protein-mediated frameshifting in PRRsv-infected cells
The cellular expression levels of PCBPs determined the efficiency of PRF in cells trans-
fected with a plasmid expressing nsp1β and nsp2 (Chapter 8). It will be interesting to 
determine to which extent siRNA-mediated knockdown of PCBPs also affects –2/–1 PRF 
in PRRSV-infected cells and to which extent other processes such as viral replication 
and protein synthesis are affected. One study reported no effect on viral polyprotein 
synthesis after siRNA knockdown of PCBP1 and PCBP2 [463], while another study re-
ported a significant reduction after PCBP2 knockdown [493]. Modest reductions (~0.5-1 
log) of viral progeny titers upon knockdown of PCBP1 and PCBP2 have been reported 
[463, 493]. This was slightly less than the ~1.5 log reduction that was observed with 
the KO2 mutant virus in which frameshifting was knocked out by mutating the PRF 
signal (figure 6, chapter 6). This difference in titer reduction could be explained by 
incomplete knockdown of PCBPs, since we observed that total frameshifting could only 
be reduced by ~50-70% with simultaneous knockdown of PCBP1 and PCBP2. It is also 
possible that PCBPs have additional functions during the PRRSV replicative cycle that 
are unrelated to their frameshift stimulatory role. Beura et al. reported an interaction of 
PCBP1 and PCBP2 with the 5’UTR of the PRRSV genome in an in vitro mobility shift as-
say, although this interaction did not appear to be very strong [463]. Additional roles of 
PCBPs during the viral replicative cycle will complicate our future studies to determine 
the exact function of PCBPs during ribosomal frameshifting. The potential additional 
roles of PCBPs during PRRSV infection could be studied by using the KO2 mutant virus 
in combination with cellular PCBP knockdown, since any observed effects should be 
mediated through non-frameshift stimulatory functions. Studying the role of PCBPs in 
PRF, without interference of any other function these proteins may have during PRRSV 
infection, may prove to be more problematical. If it will be possible to prevent the in-
teraction of PCBPs with the PRRSV 5’UTR while maintaining virus viability, there is no 
guarantee that other virus-PCBP interactions will not emerge, which may still interfere 
with our studies. 
It is not yet certain whether the other PCBP family members, PCBP3, PCBP4 and 
hnRNPK can also transactivate –2/–1 PRF. Given their sequence similarity it seems likely 
that they can. It may not be possible to successfully knock down three or even more 
proteins from this family simultaneously without causing cellular toxicity. Knockdown 
of PCBP3 on its own proved to be a problem during vaccinia virus infection as these 
cells died much faster (figure 5, chapter 8), but this might not be the case when the 
siRNA-treated cells are infected with PRRSV instead.
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The function of the frameshift products, nsp2TF and nsp2N, during the viral rep-
licative cycle is still unknown. Nsp1β has been implicated in innate immune evasion 
(reviewed by [361, 489]) and it is possible that this is at least partially mediated through 
the expression of nsp2TF and nsp2N. The mutant viruses KO1 and KO2 which express 
a truncated form of nsp2TF (KO1), or no frameshift products at all (KO2), were crippled 
and displayed a small-plaque phenotype, with KO2 being more crippled than KO1 
(figure 6, chapter 6). The nsp1βKO mutant was even more crippled and produced tiny 
plaques that could only be visualized when held up against a light source (Chapter 7 
and unpublished data). These phenotypes highlight that expression of the frameshift 
products is important during PRRSV infection. It may be possible to distinguish between 
the innate immune functions of nsp1β itself and any effects mediated through its role 
as a frameshift stimulator by using the KO2 mutant virus since any potential innate im-
mune modulating effects mediated by nsp2TF and nsp2N have been knocked out in 
this virus. It will be much more difficult, if not impossible, to determine the functions of 
nsp2TF and nsp2N in the context of viral infection without nsp1β present. Arteriviruses 
lacking the nsp1 region are not viable [451, 476], and the expression of the two frame-
shift products depends on the presence of nsp1β. It may be possible to study some 
of the nsp2TF and nsp2N functions using transient expression, but when the proteins 
are expressed from separate plasmids it may be difficult to achieve the correct ratio 
between them, which normally is determined by the frameshifting mechanism. Another 
potential problem with nsp2TF overexpression to determine its biological function is 
the observation that the localization of nsp2TF in this context may not be the same 
as it is during a PRRSV infection (figure 7, chapter 6). During PRRSV infection nsp2 
and nsp2TF appear to be targeted to different cellular compartments, presumably via 
their different transmembrane domains, and this suggests that they may have different 
functions (figure 7, chapter 6). Nsp2N does not have a transmembrane domain and 
probably localizes to the cytosol. It will be interesting to determine whether these dif-
ferent localizations and potential different functions are linked to the deubiquitinating 
and deISGylating activities of their shared papain-like protease (PLP2) domains [167, 
420-422]. Arterivirus nsp2 is also one of the proteins responsible for the formation of the 
membranous structures that are used to scaffold the viral replication and transcription 
complex [369, 404]. It may be possible that nsp2TF plays a role in the formation of these 
complexes as well. Certain domains of nsp2 itself, which are shared with nsp2TF and 
nsp2N, have also been implicated in modulation of the host immune response [424]. 
For any virus with mutations in nsp1β or nsp2, it will be important to determine 
whether its phenotype is not (partially) mediated through disruption of efficient –2/–1 
PRF. Mutations in the nsp2 sequence overlapping the nsp2TF sequence may not be 
silent in nsp2TF (and vice versa) and this should be taken into account when mutations 
are made in this part of the protein. 
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Conclusion
The novel features of the arterivirus PRF mechanism described in this thesis show that 
the mechanistic possibilities for inducing efficient PRF are much broader than previously 
thought. While several features thus far appear to be unique for arteriviruses, it does 
seem likely that efficient –2 PRF, alternative shifts at the same site and protein-mediated 
frameshifting are more widely employed in biological systems. Especially the alternative 
shifts and the use of protein stimulators offer additional options for regulating protein 
expression. 
The stimulation of PRF by PCBPs during PRRSV infection is an example of a novel 
class of virus-host interactions. Further studies into the functions of PCBPs in the PRRSV 
replicative cycle may prove PRRSV-PCBP interactions to be even more widespread, as 
there are multiple potential roles for PCBPs during infection. The biological function 
of the two frameshift products, nsp2TF and nsp2N remains elusive thus far and their 
synthesis is inevitably linked to nsp1β expression. While many questions still remain, this 
frameshifting mechanism is a perfect example of how multifaceted +RNA virus genome 
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Dit proefschrift bestaat uit twee delen en beschrijft onderzoek aan twee virussen die 
beide een positiefstrengig RNA genoom hebben. Het gaat om het humane pathogeen 
chikungunya virus (CHIKV) en het economisch belangrijke porcine reproductive and 
respiratory syndrome virus (PRRSV) dat wereldwijd varkens infecteert. 
dEEL 1: KWANTiTATiEvE PRoTEomiCs ANALYsE vAN ChiKuNGuNYA viRus 
iNfECTiE
Dit deel van het proefschrift beschrijft de veranderingen die optreden in het expres-
sieniveau en de fosforyleringsstatus van gastheereiwitten tijdens een CHIKV infectie. 
CHIKV is een alphavirus en wordt op mensen overgedragen door muskieten. Een 
CHIKV infectie veroorzaakt hoge koorts, uitslag en gewrichtspijnen die maanden kun-
nen aanhouden. CHIKV werd in 1952 voor het eerst beschreven in Tanzania maar tot 
2006 veroorzaakte het virus alleen relatief kleine lokale uitbraken in Afrika en Azië. 
In 2005/2006 was er in het gebied rondom de Indische Oceaan een ongekend grote 
uitbraak waarbij naar schatting meer dan 4 miljoen mensen werden geïnfecteerd. Eind 
2013 werd er voor het eerst een CHIKV uitbraak gemeld in het Caribische gebied en in 
de daaropvolgende maanden verspreidde het virus zich verder over Zuid- en Centraal 
Amerika. Tijdens deze laatste uitbraak zijn inmiddels meer dan een miljoen mensen 
besmet geraakt met CHIKV. In Europa is er een toename van het aantal reizigers dat ge-
infecteerd met CHIKV terugkeert uit landen waar het virus voorkomt. In regio’s waar de 
muskieten voorkomen die CHIKV kunnen overdragen brengt dit het risico met zich mee 
dat het virus lokaal verder wordt verspreid. In Italië, Frankrijk en Spanje zijn al kleinscha-
lige uitbraken geweest waarbij patiënten door lokale muskieten werden geïnfecteerd. 
CHIKV is, net als andere virussen, sterk afhankelijk van cellulaire factoren tijdens de 
infectiecyclus. Om meer inzicht te krijgen in deze virus-gastheerinteracties is voor de 
studies in hoofdstuk 2 en 3 een kwantitatieve proteomics methode gebruikt. Proteo-
mics is de studie van het proteoom, alle eiwitten die in een cel, weefsel of organisme tot 
expressie komen. In tegenstelling tot het genoom, de genetische informatie, die voor 
alle cellen van een organisme hetzelfde is, is het proteoom zeer dynamisch. Het pro-
teoom verandert onder invloed van interne en externe stimuli, zoals een virusinfectie. 
Voor de analyse van het proteoom worden de eiwitten eerst met enzymen in stukjes 
geknipt, zodat er korte fragmenten (peptiden) overblijven. Van deze peptiden kan met 
een massaspectrometer de aminozuursequentie bepaald worden en deze sequentie is 
meestal uniek voor een specifiek eiwit. Met kwantitatieve proteomics kunnen verschil-
len in expressieniveau tussen twee of meer monsters bepaald worden. Voor de studies 
in dit proefschrift is de stabiele isotoop labeling met aminozuren in celkweek (SILAC) 
methode gebruikt om deze verschillen te kwantificeren. SILAC is een labelingsmethode 
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waarmee alle eiwitten in de cel voorafgaand aan een experiment gelabeld worden door 
de cellen te kweken in medium met aminozuren (de bouwstenen van eiwitten) die iets 
zwaarder zijn dan de standaard aminozuren. Deze aminozuren zijn zwaarder doordat 
een aantal koolstof-, stikstof- of waterstofatomen zijn vervangen door niet-radioactieve 
isotopen. De zwaardere aminozuren hebben dezelfde chemische eigenschappen als de 
lichtere variant en maken het mogelijk om met een massaspectrometer onderscheid te 
maken tussen peptiden die afkomstig zijn van monsters gelabeld met lichtere dan wel 
zwaardere aminozuren. Op deze manier kan de relatieve expressie van een eiwit in het 
geïnfecteerde en niet geïnfecteerde monster bepaald worden. 
hoofdstuk 2 beschrijft een SILAC studie waarin veranderingen in expressieniveau van 
gastheereiwitten op 8, 10 en 12 uur na een CHIKV infectie zijn bepaald. Hieruit bleek dat 
het expressieniveau van de meeste gastheereiwitten in de cel tijdens een infectie niet of 
nauwelijks verandert. In totaal werden meer dan 4700 eiwitten geïdentificeerd en 2800-
3600 eiwitten konden op elk van de verschillende tijdstippen worden gekwantificeerd. 
Op 8, 10 en 12 uur na CHIKV infectie werden respectievelijk 13, 38 en 106 eiwitten ge-
identificeerd waarvan de hoeveelheid significant veranderd was tijdens de infectie. Van 
bijna alle eiwitten waarvan de expressie tijdens de infectie significant veranderde nam 
de hoeveelheid af. Dit is deels te verklaren doordat de aanmaak van nieuwe (cellulaire) 
eiwitten geremd wordt door CHIKV vanaf ongeveer 8 uur na infectie, via de blokkade 
van zowel de cellulaire transcriptie (RNA synthese) als translatie (eiwitsynthese). Het 
expressieniveau van de meeste onderdelen van het RNA polymerase II complex, verant-
woordelijk voor RNA synthese, nam significant af tijdens de CHIKV infectie en dit draagt 
waarschijnlijk bij aan de door CHIKV geïnduceerde blokkade van cellulaire transcriptie.
Vier eiwitten, Rnd3, DDX56, Plk1 en UbcH10, waarvan de hoeveelheid significant afnam 
tijdens het SILAC experiment werden geselecteerd voor nader onderzoek. Deze eiwitten 
werden in cellen tot overexpressie gebracht voorafgaand aan een CHIKV infectie, wat 
resulteerde in een vermindering van het aantal cellen dat vervolgens geïnfecteerd kon 
worden. Dit suggereert dat de geobserveerde downregulatie van deze eiwitten tijdens 
een CHIKV infectie gunstig is voor de virale replicatie. 
hoofdstuk 3 beschrijft een SILAC studie waarin veranderingen in de fosforylerings-
status van gastheereiwitten op 2, 8 en 12 uur na een chikungunya infectie zijn bestu-
deerd. Fosforylering is een chemische modificatie van eiwitten die onder andere een 
belangrijke rol speelt in de signaaltransductie, de reactie van cellen op signalen uit de 
omgeving (b.v. stress, nutriënten, infectie). Een fosfaatgroep kan aan de aminozuren se-
rine, threonine en tyrosine van een eiwit worden gekoppeld om de activiteit, functie en/
of lokalisatie te reguleren. Tijdens de CHIKV infectie konden bijna 3000 gefosforyleerde 
aminozuren worden geïdentificeerd en per tijdstip kon van 800-1200 aminozuren de 
fosforyleringsstatus gekwantificeerd worden. Op 2, 8 en 12 uur na CHIKV infectie werd 
voor respectievelijk 10, 71 en 136 aminozuren een significante verandering van de fos-
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foryleringsstatus vastgesteld, waarbij zowel toenames als afnames werden gemeten. De 
toename van fosforylering op threonine 56 van eukaryote elongatie factor 2 (eEF2) was 
zo groot dat dit eiwit werd geselecteerd voor verdere analyse. eEF2 is belangrijk tijdens 
de translocatiestap van de synthese van eiwitten door ribosomen. Gefosforyleerd eEF2 is 
inactief en fosforylering zal dus leiden tot remming van (de elongatie fase van) de eiwit-
synthese. De toename in fosforylering was met massaspectrometrie al waarneembaar 
op 2 uur na infectie en nam daarna nog sterk toe, tot een toename van meer dan 50x op 
8 en 12 uur na infectie. Deze toename in eEF2 fosforylering bleek ook plaats te vinden 
tijdens infecties met Sindbis virus en Semliki Forest virus, twee andere alphavirussen. 
De fosforylering van eEF2 treedt ook op tijdens infectie met coxsackievirus (+RNA virus, 
picornavirus familie), maar niet tijdens infectie met humaan adenovirus (DNA virus) of 
equine arteritis virus (+RNA virus, arterivirus familie). Er zijn een aantal experimenten 
gedaan om het mechanisme achter de sterke toename van eEF2 fosforylering tijdens 
alphavirusinfecties te identificeren. Het remmen van PKA en AMPK en het activeren 
van mTORC1, bekende regulatoren van eEF2 fosforylering resulteerde niet in een ver-
mindering van fosforylering tijdens CHIKV infectie. Activatie van RIG-I, een belangrijk 
sensor eiwit van het aangeboren immuunsysteem, was ook niet verantwoordelijk voor 
de inductie van eEF2 fosforylering. De expressie van de virale structurele eiwitten en het 
proces waarbij het virusdeeltje door de cel wordt opgenomen bleken de fosforylering 
ook niet te veroorzaken. Aangezien de fosforylering van eEF2 wordt geïnduceerd door 
infecties met diverse virussen zou het een niet eerder beschreven algemeen antiviraal 
mechanisme kunnen zijn dat de translatie afremt wanneer de cel door een virus wordt 
geïnfecteerd. 
dEEL 2: GEPRoGRAmmEERdE –2/–1 RibosomALE LEEsRAAmvERsChuiviNG 
iN ARTERiviRussEN
Dit deel van het proefschrift beschrijft een nieuw en ongebruikelijk transatiemecha-
nisme waarbij het leesraam verschuift tijdens de synthese van het niet-structurele 
polyproteïne van het arterivirus PRRSV. 
Ribosomen zijn de cellulaire eiwitfabrieken. Ze lezen de nucleotidensequentie van 
RNA af en gebruiken deze informatie om aminozuren aan elkaar te koppelen tot eiwit-
ten. Dit proces heet translatie. Drie nucleotiden, een zogenaamd codon, coderen voor 
één aminozuur. Normaalgesproken schuift het ribosoom steeds precies drie nucleotiden 
op om een volgend aminozuur in te bouwen, totdat dit zogenaamde leesraam eindigt 
met een stopcodon. 
+RNA virussen zijn goed in het manipuleren van het gedrag van ribosomen om te zor-
gen dat hun kleine genoom zo efficiënt mogelijk wordt afgelezen. Hierbij coderen delen 
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van het genoom soms voor meerdere eiwitten door gebruik te maken van overlappende 
leesramen. Een van de mechanismen die hierbij gebruikt wordt is ribosomale leesraam-
verschuiving. Een leesraamverschuiving treedt meestal op doordat een structuur in het 
RNA een blokkade vormt voor een ribosoom, waardoor dit een nucleotide naar voren 
(+1) of achteren (–1) schuift. Als het ribosoom daarna verder gaat met het synthetiseren 
van het eiwit is het leesraam verschoven en wordt een eiwit met een andere sequentie 
gemaakt. Voor virussen is dit een methode om extra eiwitten te produceren vanaf een 
enkele RNA sequentie en/of om de expressieratio tussen verschillende eiwitten te regu-
leren. 
De hoofdstukken in deel 2 van dit proefschrift beschrijven een nieuw leesraamver-
schuivingsmechanisme dat een belangrijke rol speelt tijdens de translatie van het 
PRRSV genoom. In hoofdstuk 6 wordt de ontdekking van het mechanisme beschreven. 
Een bioinformatica analyse van PRRSV genomen liet zien dat in het gebied dat codeert 
voor het C-terminale deel van nsp2 veel minder synonieme mutaties (mutaties die het 
gecodeerde aminozuur niet veranderen) voorkomen dan in de rest van het genoom. 
Dit wijst erop dat er in dit gebied een belangrijke RNA structuur of een tweede eiwit 
in een ander leesraam zou kunnen worden gecodeerd. In dit geval bleek dat een lees-
raamverschuiving resulteert in de synthese van een eiwit dat het N-terminale gedeelte 
gemeen heeft met nsp2, maar dat een andere C-terminale sequentie heeft. Bijzonder 
aan dit mechanisme is dat het zogenaamde transframe eiwit, nsp2TF, gesynthetiseerd 
wordt na een –2 leesraamverschuiving. In geïnfecteerde cellen maakt ongeveer 20% van 
de ribosomen de –2 leesraamverschuiving. Een efficiënte –2 leesraamverschuiving die 
optreedt in eukaryote cellen was nog niet eerder beschreven. Er zijn aanwijzingen dat 
op dezelfde locatie in het genoom ook een –1 leesraamverschuiving optreedt, waarna 
het ribosoom meteen een stopcodon tegenkomt, resulterend in de translatie van een 
kortere variant van nsp2, nsp2N. De sequentie waarop de leesraamverschuiving plaats-
vindt (G_GUU_UUU) en een kort daarachter gelegen C-rijke sequentie (CCCANCUCC) 
zijn geconserveerd in drie van de vier arterivirussen, maar er zijn geen aanwijzingen 
dat de RNA sequentie achter de leesraamverschuivingslokatie een structuur vormt die 
de leesraamverschuiving zou kunnen stimuleren. Het bestaan van nsp2TF werd aange-
toond met specifieke antilichamen en de positie en richting van de leesraamverschui-
ving werden vastgesteld met massaspectrometrie. De expressie van nsp2TF is belangrijk 
voor PRRSV want virussen waarin de expressie door mutaties in leesraamverschuivings-
signalen werd verhinderd repliceerden aanzienlijk minder goed. Tijdens een infectie 
lokaliseren nsp2 en nsp2TF op verschillende plekken in de cel en dit suggereert dat de 
twee eiwitten verschillende functies hebben tijdens een infectie. 
In hoofdstuk 7 wordt beschreven dat ook de aanwezigheid van nsp1β, een van de 
virale eiwitten, noodzakelijk is voor het optreden van de bovengenoemde leesraamver-
schuiving. Dit was de eerste keer dat is aangetoond dat een eiwit in staat is om een lees-
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raamverschuiving te stimuleren. Een geconserveerde sequentie in het papaine-achtige 
autoprotease domein van nsp1β, die mogelijk RNA zou kunnen binden, werd gemuteerd 
en deze mutant was niet meer in staat om de leesraamverschuiving te stimuleren. Deze 
nsp1β mutant was ook niet meer in staat om te binden aan een stuk RNA dat de PRRSV 
leesraamverschuivingscassette bevatte. De minimale RNA sequentie die nodig is om 
de leesraamverschuiving te induceren is 34 nucleotiden lang en bevat zowel de eerder 
beschreven leesraamverschuivingslokatie en de C-rijke sequentie. Het optreden van de 
–1 leesraamverschuiving en expressie van nsp2N werden bevestigd met massaspectro-
metrie. Dit was de eerste keer dat werd beschreven dat in een natuurlijke situatie twee 
verschillende leesraamverschuivingen op dezelfde positie in het RNA kunnen optreden.
In hoofdstuk 8 wordt beschreven dat niet alleen het virale eiwit nsp1β nodig is om de 
beide leesraamverschuivingen te induceren, maar dat ook de gastheereiwitten poly(C) 
binding proteins (PCBP) 1 en 2 betrokken zijn. Van deze eiwitten was eerder beschreven 
dat ze interactiepartners zijn van nsp1β. In een in vitro translatie systeem traden de –2 en 
–1 leesraamverschuivingen alleen op wanneer gezuiverd nsp1β en PCBP1 en/of PCBP2 
tegelijkertijd werden toegevoegd. Vermindering van de hoeveelheid PCBP1 en PCBP2 
in een cel door middel van siRNA transfectie en daaropvolgend transfectie van een 
plasmide dat nsp1β en nsp2 tot expressie brengt resulteerde in een 40% reductie van 
de expressie van de twee leesraamverschuivingsproducten, nsp2TF en nsp2N. PCBP1 
stimuleert voornamelijk de –2 leesraamverschuiving terwijl PCBP2 vooral de –1 lees-
raamverschuiving stimuleert. We denken dat een complex van nsp1β en nsp2 aan het 
C-rijke gebied van het PRRSV RNA bindt en daar eenzelfde vertragend effect heeft op de 
eiwit-synthetiserende ribosomen als de eerder beschreven RNA structuren. Door deze 
vertraging wordt de efficiëntie van de leesraamverschuiving aanmerkelijk verhoogd. 
Het stimuleren van een ribosomale leesraamverschuiving is een nieuwe functie voor de 
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